Exact Molecular Typing of Aspergillus fumigatus. Methods and Applications. by Valk-van Haren, J.A. de
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/65557
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
 
 
 
 
Exact Molecular Typing of Aspergillus fumigatus 
Methods and Applications 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ISBN 978-90-9023562-2 
© Hanneke de Valk, 2008 
All rights reserved. No part of this thesis may be reproduced or transmitted in any form or 
by any means without written permission of the author.  
 
Cover: Corina Bens 
 
Printed by Ponsen & Looijen bv, Wageningen, The Netherlands
Exact Molecular Typing of Aspergillus fumigatus 
Methods and Applications 
 
 
 
Een wetenschappelijke proeve op het gebied van de  
Medische Wetenschappen 
 
 
 
Proefschrift 
 
 
ter verkrijging van de graad van doctor  
aan de Radboud Universiteit Nijmegen  
op gezag van de rector magnificus prof. mr. S.C.J.J. Kortmann,  
volgens besluit van het College van Decanen  
in het openbaar te verdedigen op dinsdag 25 november 2008  
om 13:30 uur precies 
 
 
 
 
Door  
 
Hanneke Johanna Anna de Valk-van Haren 
geboren op 6 december 1976 
te Nijmegen 
Promotor:  Prof. dr. A. Voss 
 
Co-promotores: Dr. C.H.W. Klaassen, Canisius Wilhelmina Ziekenhuis, Nijmegen  
 Dr. J.F.G.M. Meis, Canisius Wilhelmina Ziekenhuis, Nijmegen 
 
 
 
 
 
Manuscriptcommissie:  Prof. dr. P.E. Verweij (voorzitter) 
 Prof. dr. B.J. Kullberg 
 Prof. dr. G.S. de Hoog, Universiteit van Amsterdam 
 
 
 
 
 
 
 
Financial support for publication of this thesis was kindly provided by:  
Center for Pharmacodynamic Research 
Pathoscreen BV 
Pfizer BV 
MSD BV 
Gilead BV 
Lab Land BV 
Cephalon BV 
Schering/Plough BV 
BioMérieux Benelux BV 
Roche Diagnostics Nederland BV 

Contents 
 
Chapter 1 Introduction and outline of the thesis 
 
9
Part 1 Technical aspects of the STRAf assay 
 
Chapter 2 Use of a novel panel of nine short tandem repeats for exact and 
high-resolution fingerprinting of Aspergillus fumigatus isolates 
 
39
Chapter 3 Comparison of two highly discriminatory molecular 
fingerprinting assays for analysis of multiple Aspergillus 
fumigatus isolates from patients with invasive aspergillosis 
 
61
Chapter 4 Retrotransposon insertion-site context (RISC) typing: a novel 
typing method for Aspergillus fumigatus and a convenient PCR 
alternative to restriction fragment length polymorphism analysis 
 
77
Chapter 5 Microsatellite based typing of Aspergillus fumigatus: Strengths, 
pitfalls and solutions 
 
93
Chapter 6 Interlaboratory reproducibility of a microsatellite based typing 
assay for Aspergillus fumigatus through the use of allelic 
ladders: Proof of concept  
 
107
Chapter 7 Stability of microsatellite markers in Aspergillus fumigatus 
 
125
 
Part 2 Clinical applications 
 
Chapter 8 Utility of a microsatellite assay for identifying clonally related 
isolates of Aspergillus fumigatus 
 
137
Chapter 9 Molecular typing and colonization patterns of Aspergillus 
fumigatus in patients with cystic fibrosis  
 
149
Chapter 10 Detection and direct genotyping of Aspergillus fumigatus in 
tissue and serum samples in patient with invasive aspergillosis  
 
163
Chapter 11 Summary and general discussion 
 
175
 Nederlandse samenvatting  
 
187
 Dankwoord  
 
199
 List of Publications and Curriculum Vitae 
 
201
  
 
 
Chapter 1 
 
 
 
Introduction and outline of the thesis 
 
 
 
 
 
 
 
 
 
 
 
Adapted from:  
 
Hanneke A. de Valk, Jacques F.G.M. Meis en Corné H.W. Klaassen 
Moleculaire genotypering van Aspergillus fumigatus-isolaten 
Nederlands Tijdschrift voor Medische Microbiologie 2005, 2: 40-43 
 
Hanneke A. de Valk, Corné H.W. Klaassen and Jacques F.G.M. Meis. 
Molecular typing of Aspergillus species. 
Mycoses 2008 Digital published doi:10.1111/j.1439-0507.2008.01538.x 
 
 
Chapter 1 
 10 
 
 
Introduction and outline of the thesis 
 11
Introduction 
  
Aspergillus species occur most frequently in soil, water, decaying vegetation and 
organic debris. Aspergillus is the most ubiquitous fungus with airborne conidia. It 
sporulates abundantly and the spores are simply dispersed into the environment by air. As 
a result of this ubiquitous presence, people are probably constantly exposed to Aspergillus 
spores. Several species have been described as human pathogens.  
There are severe clinical manifestations in which Aspergillus plays an important 
role. In immunocompromised individuals it can cause invasive aspergillosis (IA), which is 
a life-threatening disease. Pulmonary infections are thought to arise by local tissue 
invasion, and eventually disseminate to other deep seated organs. IA is a growing problem 
in hospitals, because of the increase in the number of patients undergoing bone marrow or 
solid organ transplantations and because of therapy with corticosteroids. The incidence of 
IA has increased dramatically in recent years 37, 50. The main causes of nosocomial 
Aspergillus outbreaks are attributable to construction, renovation, demolition and 
excavation activities. This is plausible since renovation and demolition work have been 
shown to dramatically increase the amount of airborne fungal spores and consequently 
increase the risk for Aspergillus infections in susceptible patients 105. 
Allergic bronchopulmonary aspergillosis (ABPA) is an uncommon but serious 
respiratory condition characterized by chronic airway inflammation and airway damage 
resulting from persistent colonization by and sensitization to Aspergillus. ABPA is a 
severe complication in children, adolescents and adults with cystic fibrosis (CF) 23. In 
57% of these patients the respiratory tract is colonized with Aspergillus species, in up to 
11% of these patients sensitization to Aspergillus allergens may lead to the development 
of ABPA 66.  
Of all aspergilli, A. fumigatus is the organism most frequently isolated from human 
infections 52. A. flavus is the second most common etiologic agent of human aspergillosis 
43. Besides these two, other aspergilli like A. niger, A. nidulans and A. terreus can also be 
the causative agents of various forms of infections.  
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Some Aspergillus species produce mycotoxins, which are a serious problem as they 
have adverse effects on human health. Aflatoxins are produced by some isolates from the 
section Flavi such as A. flavus, A. parasiticus, and A. nomius. These are highly 
carcinogenic, mutagenic and teratogenic secondary metabolites 9, 46. Another important 
mycotoxin is ochratoxin A (OTA), this has been implicated in a diverse range of 
toxicological effects, including renal toxicity, mutagenicity, teratogenicity and 
immunotoxicity in humans and it is a possible human carcinogen. OTA is produced by A. 
ochraceus and A. carbonarius belonging to Aspergillus section Nigri, also known as black 
aspergilli 32, 38, 71 
 By typing Aspergillus isolates the understanding of the genetic and 
epidemiological relationships between environmental and clinical isolates can be 
improved. Understanding pathogen distribution and relatedness is essential for 
determining the epidemiology of nosocomial infections and aiding in the design of 
rational pathogen control methods 85. Typing techniques can also give a deeper 
understanding of the colonization pattern of patients. Whether colonization of the 
respiratory tract is due to one or several isolates or if frequent recolonization takes place 
can be evaluated by typing cultured isolates from sequential sputum samples 104. The 
genetic diversity in patients with IA can also be investigated to visualize the dissemination 
routes of isolates from the respiratory tract to the lung tissue and other organs 26, 37.  
Several phenotypic and genotypic studies have been used to distinguish between 
individual Aspergillus isolates. With the development and implementation of new typing 
technologies based on DNA rather than on phenotypic characteristics such as multilocus 
enzyme electrophoresis (MLEE), the way of typing has dramatically changed 85.  
In this review a summary is given of the different available typing methods for 
Aspergillus species. The advantages and disadvantages of the different typing techniques 
will be evaluated in terms of their discriminatory power and applicability, as well as 
technical aspects and interpretation. We will also address the issue which typing method 
best serves the purpose of epidemiological studies.  
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Random amplified polymorphic DNA (RAPD) 
In a standard PCR reaction two primers will anneal to genomic DNA under highly 
stringent conditions. RAPD is based on a single primer (8 to 20 base pairs (bp) long) in 
combination with low annealing temperatures during the PCR reaction. Under such 
conditions a primer can anneal to multiple positions on the genome in an aspecific 
fashion. In this way a number of arbitrary fragments will be formed. Following 
amplification, the resulting fragments are separated by agarose gel electrophoresis. The 
number and sizes of the obtained fragments can be determined by the number and location 
of annealing sites. Unrelated isolates usually yield different banding patterns.  
 The RAPD technique is sometimes also called arbitrarily primed PCR (AP-PCR). 
The repetitive extragenic palindromic PCR (rep-PCR) 100 or interrepeat PCR 41 are 
techniques similar to RAPD with only little modifications. The rep-PCR primers are based 
on specific repetitive sequences present in certain microbial genomes.  
 Aufauvre-Brown et al. 6 tested a total of 44 different primers on three different A. 
fumigatus isolates. An often used primer is R108, which also seems suitable for other 
Aspergillus species 7, 31, 48, 59, 73 , 75, 77. Several other primers suitable for typing Aspergillus 
species have later been described by other groups as well 54, 58, 80, 103. 
 
Restriction Fragment Length Polymorphism without hybridization  
 When genomic DNA from an Aspergillus isolate is cut with a restriction enzyme 
with a six base pair (bp) recognition sequence, up to 10,000 different DNA fragments may 
be obtained. These DNA fragments are on average some 4,000 bp long. The vast majority 
of these fragments cannot be distinguished from each other. By restricting the analysis to 
only the large fragments (10 - 50 kbp), different isolates may show different banding 
patterns. Differences in banding patterns originate by substitution, insertion or deletion of 
nucleotides in the recognition sequence of the restriction enzymes or by insertions and 
deletions in the region between the recognition sites. Denning et al. 30 tested different 
restriction enzymes for their ability to type a collection of 31 A. fumigatus isolates. The 
enzymes XhoI and SalI seemed to yield the highest discriminatory power with this 
approach. This technique was originally referred to as restriction enzyme analysis (REA). 
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This RFLP technique has also been used for A. flavus on mitochondrial DNA. It clearly 
identified A. flavus in a heterogeneous group of Aspergillus, but isolates from identical 
species could not be distinguished from each other 64. 
  
Restriction Fragment Length Polymorphism with hybridization 
 The major difference of the RFLP technique with hybridization is that a specific 
subset of restriction fragments is analyzed. Genomic DNA is cut by a restriction enzyme. 
The obtained fragments are separated by size using agarose gel-electrophoresis, and are 
subsequently transferred to a nylon filter by Southern blotting. A subset of the restriction 
fragments is then detected by hybridization with a labeled probe. The application of 
repeated sequences as probes will yield a multiple banding pattern. Differences in patterns 
between unrelated isolates can be expected because of variations in copy-number and/or 
flanking sequences of the target regions.  
 Different restriction enzyme and probe combinations have been analyzed for 
discrimination between isolates from several Aspergillus species. Girardin et al. 35 looked 
for multicopy elements in the A. fumigatus genome and tested them in combination with 
the restriction enzyme EcoRI for their utility as an effective typing technique. This probe, 
called Afut1, possesses specific characteristics of a retrotransposon-like element 68 and 
has been used in most RFLP studies so far 47, 52, 104. Other probes used for fingerprinting of 
A. fumigatus, which are based on retrotransposon-like elements are Afut2 69 and Af4A 84. 
 McAlphin et al. constructed and characterized a species specific probe for A. flavus 
named pAF28 56. This probe has been applied to type clinical and environmental isolates 
in a neonatal intensive care unit 43. To discriminate A. flavus isolates from outbreak and 
non-outbreak related situations, a RFLP analysis of Sma I-digested DNA using RAPD 
generated probes was performed 19. 
 Non-species specific probe sequences such as the intergenic spacer from the 
ribosomal RNA gene of Aspergillus nidulans pMN1 45, 79, plasmid pFOLT4R4 harboring 
Fusarium oxysporum telomeric sequences 92 or southern hybridization with labeled 
bacteriophage M13 4 also displayed complex patterns of hybridization bands but have 
only occasionally been reported.  
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For A. terreus a repetitive sequence probe was used to type 12 isolates, six patterns could 
be distinguished 76. For the determination of a strain belonging to the group of black 
aspergilli, RFLP analysis was used with three different genes as probes. The RFLP 
method is used in here to confirm the differences of this new species with known species. 
Unique RFLP patterns were obtained for this isolate and it was therefore designated as a 
novel species 28.  
 In a simpler version of this technique, the analysis is performed on only one 
specific PCR amplified target. This fragment is then cut by a (several) restriction 
enzyme(s) and the obtained fragments can be separated by gel-electrophoresis. This is 
often referred to as PCR-RFLP. This approach is generally suitable to discriminate 
between different species, but has insufficient discriminatory power to distinguish 
between unrelated isolates within a species 2, 88. 
  
Amplified Fragment Length Polymorphism (AFLP) 
 In AFLP-analysis, first described by Vos et al. 106, genomic DNA is usually cut 
with two restriction enzymes, one with an average cutting frequency and a second one 
with a higher cutting frequency. Synthetic double stranded DNA fragments are ligated to 
the obtained sticky ends to serve as primer binding sites in a successive PCR reaction. The 
ligated fragments are subsequently amplified in a PCR reaction using stringent PCR 
annealing temperatures. The number of fragments that will be generated can be modulated 
by extending the amplification primer(s) at the 3’ site with one or more selective 
nucleotides. The addition of each nucleotide reduces the number of amplified fragments 
by a factor four. The PCR primer that spans the average-frequency restriction site is 
labeled. At first the primers were radioactive labeled, a major improvement is the 
switching from radioactive to fluorescently labeled primers for detection of fragments on 
a high-resolution electrophoresis platforms 81. A highly informative complex DNA 
banding pattern of 50 to 500 bp is obtained. Variations between different isolates originate 
by differences in the number and location of restriction enzyme recognition sites in the 
genome.  
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 Warris et al. 107 investigated a collection of 96 clinical and environmental A. 
fumigatus isolates using the restriction enzymes EcoRI and MseI with three selective 
nucleotides. The different isolates could be separated from each other. With the same 
enzyme combination but with other selective nucleotides, the genetic diversity of 
Aspergillus sections Flavi and Nigri was examined 63, 70. All these studies demonstrated 
AFLP to be an excellent typing method to differentiate at and below the species level in 
these groups of Aspergillus species. 
Schmidt et al. 83 used AFLP patterns to detect specific markers for A. carbonarius. 
In another study specific markers for A. ochraceus were developed based on AFLP 
patterns 82. Specific primers were designed, based on the sequences of the obtained 
markers to detect the species, which yielded specific products for their respective target 
organism. The species belonging to the Aspergillus section Nigri are regularly isolated 
from food. The latter species are responsible for the production of the mycotoxin OTA in 
coffee and grape-derived products. The developed PCR assays allow specific and 
sensitive detection and identification of A. carbonarius and A. ochraceus, which make 
these assays a powerful tool to improve quality control and consumer safety in the food 
processing industry 83.  
 
Microsatellites or Short Tandem Repeats (STR’s) 
 Microsatellites or STR’s are short repetitive sequences that are abundantly present 
in the genomes of most higher organisms and to a lesser extent in several prokaryotic 
genomes as well 3, 55, 72, 86, 99. Different isolates can be distinguished from each other based 
on differences in repeat numbers. Microsatellite markers are easily amplified by PCR 
using primers based on their flanking sequences. If one of the primers is fluorescently 
labeled, they can be sized very accurately using high-resolution electrophoresis platforms. 
The number of repeats in each marker can be deduced from the sizes of the fragments. All 
repeat numbers of the analyzed markers form a genotype for each individual isolate. 
These genotypes are easily compared to each other. Microsatellite based typing schemes 
yield unambiguous typing- and highly portable data.  
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 Bart-Delabesse et al. 14 used microsatellites to type A. fumigatus. Four different 
dinucleotide markers were used to discriminate between unrelated isolates. With this 
panel of markers, some 30.000 different genotypes can be identified. Microsatellite based 
assays are sometimes also referred to as MLP (microsatellite length polymorphism) 14, 
MSP (microsatellite polymorphism) 17 or PMM (polymorphic microsatellite marker) 47. 
 For A. flavus and A. parasiticus seven polymorphic microsatellite loci have been 
characterized 96. Searches for microsatellite motifs were performed on genomic sequences 
of Aspergillus section Flavi. These 7 markers are tested on 20 A. flavus and 15 A. 
parasiticus isolates and yielded 2 to 11 alleles for A. flavus and 1 to 9 alleles for A. 
parasiticus 96. For A. niger six polymorphic loci were developed to analyze 28 isolates. 
These markers displayed 6 to 13 alleles, which demonstrated diversity within A. niger 33. 
For Emericella nidulans (teleomorph of A. nidulans) five to 12 alleles were found with 7 
microsatellite loci on a collection of 44 isolates 42.  
 
Multilocus Sequence Typing (MLST) 
 MLST, originally developed for characterizing isolates of bacterial species, 
compares the nucleotide sequence of internal 400-500 bp regions of a series of genes 
(typically six to ten) which are present in all isolates of a particular species 93. For all 
unique sequences an arbitrary allele number will be assigned (usually in the order of 
discovery). Each isolate is defined by the alleles at each of the sequenced housekeeping 
loci, which together comprise the allelic profile or sequence type (ST). Relationships 
among isolates are apparent by comparisons of allelic profiles: closely related isolates 
have identical STs, or STs that differ at only a few loci, whereas unrelated isolates have 
unrelated STs. MLST is the molecular alternative of MLEE (multilocus enzyme 
electrophoresis) by targeting the variation present in multiple housekeeping loci 98. The 
advantage of MLST compared to MLEE is that as DNA is more variable than protein 
encoded (due primarily to synonymous mutations) fewer loci need to be examined in 
MLST. Furthermore, MLST data is portable. 
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MLST is increasingly applied as a routine typing tool that enables international 
comparison of isolates. MLST data have also been exploited in evolutionary and 
population analyses that estimate recombination and mutation rates and investigate 
evolutionary relationships among bacteria that are classified as belonging to the same 
genus 98. In the Aspergillus section Fumigati, the MLST method has led to the description 
of new pathogenic species, among which is A. lentulus. 10 
 Recently, Bain et al. described an MLST scheme for A. fumigatus, where seven 
genes were selected to genotype a panel of 100 clinical and environmental A. fumigatus 
isolates. Among the 100 isolates analyzed, 30 STs were distinguished 8.  
 
Other less-frequently reported PCR based typing techniques 
 Random amplified microsatellites (RAMS) is based on PCR and uses primers 
containing microsatellite sequences and degenerate anchors at the 5’ site. The DNA 
between the distal ends of two closely located microsatellites is amplified. The resulting 
PCR products are separated by electrophoresis. RAMS marker polymorphism is due to the 
length differences in the sizes of amplified products between different isolates. Since it 
has not been shown that the amplified fragments are indeed flanked by microsatellites, 
this technique fundamentally differs little from RAPD. This method has been used to 
fingerprint 24  A. fumigatus and 13 A. flavus isolates from respectively 14 and 10 patients 
40. 
 Another PCR based method is sequence specific DNA primers (SSDP), described 
for the first time by Mondon et al. 62. RAPD fragments that differentiate unrelated A. 
fumigatus isolates were selected and sequenced. Primer sets are formulated on the basis of 
these sequences and the resulting PCR products are scored as either present or absent. A 
total of 18 different fragments obtained with three different RAPD-primers, were 
analyzed. Five of these primer combinations made it possible to distinguish between nine 
unrelated isolates. These five SSDP primers have been applied to investigate 43 clinical 
isolates 62. Theoretically, with these primer combinations 32 genotypes can be 
distinguished. 
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Intergenic spacer-analysis (IGS-PCR) is a PCR based method in which the primers 
flank the region between the small and large subunit of the ribosomal RNA-gene. The 
genome of a fungus contain about 100 highly conserved copies of this gene, which are 
tandemly repeated head to tail with spacer regions in between. Since these intergenic 
spacer-regions may vary in length, unrelated isolates may yield a different banding 
pattern. Radford et al. 74 tested this technique on a population of 119 patient- and 
environmental isolates from one hospital; in this collection 11 different types were 
recognized. 
 Recently a novel single-locus sequence based typing method was developed based 
on the presence of tandem repeats in a gene encoding a putative cell surface protein. This 
method is referred to as CSP typing 12. Since the repeat is not fully conserved, differences 
in genotype are the result of both repeat number variation and nucleotide sequence 
variation. The discriminatory power of this technique was evaluated on a collection of 55 
epidemiological linked A. fumigatus isolates from six different outbreak investigations.  
 
Comparison of the typing techniques 
 
The performance of typing techniques can be compared to each other in respect of 
their practical feasibility. Specific advantages and disadvantages are evaluated in terms of 
applicability, the ease of use, the exchangeability and the reproducibility within a 
laboratory and between laboratories. The discriminatory power and interpretation of the 
typing methods will be evaluated in separate paragraphs. Table 1 gives an overview of the 
different aspects for all typing techniques discussed before.  
  Firstly the ease of use of methods will be compared to each other. Most of the 
techniques described in this review are PCR based methods. PCR based techniques 
require only small amounts of amplifiable DNA, which are easily obtained 15. In contrast, 
RFLP either with or without hybridization, as non-PCR based methods, need relatively 
large amounts of highly purified DNA which make them time-consuming and labor 
intensive 52, 47.  
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Several PCR based methods like AFLP, CSP, MLST, microsatellites and RAMS need 
special equipment to separate obtained fragments with high resolution electrophoresis 
conditions. On the other hand the RAPD method can be performed with relatively 
inexpensive equipment and is therefore the most widely used method for typing 
Aspergillus isolates 47. 
Not all techniques are able to generate a genotype for any given organism. 
Microsatellite based approaches appear to be species specific  14, 252, 63 as are SSDP, IGS 
and MLST 8, 24, 62, 741. For RFLP both species specific and non-species specific probes have 
been described. Probes based on repetitive chromosomal DNA sequences, like pAF28 56 
and Afut1 35 or probes based on RAPD patterns 19 hybridize strongly only to the species 
for which the probe has been developed. Southern blotting in combination with labeled 
bacteriophage M13, however, has also successfully been used to differentiate isolates of 
several fungal species from different genera 61. In contrast, the AFLP technique is 
basically applicable to any organism’s genome without the need for prior sequence 
information 81. Besides aspergilli, AFLP fingerprinting has already successfully been used 
with a large variety of other microorganisms 65, 81 including other fungi 97, but also in 
plants and animals 16. This is also the case for RAPD, which has been applied to many 
bacteria 39, 78, 101, parasites 20, viruses 5 and fungi 57. The RAMS technique has been used to 
determine genetic diversity in plants and animals and, more recently, also in other fungi 40. 
Reproducibility refers to the ability of a technique to yield the same result when a 
particular isolate is repeatedly tested. For large scale and longitudinal epidemiological 
studies, stable fingerprinting techniques are required. The main source of ambiguity in 
band-based approaches like RAPD, RFLP, RAMS, IGS, SSDP and AFLP concerning 
reproducibility is the variable intensity of bands, which is probably due to small variations 
in the various steps of the procedures that may affect the final peak intensity 15, 26, 81. In 
contrast, exact techniques, like CSP, microsatellites and MLST are potentially 100% 
reproducible 9, 25.  
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Another important aspect in evaluating typing techniques is the ability to exchange 
data between different laboratories. As a consequence of the easy exchange of data, 
genotypes obtained from all over the world can be compared to each other, which would 
facilitate our understanding of the global epidemiology of microorganisms. Therefore 
exact techniques seem to be most suitable, because the data generated with these 
techniques can be fully expressed in a simple, digital format. For MLST,  schemes for 
several microorganisms are publicly available at http://www.mlst.net/ and on 
http://pubmlst.org, where sequence data for MLST alleles can be uploaded to ascertain 
allele genotypes and strain STs 44, 98. The data obtained with CSP typing also allows the 
creation of unambiguous data sets that can be readily exchanged between labs 12. Digital 
fingerprinting data in the shape of banding patterns is more complex and therefore 
difficult to exchange. In addition, standard procedures have to be followed by all 
laboratories to avoid differences in the banding patterns 81.  
 
Table 1. Overview of different aspects of typing techniques used for Aspergilli 
Typing technique Discriminatory Power Reproducibility Exchangeability
Ease of 
use 
Species 
specific Interpretation
       
AFLP High Good Poor Moderate No Difficult 
CSP typing Limited Excellent Excellent Moderate Unknown Easy 
IGS-PCR Unknown Limited Poor Easy Yes Moderate 
Microsatellites High Good Poor Moderate Yes Easy 
MLST Limited Excellent Excellent Moderate Yes Easy 
RAMS Unknown Good Poor Easy No Moderate 
RAPD Limited Limited Poor Easy No Moderate 
RFLP without 
hybridization  Limited Limited Poor Moderate No Difficult 
       
Afut1-RFLP  High Good Poor Difficult Yes Difficult 
SSDP Limited Excellent Good Easy Yes Moderate 
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Interpretation  
 
 All techniques mentioned in this review, can roughly be divided in pattern-based 
approaches and exact techniques. With respect to the interpretation of these kinds of 
results, different pitfalls can be encountered. The techniques used for distinguishing 
Aspergillus isolates rely on electrophoretic separation of DNA fragments of different 
lengths, which results in a complex pattern of bands. The following techniques described 
for fingerprinting of Aspergillus species are band-based approaches: RAPD, RFLP, 
RAMS, IGS, and AFLP. Exact typing techniques yield unambiguous typing results, like 
the peak length (bp) typing results obtained with the MLP assay, and sequence data 
obtained with MLST and CSP typing. The SSDP technique could be an exact technique 
since bands are either scored present or absent. However, Lasker found that some SSDP-
primers sporadically generate faint bands, which undermines the potential exact character 
of this technique 47. 
 The patterns obtained with band based techniques can be extremely complex, 
because they are composed of both strong and faint bands which makes the interpretation 
of these methods difficult 15, 81. In order to compare different fingerprints to each other, 
and to determine the genetic relatedness between multiple isolates, one has to rely on 
specialized computer software. Computerized analyses are usually performed using either 
band based or pattern based algorithms. Band based algorithms, where individual bands 
are either scored as present or absent, still need visual inspection, which makes it more 
laborious and subjective. However, pattern based approaches, which use all the 
information from all bands in the fingerprint, hardly ever give 100% identical values for 
the same samples although they may appear to be identical upon visual examination. 
When relying solely on the computer-based comparison, wrong conclusions could be 
drawn. This requires a visual inspection of the fingerprints to be included in the final 
interpretation.  
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In contrast, exact fingerprinting techniques are much easier to interpret. Artifacts 
that may compromise correct interpretation of microsatellite data can be avoided by 
choosing appropriate reaction conditions 14, 27. Sequence data obtained with MLST can be 
interpreted and compared in a central web database (http://pubmlst.org 44). The sequence 
of any new allele is entered into the database when the forward and reverse trace files are 
submitted to the MLST scheme curator, before a new allele number is assigned by the 
curator for the novel sequence 1. This is to avoid that the database is corrupted by 
nonexistent alleles and sequence types.  
Another problem among the analysis of general typing data is the subjective 
interpretation of a “genotype”. The assignment of a genotype is user dependent when 
using band-based approaches, whereas the genotype resulting from exact techniques is 
unambiguous. Unfortunately, at present there are no established guidelines for defining a 
genotype for the methods described here (such as the criteria of Tenover et al. 94 for the 
interpretation of pulsed-field gel electrophoresis fingerprints) 53, 81. By comparing banding 
patterns with each other it is assumed that bands with the same size contain the same gene 
fragments. This can be misleading, because bands with the same size can consist of 
completely different gene fragments and thus give false identical strains 53. This is 
avoided in exact genotyping methods, where the target is well defined and primers can be 
designed very specific 53. With exact approaches unambiguous data can be obtained, to 
determine if isolates with different genotypes may be related.  
 
Discriminatory power 
 
 Apart from the advantages and disadvantages of practical feasibility and the 
interpretation of the different techniques, another important factor, the discriminatory 
power, must be evaluated. One way to assess whether a DNA fingerprinting method is 
sufficiently discriminating, is to compare the data generated by one method with those 
generated by a completely unrelated DNA fingerprinting method for the same set of test 
isolates 87. For A. fumigatus, several studies have been performed to compare different 
typing techniques.  
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RAPD, Afut1-RFLP and MLP have been compared to each other in two comparative 
studies 15, 47. In both investigations RAPD yielded the lowest discriminatory power, while 
Afut1-RFLP and MLP proved to be equally discriminatory in one study 47, in another 
study RFLP appeared to be superior 15.  
 The choice or design of a specific probe is essential for high discriminatory power 
for RFLP assays. Several probes have already been used to type A. fumigatus. Although 
the M13 probe has the advantage that it is readily available from commercial suppliers, it 
seems that the Afut1 probe, which is based on a moderately repetitive sequence from A. 
fumigatus, discriminates best between unrelated isolates 21, 29.  
 AFLP analysis can be used both for identification of isolates to the species level as 
well as for discriminating of the intraspecies level, more commonly referred to as 
“typing”. This was already demonstrated for the Aspergillus section Nigri group 70. The 
AFLP method was also used for determining the epidemiological relatedness between 96 
clinical and environmental A. fumigatus isolates. The AFLP could differentiate most of 
the isolates, indicating the high discriminatory power of this technique 107. 
 Sequence based typing of genes can be used to distinguish new species in the 
section Fumigati 10, 11. Differentiation between A. fumigatus isolates can also be 
accomplished by MLST. Bain et al. applied seven gene fragments on a collection of 100 
isolates from diverse sources. This yielded different types amounting to approximately 
one-third of the number of isolates tested 8, which renders the discriminatory power less 
discriminating than other exact fingerprinting methods. If the level of nucleotide variation 
is not discriminating enough to answer epidemiological questions, more variable loci have 
to be tested.  
 The SSDP method makes use of five primer combinations, therefore this method is 
limited to discriminate between only 32 (25) genotypes. Cimon et al. examined 109 
isolates from 7 different CF patients with SSDP. In 6 of the 7 patients identical genotypes 
were found 22. Isolates from six different locations tested by Symoens et al. showed also 
identical genotypes 91. The genotypes found in CF-patients 22 and the genotypes found in 
the environment of IA-patients 91 appeared to be identical. 
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 Unfortunately the discriminatory power of methods like IGS and RAMS is difficult 
to assess since the discriminatory power of these methods has not been compared to other 
typing techniques.  
 
Clinical aspects 
 
  Aspergillus species are widely distributed fungi whose conidia are ubiquitous in 
their distribution and inhalation of spores is believed to be the major route of transmission 
105. Prior to invasion, colonization with Aspergillus species may be necessary. 
Colonization of the lower respiratory tract is a risk factor for patients, especially patients 
with chronic lung disease (e.g. chronic obstructive lung disease, cystic fibrosis (CF), 
inactive tuberculosis and α1-antitrypsin deficiency) to acquire pulmonary or disseminated 
infections 34.  
 To visualize the colonization pattern of Aspergillus isolates in CF patients, several 
studies where sequential isolates were typed, have been performed. Verweij et al. 104 
presented two CF-patients with A. fumigatus isolates cultured in sequential sputum 
samples over a period of two years, which were analyzed with Afut1-RFLP and RAPD. 
The fingerprints of these samples showed three different genotypes in 11 samples for one 
patient, of which one genotype was predominant present in the sputum samples. In the 
other patient about 9 different genotypes were seen in 12 samples. In another study, six 
CF patients were followed over a period of two years. In total 412 A. fumigatus isolates, 
collected from sequential sputum samples from these patients, yielded 54 unique 
genotypes with the Afut1-RFLP method. In all samples of the six patients several A. 
fumigatus genotypes were found, whereas two patients harbored a predominated isolate. 
From one of these patients 10 different genotypes were identified in the first year, while in 
the second year a single genotype was found from 40 consecutive samples. This patient 
did not show any clinical symptoms of aspergillosis. However, the other patient, with a 
predominant genotype in nine sputum samples, developed a pulmonary infection 67. 
Cimon et al. observed that two out of seven patients harbored a unique genotype, whereas 
several genotypes were simultaneously and/or successively displayed in the other patients. 
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The results of these studies are in agreement, CF patients appeared to have different 
patterns of colonization with A. fumigatus, since analysis of sequential isolates showed 
that some CF patients exhibited a predominant genotype and others had multiple 
genotypes 22, 67, 104. In most of the CF patients airway colonization with A. fumigatus 
seems to be a recurrent event. The repeated isolation of one unique genotype in these 
patients does not necessarily forecast the occurrence of aspergillosis 67. 
 The presence of various genotypes in sequential isolates has also been shown in 
other patients, like lung transplant recipients 18 89, aspergilloma patients 36 and patients 
with invasive aspergillosis 13, 29. In general, the variability of genotypes of  isolates from 
patients with invasive aspergillosis or aspergilloma is lower than in CF patients 13, 29 36. 
One must take into account that in most studies either the number of isolates or the time 
interval between the first and the last isolate is lower in patients with invasive 
aspergillosis compared to CF patients. In two studies, the genotypes of invasive A. 
fumigatus isolates, collected from deeper tissue samples, are compared to the genotypes of 
isolates from respiratory samples 25, 30, 37. Overall results show that intrapatient samples of 
non-respiratory origin belonged to the same genotype. By contrast, multiple genotypes 
were detected in isolates originating from respiratory samples.  
 Aspergillus conidia are permanently present in the air 21. The extent of genetic 
diversity of environmental and clinical isolates has been demonstrated in an Afut1-RFLP 
based study including 700 A. fumigatus isolates from hospital air and patients. Analyses of 
the environmental isolates represent in 85% of the isolates a single genotype. The 
remaining 15% of the isolates were found multiple times and persisted in the same 
hospital for several months 21. In another study 879 A. fumigatus isolates from different 
hosts and geographical origins were analyzed with Afut1-RFLP. The patterns obtained 
with the Afut1 probe gave distinct and unique genotypes for 424 isolates. Only 14 
matches were found between isolates of different origins 29. The high genetic variability in 
the air together with the high genetic variability of A. fumigatus in respiratory samples 
confirm that individuals may well be constantly exposed to a large variety of different 
genotypes from the environment 21, 60. Even if typing is helpful towards the epidemiology 
of A. fumigatus, it remains difficult to identify the origin of a nosocomial outbreak 91.  
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Genetic variability of Aspergillus species other than A. fumigatus is less 
pronounced 102 and spores of other Aspergillus species are less prominent present in the 
environment 21, 51, 91. Therefore it is more difficult to identify a nosocomial source of 
contamination for other aspergilli than A. fumigatus. However, James et al. 43 indicated 
that a roll of adhesive tape was the probable source of the infecting isolate of A. flavus 
recovered from two low-birth-weight infants. Genotyping of these samples was performed 
with RFLP with the pAF28 repetitive DNA sequence probe. Fingerprinting of  successive 
A. terreus isolates from two patients with CF and two with invasive aspergillosis yielded 
identical genotypes within patients 90. RAPD analysis was also used to identify the source 
of A. terreus infections in a hematology unit 49 and was recently performed on a collection 
from three geographically distinct centers 48.  
 Vonberg et al. 105 summarized numerous outbreaks of IA. From the 53 outbreaks 
that were included, genotyping of clinical and environmental isolates was performed in 11 
studies. Construction work or renovation activities within the hospital or in the 
surrounding areas were most commonly considered to be the probable or possible source 
of the nosocomial Aspergillus outbreak, followed by a contaminated or defective air 
supply system 105. This is plausible because renovation and demolition work have been 
shown to increase the amount of airborne fungal spores dramatically, and consequently 
increase the risk for Aspergillus transmission to susceptible patients 51, 95. Routes of 
Aspergillus transmission in nosocomial outbreaks other than airborne spores are rarely 
described 105. Detection of airborne aspergilli in high-risk patient care areas should always 
draw attention to the potential risk of a serious infection 105. 
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Conclusions 
 
Several molecular methods have been described for typing various Aspergillus 
species. Most of the techniques are developed to analyze A. fumigatus isolates, which is 
the most common species. Fingerprinting isolates collected from respiratory samples and 
from the environment showed that a high extent of genetic variability can be found in A. 
fumigatus. Therefore typing techniques with high discriminatory power are necessary. 
Techniques which fulfill this criterion are RFLP in combination with the Afut1 probe and 
MLP. Another important aspect of typing methods is the reproducibility. Exact typing 
methods, like MLST and CSP, are highly reproducible, which make them eligible to 
analyze epidemiological relationships between large amounts of isolates over a longer 
period of time. Unfortunately, CSP typing and the loci described so far for MLST are 
probably not discriminating enough to identify a true source in an outbreak situation. The 
RAPD method has been used most, probably because this technique needs less equipment 
and no genomic sequence information is necessary to perform this assay.  
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Outline of the thesis 
 
Aspergillus fumigatus is by far the predominant cause of invasive fungal disease. 
Many different molecular methods have been developed to distinguish between individual 
A. fumigatus isolates. Some techniques showed to be highly discriminating, but they lack 
reproducibility. Other methods are highly reproducible, but fell short of discriminatory 
power. Therefore we developed a novel assay for A. fumigatus based on short tandem 
repeats, the so-called STRAf assay (Short Tandem Repeats for A. fumigatus) which was 
found to be reproducible and highly discriminating. This assay is described in detail in 
Chapter 2. The remaining of this thesis is focused on two main themes: Technical aspects 
of this new typing assay and clinical applications. 
 
Part 1. Technical aspects of the STRAf assay 
 
Firstly the STRAf assay was compared to other typing techniques. In Chapter 3 
this assay was compared with a high-resolution fingerprinting technique, the AFLP 
(Amplified Fragment Length Polymorphism) method. In Chapter 4 the STRAf assay was 
tested against the RISC (Retrotransposon Insertion-Site Context typing) method, which is 
a PCR alternative to RFLP (Restriction Fragment Length Polymorphism), the so-called 
gold standard for A. fumigatus typing. To gain more insight in the genetic relationships 
between isolates from worldwide origin, it is important that fingerprinting methods are 
reproducible and transferable regardless of the place of analysis. We tested varying 
components of the PCR amplification mixtures in Chapter 5 to evaluate the robustness of 
the STRAf assay.  Although the STRAf assay proved to be an extremely robust assay, one 
has to be aware that different electrophoresis platforms need careful calibration to 
exchange STRAf data between laboratories. This has to be established with the use of 
allelic ladders. In Chapter 6 we describe the development of these allelic ladders, which 
were subsequently tested in an international multicenter study.  
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In Chapter 7 the extent of stability of the STRAf markers in successive generations of 
clonally expanded A. fumigatus isolates was investigated. This data is useful to interpret 
relations between isolates with minor differences in the STRAf typing results.  
 
Part 2. Clinical applications 
 
There are several clinical manifestations in which A. fumigatus plays an important 
role. One of these is invasive aspergillosis, which has emerged as a leading cause of 
morbidity and mortality in immunocompromised patients. To provide a better 
understanding of the epidemiology and pathogenesis of this disease, 55 isolates from 15 
patients with proven IA were investigated in Chapter 3. STRAf typing was subsequently 
tested for its utility in outbreak settings where it is important to recognize genetically 
related clusters from genetically unrelated genotypes. Several epidemiologically linked A. 
fumigatus isolates from multiple outbreak investigations across Northern America were 
typed and described in Chapter 8. A. fumigatus can colonize the respiratory tract of 
patients with compromised airways. Whether colonization of the respiratory tract is due to 
one or several isolates or if frequent recolonization takes place can be evaluated by typing 
cultured isolates from sequential respiratory samples. In Chapter 9 several A. fumigatus 
isolates from cystic fibrosis patients were typed and the different colonization patterns in 
the patients were linked to the clinical aspects. In Chapter 10 the STRAf assay was used 
for detection and genotyping of A. fumigatus directly in clinical samples. Genotypes, 
obtained from cultured isolates, were compared with the STRAf results from formalin 
fixed, paraffin-embedded (FFPE) deep tissue samples and from corresponding patient 
sera. 
  
Overall results and conclusions of the studies in this thesis are discussed and summarized 
in Chapter 11. 
 
Chapter 2 
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Abstract 
 
In this chapter we describe a new panel of short tandem repeats (STRs) for a novel exact 
typing assay that can be used to discriminate between Aspergillus fumigatus isolates. A 
total of nine STR markers were selected from available genomic A. fumigatus sequences 
and were divided into three multicolor multiplex PCRs. Each multiplex reaction amplified 
three di-, tri-, or tetranucleotide repeats, respectively. All nine STR markers were used to 
analyze 100 presumably unrelated A. fumigatus isolates. For each marker, between 11 and 
37 alleles were found in this population. One isolate proved to be a mixture of at least two 
different isolates. With the remaining 99 isolates, 96 different fingerprinting profiles were 
obtained. The Simpson’s diversity index for the individual markers ranged from 0.77 to 
0.97. The diversity index for the multiplex combination of di-, tri-, and tetranucleotide 
repeats ranged from 0.9784 to 0.9968. The combination of all nine markers yielded a 
Simpson’s diversity index of 0.9994, indicative of the high discriminatory power of these 
new loci. In theory, this panel of markers is able to discriminate between no less than 27 × 
109 different genotypes. The multicolor multiplex approach allows large numbers of 
markers to be tested in a short period of time. The exact nature of the assay combines high 
reproducibility with the easy exchange of results and makes it a very suitable tool for 
large-scale epidemiological studies. 
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Introduction 
 
Aspergillus species are widely distributed fungi which release large amounts of 
conidia that are dispersed into the environment by air. Inhalation of Aspergillus conidia is 
a common event but rarely causes complications in immunocompetent hosts. In 
immunocompromised individuals, however, it can cause invasive aspergillosis (IA), often 
with fatal consequences. Because of the increase in the numbers of patients undergoing 
bone marrow or solid organ transplantation, the incidence of IA has increased 
dramatically in recent years. Aspergillus fumigatus is the most common species 
responsible for IA 9. 
Molecular tools may provide a better understanding of the genetic and the 
epidemiological relationships between environmental and clinical isolates and thereby 
allow assessment of potential routes of transmission. Understanding of these routes may 
lead to improved strategies toward the prevention of Aspergillus infections. Several 
phenotypic and genotypic studies that can be used to distinguish between individual A. 
fumigatus isolates have been described. Phenotypic typing schemes include morphological 
and serological features as well as isoenzyme analysis. Genotypic methods include several 
techniques, such as random amplified polymorphic DNA (RAPD) analysis 1, 10, 11, 
restriction fragment length polymorphism (RFLP) analysis 13, amplified fragment length 
polymorphism (AFLP) analysis 18, and microsatellite length polymorphism 2. The last 
technique is sometimes also called microsatellite polymorphism analysis 5 or polymorphic 
microsatellites marker analysis 8. However, a major problem with pattern-based 
techniques, such as RAPD, RFLP, and AFLP analyses, is the poor interlaboratory 
reproducibility. The exchange of the results obtained by these techniques is therefore very 
difficult, if not impossible. Microsatellites, or short tandem repeats (STRs), are 
extensively being used for highresolution fingerprinting of the human genome, but they 
have also been shown to provide a high level of discrimination between different isolates 
of several bacterial pathogens 7, 14, 16 and yeast 17. If they are properly performed, STR 
analyses yield highly reproducible, exact typing results. This would eliminate the need for 
repetitive analyses and would allow the easy exchange of data.  
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We describe in this chapter a new panel of nine STRs for the exact and high-resolution 
fingerprinting of A. fumigatus. 
 
Materials and Methods 
 
Tandem repeat locus identification. Preliminary sequence data were obtained from The 
Wellcome Trust Sanger Institute (www.sanger.ac.uk) and were analyzed for the presence 
of STRs by using the Tandem Repeats Finder software 
(http://c3.biomath.mssm.edu/trf.html) 4. Since the A. fumigatus genome is estimated to 
contain about 35 × 106 bp, the available genomic sequences may represent nearly the 
entire genome. The minimum alignment score was set at 40, and the maximum period size 
(repeat unit) was set at 10 nucleotides. We selected three di-, tri-, and tetranucleotide 
repeats based on loci with the highest repeat numbers and counterselected on loci 
containing two or more repeat sequences within the boundaries of potential PCR primer 
regions. Interrupted repeats which may have a lower chance of displaying interstrain 
repeat number variation were not taken into consideration. 
 
Isolates. Ninety-nine clinical A. fumigatus isolates and one reference strain (CBS 487.65) 
were used in this study. The isolates were assumed to be unrelated because they were all 
collected from different patients either at different hospitals, from different wards, or at 
different points in time. The isolates were collected at six different hospital centers; five 
are located in The Netherlands, and one is located in Bern, Switzerland. Fifteen isolates 
were collected from patients with IA over a period of 4 years obtained from the University 
Hospital Nijmegen (Nijmegen, The Netherlands; location A). Another 29 isolates were 
obtained from the Canisius Wilhelmina Hospital (Nijmegen, The Netherlands); of these 
29 isolates, 16 were from patients on the Intensive Care Unit (location B) and 13 were 
from patients the Pulmonology Ward (location C). Eleven isolates were collected over a 
period of 2 years from a cystic fibrosis center (Dekkerswald, Nijmegen, The Netherlands; 
location D). Another 14 isolates were from the Maashospital (Boxmeer, The Netherlands; 
location E).  
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Eight isolates were from the University Hospital Maastricht (Maastricht, The Netherlands; 
location F), and 22 isolates were collected at the University Hospital Bern (Bern, 
Switzerland; location G). Isolates were stored at -80°C, according to standard procedures. 
Eleven Aspergillus species other than A. fumigatus were taken from the private collection 
at the Canisius Wilhelmina Hospital. 
 
Identification of isolates. Fungal isolates were identified by their macroscopic and 
microscopic characteristics. Furthermore, all A. fumigatus isolates were tested for their 
ability to grow at 48°C.  
 
DNA isolation. DNA was isolated by using the following culture and pretreatment 
conditions. Isolates were grown on Sabouraud agar plates at 30°C until sporulation. A 
prewetted cotton swab was saturated with conidia from a sporulating culture. Next, the 
spores were resuspended in a vial containing 350 µl lysis buffer and ceramic beads 
(Roche Diagnostics, Almere, The Netherlands) and subjected to mechanical lysis in a 
Magnalyzer instrument (Roche Diagnostics) for 30 s at 6,500 rpm. Following 
pretreatment, the DNA was further extracted and purified with a MagNA Pure LC 
instrument (Roche Diagnostics) in combination with a MagNA Pure DNA isolation kit III, 
according to the recommendations of the manufacturer. This DNA extraction protocol 
routinely yielded 5 to 20 µg DNA of excellent purity, as determined by UV absorbance 
measurements. 
 
PCR amplification and genotyping. Three separate multiplex PCRs (M2, M3, and M4, 
respectively), each of which contained three different STRs, were developed. Multiplex 
PCR STRAf 2 (M2) amplified three dinucleotide loci. Multiplex PCR STRAf 3 (M3) 
amplified three trinucleotide loci, and multiplex PCR STRAf 4 (M4) contained three 
tetranucleotide loci. For all loci selected, PCR primers were designed with the use of the 
Primer3 software (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) 15.  
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For each of the three multiplex PCRs, the forward primers were labeled with 
carboxyfluorescein (FAM), hexachlorofluorescein (HEX), or tetrachlorofluorescein (TET) 
at the 5’ end, respectively. An overview of the PCR primer sequences is shown in Table 1. 
Each PCR mixture contained 1 µM of all amplification primers, 0.2 mM deoxynucleoside 
triphosphates, 1 U of FastStart Taq DNA polymerase (Roche Diagnostics), and 1 ng of 
genomic DNA in 1 × reaction buffer. The optimal MgCl2 concentrations were 1.5 mM for 
M2 and 3.0 mM for M3 and M4. Thermocycling was performed in a T1 thermocycler 
(Biometra, Göttingen, Germany) by using the following thermal protocol: 10 min of 
denaturation at 95°C, followed by 30 cycles of 30 s of denaturation at 95°C, 30 s of 
annealing at 60°C, and 1 min of extension at 72°C. Before the reaction mixtures were 
cooled to room temperature, an additional incubation for 10 min at 72°C was performed. 
All temperature transitions were performed with maximal heating and cooling settings 
(5°C/s). The fragments obtained were combined with the ET400-R size standard (GE 
Healthcare, Roosendaal, The Netherlands) and analyzed on a MegaBACE 500 automated 
DNA platform (GE Healthcare), according to the instructions of the manufacturer. In 
order to avoid PCR amplicon contamination, pre- and post-PCR procedures (DNA 
isolation, preparation of master mixes, amplicon analysis) were performed in physically 
separated facilities. 
 
DNA sequence analysis. To determine the exact number of repeats in the obtained PCR 
products, a selected number of fragments (see Table 3) were inserted into the pGEM-T 
Easy Vector (Promega, Leiden, The Netherlands). After transformation of competent 
JM109 cells, individual colonies were selected and grown in liquid Luria-Bertani medium 
under selective pressure. Plasmid DNA was purified from the cultures that were obtained 
by using High Pure chemistry (Roche Diagnostics) and were sequenced with a universal 
M13 primer by using the MegaBACE DYEnamic ET Dye terminator kit, as suggested by 
the manufacturer (GE Healthcare).  
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The reaction products were purified by using SPRI chemistry (GC-Biotech, Schiedam, 
The Netherlands), eluted in distilled water, and analyzed on a MegaBACE 500 capillary 
DNA analysis platform (GE Healthcare) by using standard electrophoretic conditions. 
 
Table 1. Overview of amplification primers for selected STR loci, details of repeat characteristics, and 
discriminatory indices 
 
No. of repeatsb PCR and 
primer 
name 
Forward primer sequencea Reverse primer sequencea Repeat unit Min Max Refc 
No. of 
alleles
D 
valued 
M2         
STRAf 2A FAM-AAGGGTTATGGCCATTAGGG GACCTCCAGGCAAAATGAGA GA 10 28 26 14 0.88 
STRAf 2B HEX-TATTGGATCTGCTCCCAAGC  GAGATCATGCCCAAGGATGT AG 9 29 18 16 0.88 
STRAf 2C TET-TCGGAGTAGTTGCAGGAAGG AACGCGTCCTAGAATGTTGC CA 8 33 18 17 0.88 
M3         
STRAf 3A FAM-GCTTCGTAGAGCGGAATCAC GTACCGCTGCAAAGGACAGT TCT 10 61 46 37 0.97 
STRAf 3B HEX-CAACTTGGTGTCAGCGAAGA GAGGTACCACAACACAGCACA AAG 8 73 20 14 0.84 
STRAf 3C TET-GGTTACATGGCTTGGAGCAT GTACACAAAGGGTGGGATGG TAG 5 51 23 32 0.86 
M4         
STRAf 4A FAM-TTGTTGGCCGCTTTTACTTC GACCCAGCGCCTATAAATCA TTCT 5 24 11 14 0.84 
STRAf 4B HEX-CGTAGTGACCTGAGCCTTCA GGAAGGCTGTACCGTCAATCT CTAT 5 26 10 11 0.80 
STRAf 4C TET-CATATTGGGAAACCCACTCG ACCAACCCATCCAATTCGTAA ATGT 5 45 8 15 0.77 
a All primer sequences are given in the 5’ to 3’ direction. 
b Number of repeats found in the reference population described in this study. 
c Number of repeats in the reference strain AF293, upon which the genome sequences available from the A. fumigatus Sequencing Group at 
The Sanger Institute are based. 
d The calculated D value according to Simpson’s index of diversity. 
 
Data analysis. The repeat numbers of the nine markers of all isolates were analyzed by 
using BioNumerics, version 3.5, software (Applied Maths, Kortrijk, Belgium) and the 
unweighted pair group method with arithmetic averages with the multistate categorical 
similarity coefficient. All markers were given an equal weight. In the resulting 
dendrogram, the indicated percentages reflect the number of corresponding markers. 
Accordingly, two strains with six of the nine corresponding markers are 66.7% identical.  
 
Discriminatory power. The discriminatory power of a typing method can be defined 
mathematically as the probability that two unrelated isolates chosen at random from a test 
population will be different by that typing method and can be calculated by using the 
Simpson index of diversity (D): 
1 D = 1– N (N-1)
S 
Σ
j=1 
nj (nj –1) 
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where N is the total number of isolates in the test population, s is the total number of types 
described, and nj is the number of isolates belonging to the jth type 6. A D value of 1.0 
indicates that the typing method is able to discriminate between all isolates. A D value of 
0.0 indicates that all isolates are identical. 
 
Results 
 
A selection of nine loci (three dinucleotide repeats, three trinucleotide repeats, and 
three tetranucleotide repeats) was made, and three multiplex PCRs (M2, M3, and M4) 
were developed and optimized. These three multiplex PCRs were used to analyze 100 A. 
fumigatus isolates from nonoutbreak situations. Typical amplification results are shown in 
figure 1.  
The PCR amplification products of the tetranucleotide repeats consisted mainly of 
a single peak. However, the amplification products of the tri- and dinucleotide repeats 
usually contained more peaks, as they were one to three repeat units shorter. However, the 
longest peak was usually the most intense peak; this one was used for analysis (Fig. 1). 
Under some conditions (especially with high DNA concentrations), an extra peak 1 bp 
shorter than the main peak was observed; this is another established PCR artifact (Fig. 1).  
In order to determine the exact repeat number of the repeats in all markers, a 
selected number of alleles throughout the entire range of alleles obtained were analyzed 
by DNA sequence analysis (Fig. 2). The repeat numbers of the remaining alleles (being at 
regularly spaced intervals) were determined by extrapolation, so that an exact repeat 
number could be specified for all nine loci. 
The collection of 100 isolates was analyzed by using the complete panel of nine 
STR markers. One isolate displayed multiple peaks for all nine markers, which was 
probably the result of the fact that the isolate was a mixture of two different A. fumigatus 
isolates. With the remaining 99 isolates, a total of 96 different marker combinations were 
obtained. Three pairs of apparently unrelated isolates yielded the same combination. For 
all nine loci and combinations thereof, a D value was calculated (Tables 1 and 2).  
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The highest discriminatory power value for a single locus was obtained with STRAf 3A, 
with a D value of 0.97. With this marker no less than 37 different alleles were found in 
this population. An overview of all alleles obtained is shown in Table 3. The combination 
of all nine markers yielded a D value of 0.9994. 
If the variation in length between the different alleles were the sole effect of 
variations in repeat number, then the sizes of all alleles would be expected to occur at 
regularly spaced intervals (i.e., a 2-bp interval for the dinucleotide repeats and 3- and 4-bp 
intervals for the tri- and tetranucleotide repeats, respectively). Incidentally, a peak was 
found at a position halfway to the next allele (i.e., in STRAf 4C between repeat numbers 7 
and 8). DNA sequence analysis of this allele demonstrated that the fragment contained a 
2-bp deletion. Analogous to the nomenclature for such alleles in the human situation, this 
allele was denominated 7.2 (the same size as 7 full repeats plus 2 bp). Other confirmed 
aberrations were named accordingly. 
To test the stability of each locus, a random A. fumigatus isolate was subcultured a 
minimum of 30 times. DNA was isolated from every fifth subculture, and all DNA 
samples were tested by using all nine markers. The exact same number of repeats 
compared to the number in the original sample was obtained for all nine markers, 
indicating that the repeats are sufficiently stable to allow epidemiological surveys (data 
not shown). 
 
Table 2: Diversity indices for all multiplex combinations 
Combination of 
markers No. of profiles
a D valueb 
M2 60 0.9879 
M3 86 0.9968 
M4 51 0.9784 
M2+M3 94 0.9988 
M2+M4 76 0.9928 
M3+M4 95 0.9992 
M2+M3+M4 96 0.9994 
a The total number of isolates is 99. 
b The calculated D value is based on Simpson’s index of diversity. 
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In order to test the specificities of all markers for A. fumigatus, DNA from the 
following 11 other Aspergillus species were tested with all nine markers: A. clavatus, A. 
chevalieri, A. flavus, A. glaucus, A. niger, A. nidulans, A. ochraceus, A. sodowii, A. 
terreus, A. ustus, and A. versicolor. No amplification products were obtained with any of 
these species, indicating that the markers have a high specificity for A. fumigatus. 
Interestingly, one nonpigmented A. fumigatus variant from our collection yielded an 
amplification product with a single marker only, leaving the possibility of discrimination 
between cryptic A. fumigatus species. 
 
Discussion 
 
At this time sequencing and assembly of the entire A. fumigatus genome 
approaches completion. This provided the opportunity to search through already available 
genomic sequences for potential new microsatellite loci in silico by using software 
available in the public domain. We applied a number of criteria to select or deselect 
candidate loci. Obviously, a repeat sequence can be regarded as a repeat sequence only if 
the repeat number is equal to or greater than 2. Since the chance that interstrain variation 
will be displayed increases with the repeat number, we started by selecting potentially 
suitable loci at the high end. Only loci with perfect repeat sequences were included in our 
analysis; imperfect repeats containing point mutations and/or insertion or deletions were 
excluded. Another criterion used for the exclusion of loci is the presence of a second 
repeat sequence. Certain loci with high repeat numbers were not considered due to the 
presence of an additional repeat sequence within the boundaries of potential PCR primer 
binding sites. Different combinations of two repeat sequences in a single PCR amplicon 
may lead to the formation of fragments of the same length. This makes it impossible to 
determine the exact repeat number for each of the two repeats and compromises the exact 
nature of the STR assay. The final exclusion criterion involved the absence of flanking 
sequences. Obviously, in these cases no PCR primer sequences can be designed. For this 
reason, a number of potentially interesting hexanucleotide repeat sequences had to be 
excluded.  
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Figure 1. Examples of amplification results. The principle peak used for analysis is indicated with a colored dot. Blue traces represent the 
FAM label, black traces represent the HEX label, and green traces represent the TET label. Typical results obtained with the dinucleotide 
repeats (A), trinucleotide repeats (B), and tetranucleotide repeats (C) are shown. (D) Typical example of amplification artifacts obtained with 
a dinucleotide repeat. The principle peak is indicated with an “n.” A second peak exactly 1 bp shorter is the result of incomplete A addition 
(hence, n - a). A stutter peak one repeat shorter is indicated with n - 1. Other artifact peaks are indicated accordingly. (E) Multiple stutter 
peaks with a trinucleotide repeat do not influence the ability to identify the principle peak in a sample. (F) A typical result obtained with a 
mixed sample. 
Figure 2. Determination of repeat numbers by DNA sequencing. Examples are shown for a dinucleotide repeat (A), trinucleotide repeat (B), 
and tetranucleotide repeat (C). 
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Once the entire genome sequence of A. fumigatus has been assembled, these loci also 
could prove to be interesting candidates for analysis. We finally selected three 
dinucleotide loci, three trinucleotide loci, and three tetranucleotide loci for further 
analysis. 
Analysis of 100 presumed unrelated A. fumigatus isolates yielded 96 different 
profiles; 3 profiles were found twice, and in one sample double bands were obtained for 
all nine markers. As mentioned above, all isolates were assumed to be unrelated because 
they were all collected from different patients either at different hospitals, from different 
wards, or at different points in time. However, our results may indicate that the three 
profiles found twice were actually from related isolates. Unfortunately, studies comparing 
different fingerprinting techniques for A. fumigatus show that, up to now, no single 
technique can be considered the “gold standard” 3, 8. Additional fingerprinting of these 
isolates by AFLP analysis 18 also showed that these three pairs of isolates were 
indistinguishable from each other (results not shown). Since the genome of Aspergillus is 
haploid, double bands are typically a result of having started with an impure culture (i.e., a 
mixture of two different A. fumigatus isolates). In this case, the ratio between the heights 
and/or areas of these peaks will reflect the ratio between the two different isolates. The 
one isolate containing double bands for all nine markers was recultivated on Sabouraud 
agar plates. At the first occurrence of microcolonies, these were individually expanded on 
new agar plates and analyzed by using all nine markers. In these samples, two different 
profiles were obtained, each of which contained single peaks for all nine markers and each 
peak of which represented either of the two original peaks (not shown). The ability to 
easily identify the presence of multiple genotypes in a sample provides STR analysis with 
a unique advantage over other PCR fingerprinting methods like RAPD or AFLP analysis, 
by which such events usually remain unrecognized.  
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Table 3: Overview of the alleles obtained and their frequency distribution in this reference population 
Allele Fragment size (bp) 
Repeat 
no. 
Frequency 
(%) Allele 
Fragment 
size (bp) 
Repeat 
no. 
Frequency 
(%) 
STRAf 2A 163.1  10a  9 200.7  30a   3
 164.9  11  1 203.5  31   5
 168.8  13  3 206.9  32   4
 170.8  14a  8 209.9  33   2
 176.6  17  1 212.3  34   6
 178.6  18  21 215.9  35   4
 180.5  19  4 218.7  36   3
 182.4  20  5 222.0  37   4
 184.3  21  6 225.2  38   2
 188.3  23  20 228.4  39   2
 190.2  24  3 230.7  40a   2
 192.2  25a  8 249.8  46a   1
 194.0  26  9 253.2  47   1
 198.1  28  1 255.5  48   2
   258.9  49   2
STRAf 2B 124.6    9  1 262.0  50a   2
 126.5  10a  1 284.1  57a   1
 130.3  12a  15 290.2  59   1
 134.2  14  2 296.4  61   1
 138.1  16a  13     
 140.2  17  1 STRAf 3B 158.0    8   1
 142.1  18  2 160.5    9   23
 144.0  19a  12 163.5  10   21
 146.0  20a  21 166.5  11   23
 147.8  21  7 169.3  12   7
 149.8  22  1 172.4  13   11
 151.6  23a  11 177.9  15   1
 153.7  24  2 183.6  17   4
 155.6  25  8 186.6  18   1
 161.4  28  1 198.0  22a   2
 163.6  29a  1 203.9  24   2
     226.9  32   1
STRAf 2C 154.8    8  23 232.0  34a   1
 156.5    9a  3 348.9  73   1
 158.7  10  12     
 160.5  11  13 STRAf 3C  77.5    5a   1
 162.8  12  4  80.1    6   3
 164.6  13a  2  82.9    7   33
 166.4  14a  3  86.2    8   1
 168.3  15  16  89.2    9a   1
 170.6  16a  7  92.2  10   6
 172.1  17  2  98.3  12   1
 174.5  18  2 101.2  13   3
 176.4  19a  6 104.6  14a   3
 184.3  23a  1 107.5  15   1
 189.9  26  1 110.9  16   1
 195.9  29a  2 114.0  17   2
 198.0  30  1 117.2  18   1
 203.9  33a  1 120.5  19a   1
     123.4  20   11
STRAf 3A 138.1  10  5 126.4  21   12
 141.3  11a  1 129.5  22   1
 147.3  13  1 135.7  24a   1
 150.5  14  1 138.9  25   2
 153.8  15  3 144.9  27   1
 156.5  16  2 157.4  31   1
 159.7  17  2 160.4  32   1
 163.3  18  2 163.7  33   1
 166.5  19a  1 166.9  34   1
 172.1  21  1 185.2  40a   1
 175.3  22a  2 190.8  42   1
 178.6  23  2 200.5  45   1
 182.2  24  1 203.5  46   1
 184.9  25  6 206.9  47a   1
 187.8  26a  6 212.5  49a   2
 191.3  27  7 215.8  50   1
 194.4  28  3 218.8  51   1
 197.3  29  5     
Continued on facing page 
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Table 3-Continued 
Allele Fragment size (bp) 
Repeat  
no. 
Frequency  
(%) Allele 
Fragment 
size (bp) 
Repeat  
no. 
Frequency  
(%) 
STRAf 4A 167.8    5a  2 196.0    12a  1
 176.2    7  9 236.9    22  1
 180.6    8  30 240.7    23  1
 185.0    9  10 249.5    25  1
 188.9  10a  21 252.9    26  9
 197.4  12  2    
 200.6  12.3a  5 STRAf 4C 164.0      5a  41
 201.4  13  9 168.0      6  4
 209.6  15a  3 172.5      7  4
 216.7  16.3  1 174.8      7.2a  1
 221.1  17.3  1 176.4      8  23
 226.3  19a  1 185.1    10  5
 233.8  21a  4 189.1    11  1
 246.3  24  1 193.3    12  2
   201.6    14a  2
STRAf 4B 166.7    5a  9 213.7    17a  2
 175.3    7  1 225.8    20  9
 179.4    8  7 246.8    25a  1
 183.0    9  27 266.9    30a   2
 187.6  10a  32 295.8    37  1
 191.6  11  10 328.1    45  1
a The repeat was sequenced to determine the exact number of repeats; the repeat numbers of the remaining alleles were determined by 
extrapolation. 
 
Unlike what might be expected from a fingerprinting technique that covers large 
parts of an organism’s genome, this novel assay based on nine STR markers is probably 
not suitable for determination of the geographical origins of isolates. Indeed, there were 
no obvious subclusters of isolates from any of the hospitals (Fig. 3).  This, however, must 
be substantiated by analyzing many more isolates of diverse geographical origins. 
STR analysis is prone to several PCR artifacts that may influence the results. One 
of them is slippage of the Taq polymerase during amplification, a process that leads to the 
formation of so-called stutter peaks. There is a clear inverse relation between the size of 
the repeat unit and the formation of stutter peaks. With shorter repeat units, higher 
proportions of stutter peaks are generated 12. This is also clearly observed in our results, 
where stutter peaks are most prominently seen with the dinucleotide repeats, fewer stutter 
peaks are seen with trinucleotide repeats, and stutter peaks are almost absent with the 
tetranucleotide repeats. The occurrence of too many stutter peaks may complicate 
identification of the principle peak in a sample. For this reason, mononucleotide repeats, 
which often yield as many as 10 to 15 stutter peaks, were not taken into consideration.  
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It has been suggested that addition of dimethyl sulfoxide to the amplification reactions or 
replacement of Taq DNA polymerase by other thermostable polymerases with higher 
processivities might reduce the formation of stutter peaks 12. Such adaptations were also 
evaluated, but none of them yielded improved results (data not shown).  
A basic understanding of potential PCR artifacts upon amplification and analysis 
of the STR sequences (as illustrated in Fig. 1D and E) is desired, but we conclude that the 
presence of stutter peaks will not influence the ability to identify the major peak in a 
sample when repeat units of three and above are used (i.e., at least trinucleotide repeats). 
This is a clear advantage over previously reported STR assays for A. fumigatus, where 
only dinucleotide repeats were analyzed 2. Another wellknown PCR artifact is the addition 
of an extra A residue to the 3’ end of the PCR product by Taq DNA polymerase (known 
as template-independent polymerase activity or extendase activity). This activity is most 
pronounced when the ultimate residue at the 3’ end of the PCR product is a pyrimidine; 
the presence of a purine leads to incomplete A-residue addition and to the formation of 
additional unwanted peaks. To promote maximal addition of this A residue, all reverse 
amplification primers were designed to begin with a purine. 
The number of different alleles found in our reference population with each of the 
nine markers is given in Table 1. This means that in theory no less than 27 × 109 different 
combinations can be discriminated with this panel of nine markers. This is an 
improvement of close to 106-fold over that obtained with the previously reported STR 
panel 2. If we assume that all intermittent alleles (not present in our reference population) 
also exist, this number increases to an overwhelming 3 × 1013 possible combinations. 
However, since there is no known sexual reproduction of A. fumigatus, all nine markers 
do not inherit independently from parent to daughter. It is therefore unlikely that all 
possible combinations indeed occur. As a natural consequence, certain (combinations of) 
alleles will occur more frequently than others, a phenomenon that was also observed in 
our reference population. Each combination of these nine markers should therefore be 
considered a single haplotype.  
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Figure 3. Dendrogram based on profiles of nine STRAf markers from 99 presumably unrelated A. fumigatus isolates. The dendrogram was 
created by using BioNumerics, version 3.5, software (Applied Maths) and the unweighted pair group method with arithmetic averages 
method with the multistate categorical similarity coefficient. See the text for further details. 
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The total number of different haplotypes can be determined only experimentally, but since 
we already found 96 different haplotypes in a collection of 99 presumably unrelated 
isolates, this indicates that this number must be quite large. 
This novel combination of nine STR markers for fingerprinting of A. fumigatus 
with the potential to resolve 3 × 1013 combinations of alleles may appear to be somewhat 
overdone. Since each of the three multiplex PCRs already has a very high discriminatory 
power, it may not always be necessary to analyze all nine markers in order to discriminate 
between certain isolates. One could consider starting with just the M3 combination (since 
this one has the highest discriminatory power, which is even higher than that of M2 and 
M4 combined) and to include M4 or M2 only when it is necessary. The additional value 
of including the third combination appears to be rather limited, but it could always serve 
as an additional backup.  
In order to make full use of the potential of STR analysis, high-resolution analysis 
of the fragments obtained is a prerequisite. Standard agarose gel electrophoresis 
equipment usually does not yield sufficient resolution to discriminate between fragments 
that differ by as little as 2 bp, but at best, it could just suffice for the analysis of tri- and 
tetranucleotide repeats. Use of agarose gels also means that each marker must be analyzed 
individually since the different loci in our multiplex analysis overlap each other.  
We chose to make multiplex combinations using a multicolor approach, since this allows 
testing for multiple loci in one run, which greatly improves throughput capabilities and 
allows rapid analysis of large numbers of markers. Since high-resolution equipment like 
capillary-based or acrylamide-based electrophoresis platforms are increasingly finding 
their way into the laboratories, this seems to be the most logical way to go. Use of high-
resolution equipment also allows even 1-bp insertions or deletions to be identified 
reliably. If this is not an option and one would still prefer to use agarose-based systems, it 
would make more sense to restrict STR analysis to repeat units of 10 and beyond. Such 
repeats have not been analyzed in this work. 
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In this chapter we describe a new, highly discriminatory PCR fingerprinting assay 
for A. fumigatus with a novel panel of nine STRs. The multicolor multiplex approach 
allows large numbers of markers to be tested in a short period of time. The exact nature of 
the assay combines high reproducibility with the easy exchange of results. 
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Abstract 
 
Two highly discriminatory fingerprinting assays, short tandem repeat typing and 
amplified fragment length polymorphism (AFLP), were compared to determine the 
genetic relatedness between 55 isolates of Aspergillus fumigatus obtained from 15 
different patients suffering from proven invasive aspergillosis. Both techniques showed 
that interpatient isolates belonged to different genotypes and that intrapatient isolates from 
deep sites were all of the same genotype. By contrast, multiple genotypes were found 
among isolates originating from respiratory samples. Both techniques have specific 
advantages and disadvantages. AFLP is more universally applicable, but short tandem 
repeat analysis offers better discriminatory power and should be the preferred method for 
standardizing typing of clinical isolates of Aspergillus fumigatus.
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Introduction 
 
Invasive aspergillosis (IA) is a life-threatening disease of patients who are 
immunocompromised by hematopoietic stem cell or solid organ transplantation, intensive 
chemotherapy, or treatment with corticosteroids 11. Aspergillus fumigatus is most 
frequently involved in causing this life-threatening disease. IA is a growing problem in 
hospitals because of the inexorable rise in the number of severely immunocompromised 
patients 12, 14. A better understanding of the epidemiology of this disease requires 
molecular techniques to investigate interstrain relatedness and strain dissemination 12.  
Fingerprinting methods with high discriminatory power have to be applied to 
discriminate between unrelated isolates because of the wide genetic variability of A. 
fumigatus, 5 and several typing techniques have been described previously. Pattern-based 
techniques, such as random amplified polymorphic DNA (RAPD) analysis 2, 13, restriction 
fragment length polymorphism (RFLP) analysis 12, 19, and amplified fragment length 
polymorphism (AFLP) 20, have been employed but suffer from poor interlaboratory 
reproducibility and subjective interpretation of the fingerprinting data. Typing methods 
based on short tandem repeats (STRs), such as microsatellite length polymorphism 3 and 
STRAf typing 7, yield unambiguous typing data, as do those based on sequence-based 
typing schemes, such as multilocus sequence typing. These methods may be preferable to 
other typing methods, provided that they possess sufficient discriminatory power, and 
may have the characteristics necessary for the standardization of A. fumigatus typing.  
STRAf typing is a recently described highly discriminatory and potentially 
reproducible fingerprinting assay for A. fumigatus 7, 8, but its utility in epidemiological 
surveys has not yet been established. In this study, we compared AFLP and STRAf typing 
to study the genetic relatedness between isolates of A. fumigatus from respiratory and 
tissue samples that had been obtained from 15 patients with proven IA 1. Previous studies 
have shown that the genotypes of isolates from intrapatient samples of deep sites were 
identical 12, so these samples could be considered internal controls.  
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We therefore set out to evaluate the advantages and disadvantages of both techniques in 
terms of their discriminatory power and applicability as well as technical aspects and 
computerized data processing. 
 
Materials and Methods 
 
Isolates. Fifty-five isolates of A. fumigatus were obtained from ante- and postmortem 
specimens of 15 patients with proven IA who had been nursed in the hematology ward of 
the Radboud University Nijmegen Medical Center in the period from 1992 to 1998 (Table 
1). Isolates were stored as spore suspensions in regular microbial freezing broth 
containing 12.5% (vol/vol) glycerol at -80°C. The isolates were revived by scraping off 
part of the sample, plating on Sabouraud’s agar, and cultivation at 30°C. Fungal isolates 
were identified at the time of collection and again after revival by their macroscopic or 
microscopic appearance and their ability to grow at 48°C. Every isolate displayed normal 
growth characteristics after revival. 
 
DNA isolation. Isolates were grown on Sabouraud’s agar plates at 30°C until sporulation 
occurred. Spores were first mechanically lysed using the following procedures. A 
prewetted cotton swab was saturated with conidia from the sporulating culture. These 
spores were then suspended in a vial of MagNA Lyser green beads containing 350 µl lysis 
buffer and 50 µl proteinase K (all from Roche Diagnostics, Almere, The Netherlands). 
Lysis was performed in a MagNA Lyser instrument (Roche Diagnostics) for 30 s at 6,500 
rpm. Next, the DNA was extracted and purified using a MagNA Pure LC instrument 
(Roche Diagnostics) in combination with MagNA Pure DNA isolation kit III according to 
the manufacturer’s instructions. DNA yield and purity were estimated by UV absorbance 
measurements. 
 
STRAf typing. Nine STR markers specific for A. fumigatus were analyzed using the 
STRAf primers and reaction conditions as previously described 7. Briefly, three multiplex 
PCRs each amplified three STR markers.  
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The obtained PCR products were separated by size and detected on a MegaBACE 500 
platform equipped with a 48-capillary array (GE Healthcare, Diegem, Belgium). The 
assignment of repeat numbers in each marker was performed using Fragment Profiler 1.2 
software (GE Healthcare). 
 
AFLP. Approximately 50 ng of genomic DNA was subjected to a combined restriction-
ligation procedure containing 50 pmol of HpyCH4 IV adapter, 50 pmol Mse I adapter, 2 
U of HpyCH4 IV (New England Biolabs, Beverly, MA), 2 U of Mse I (New England 
Biolabs), and 1 U of T4 DNAligase (Promega, Leiden, The Netherlands) in a total volume 
of 20 µl of 1 × reaction buffer for 1 h at 20°C. Next, the mixture was diluted five times 
with 10 mM Tris-HCl (pH 8.3) buffer. Adapters were made by mixing equimolar amounts 
of complementary oligonucleotides (5’-CTCGTAGACTGCGTACC-3’ and 5’-
CGGGTACGCAGTC-3’ for HpyCH4 IV; 5’-GACGATGAGTCCTGAC-3’ and 5’-
TAGTCAGGACTCAT-3’ for Mse I) and heating to 95°C, subsequently cooling slowly to 
ambient temperature. One microliter of the diluted restriction-ligation mixture was used 
for amplification in a volume of 25 µl under the following conditions: 1 µM HpyCH4 IV 
primer with one selective residue (underlined) (5’-Flu-GTAGACT GCGTACCCGTC-3’), 
1 µM MseI primer with four selective residues (underlined) (5’-
GATGAGTCCTGACTAATGAA-3’), 0.2 mM of each deoxynucleoside triphosphate, and 
1 U of Taq DNA polymerase (Roche Diagnostics) in 1× reaction buffer containing 1.5 
mM MgCl2. Amplification was done as follows. After an initial denaturation step for 4 
min at 94°C in the first 20 cycles, a touchdown procedure was applied: 15 s of 
denaturation at 94°C, 15 s of annealing at 66°C, with the temperature for each successive 
cycle lowered by 0.5°C, and 1 min of extension at 72°C. Cycling was then continued for a 
further 30 cycles with an annealing temperature of 56°C. After completion of the cycles, 
an incubation at 72°C for 10 min was performed before the reaction mixtures were cooled 
to room temperature. The amplicons were then combined with the ET400-R size standard 
(GE Healthcare) and analyzed on a MegaBACE 500 automated DNA platform (GE 
Healthcare) according to the manufacturer’s instructions. 
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Data analysis. All data were analyzed with the BioNumerics 4.5 unweighted-pair group 
method using average linkage clustering (Applied Maths, Sint-Martens- Latem, Belgium), 
employing the multistate categorical similarity coefficient for STR data and the Pearson 
correlation coefficient for DNA fragments between 60 and 250 bases for AFLP analysis. 
 
Results 
 
All AFLP fingerprints obtained with Mse I and HpyCH4 IV contained multiple 
bands in the range of 50 to 250 bp (Fig. 1), and strong and weak bands were visible. When 
all samples were compared to each other, the fingerprints consisted of some 30 invariable 
bands present in all samples and around 20 variable bands which were present only in 
certain samples. Based on the variable bands, the different fingerprints can be 
distinguished from each other. In total, 20 visually recognizable different patterns were 
obtained. The calculated similarity for visually identical patterns ranges from 97 to 99%. 
The calculated similarity for patterns with visually recognizable differences ranges from 
89 to 99%. Originally, the collection consisted of 56 isolates. However, one isolate 
yielded a fingerprint without resemblance to any of the other isolates. The reidentification 
of this isolate by internal transcribed spacer sequencing showed that this particular isolate 
proved to be Neosartorya fischeri (results not shown). This isolate was excluded from 
further analysis.  
Using STRAf typing, all A. fumigatus isolates yielded a numerical typing result 
(Fig. 1). A total of 20 different genotypes were obtained with this technique. The N. 
fischeri isolate did not yield PCR products with the STRAf assay. 
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Table 1: Origin of A. fumigatus isolates from patients with IA 
Patient Origin 
Date of 
isolation 
(day-mo-yr) 
AFLP 
type 
STRAf 
type 
Sample 
 
      
A Bronchial secretion 22-07-1992 1 1 A1 
 Tissue 25-07-1992 1 1 A2 
      
B Bronchial secretion 26-08-1992 2 2 B1 
 Bronchial secretion 28-08-1992 2 2 B2 
 Pleural abscess 31-08-1992 2 2 B3 
      
C Bronchial secretion 15-01-1993 3 3 C1 
 Lung biopsy sample 19-01-1993 3 3 C2 
 BAL fluid 19-01-1993 3 3 C3 
      
D Left lung  28-12-1993 4 4 D1 
 Right kidney  28-12-1993 4 4 D2 
 Left kidney  28-12-1993 4 4 D3 
      
E Feces 01-06-1994 5 5 E1 
 Pharynx swab 06-06-1994 5 5 E2 
 Feces 09-06-1994 5 5 E3 
 Pharynx swab 13-06-1994 5 5 E4 
 Sputum 20-06-1994 5 5 E5 
 Lung 13-07-1994 5 5 E6 
      
F Pharynx swab 04-08-1994 6 6 F1 
 Right lung  18-08-1994 6 6 F2 
 Left kidney  18-08-1994 6 6 F3 
 Left lung  18-08-1994 6 6 F4 
      
G BAL fluid 28-10-1994 7 7 G1 
 Lung 04-11-1994 8 8 G2 
      
H Sputum 18-04-1995 9 9 H1 
 Left lung 02-05-1995 10 10 H2 
      
I Pus 29-08-1995 11 11 I1 
 Feces 31-08-1995 11 11 I2 
 Pharynx swab 04-09-1995 11 11 I3 
 Feces 14-09-1995 11 11 I4 
      
J BAL fluid 16-10-1995 12 12 J1 
 Right lung 25-10-1995 12 12 J2 
 Left lung  25-10-1995 12 12 J3 
      
K Feces 29-03-1996 13 13 K1 
 Left lung  01-04-1996 13 13 K2 
 Right kidney  01-04-1996 13 13 K3 
 Heart 01-04-1996 13 13 K4 
 Left kidney  01-04-1996 13 13 K5 
 Right lung  01-04-1996 13 13 K6 
 Spleen 01-04-1996 13 13 K7 
 Liver 01-04-1996 13 13 K8 
      
L Bronchial secretion 02-01-1997 14 14 L1 
 Bronchial secretion 03-01-1997 14 14 L2 
 Bronchial secretion 09-01-1997 14 14 L3 
 Right lung 13-01-1997 14 14 L4 
      
M Lung biopsy sample 26-03-1997 15 15 M1 
 BAL fluid 26-03-1997 16 16 M2 
 BAL fluid 26-03-1997 17 17 M3 
 Lung biopsy sample 26-03-1997 18 15 M4 
      
N Pharynx swab 11-12-1997 13 18 N1 
 Left lung  17-12-1997 13 18 N2 
 Spleen 17-12-1997 13 18 N3 
 Liver 17-12-1997 13 18 N4 
      
O BAL fluid 19-01-1998 19 19 O1 
 BAL fluid 19-01-1998 20 20 O2 
 Left lung  23-01-1998 19 19 O3 
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In general, there is an excellent agreement between the two typing methods, with 
only two tissue isolates (M1 and M4) of patient M that were differentiated by AFLP but 
not by STRAf typing, which yielded the same genotype. AFLP yielded the same genotype 
for all isolates of patients K and N, but these could be clearly distinguished from each 
other using STRAf typing. When all intrapatient isolates were compared to each other, 
samples of nonrespiratory origin belonged to the same genotype. By contrast, multiple 
genotypes were detected in isolates originating from respiratory samples, such as sputum 
and bronchoalveolar lavage (BAL) fluid samples, from the same patient. For instance, all 
eight isolates from the lung, kidney, heart, spleen, and liver of patient K shared the same 
STRAf genotype. An identical unique genotype was found in isolates from BAL fluid and 
lung samples obtained from patient O, whereas another BAL fluid sample yielded a 
different genotype. A similar observation was made for patients G, H, and M, as 
interpatient isolates belonged to different genotypes as determined by STRAf typing. 
 
Discussion 
 
We compared two high-resolution PCR fingerprinting assays for analyzing the 
epidemiological relationships between multiple A. fumigatus isolates from patients with 
proven IA. Both AFLP analysis and STRAf analysis provided high-resolution data 
allowing discrimination between clinical isolates from different patients and between 
different genotypes in multiple samples from a patient. In general, interpatient isolates 
belonged to different genotypes whereas intrapatient isolates were of the same genotype. 
Cross-infections of respiratory origin or common-source infections were highly unlikely 
since the patients were nursed at different times in the ward.  
The use of molecular epidemiological tools such as RAPD, multilocus enzyme 
electrophoresis, and sequence-specific DNA primer analyses 10 has led to suggestions that 
A. fumigatus isolates from several IA patients nursed in the same ward may originate from 
a single environmental source.  
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However, these techniques lack discriminatory power and are not considered by us 
to be sufficiently reproducible to employ for this study. Rather, our results confirm the 
results reported by Girardin et al. 12 and Denning et al. 9, who investigated the genetic 
diversity of patients with IA by using RFLP and REA analyses, respectively. Our results 
are consistent with a scenario in which the respiratory tract may be colonized by several 
different genotypes, as inhalation of fungal conidia is assumed to be the primary means of 
acquiring IA 11, but a single genotype gains supremacy and invades the surrounding tissue, 
subsequently disseminating to the lung tissue or other organs. Thus, an isolate obtained 
from respiratory samples may not necessarily represent the same genotype as that found in 
deep sites, as appeared to be the case for patients G, H, M, and O. This also confirms that 
individuals may well be constantly exposed to a large variety of different Aspergillus 
genotypes from the environment 5, 15.  
Both AFLP and the STRAf assay are seen as high-resolution and robust molecular 
fingerprinting assays for A. fumigatus isolates 7, 8, 20. As shown here, both techniques are 
suitable for unraveling the genetic relationship between clinical A. fumigatus isolates, with 
good correlation between the results of the two assays. Yet, compared to each other, both 
assays have their advantages and disadvantages. A clear advantage of the STRAf assay 
over AFLP is its ability to identify mixtures of strains. Mixed genotypes are recognized 
instantaneously by the presence of multiple peaks in each of the nine markers analyzed 7. 
Mixed AFLP genotypes are extremely difficult, if not impossible, to detect. Thus, when 
employing AFLP analysis for epidemiological analysis, it is important that pure cultures 
be obtained and analyzed. Assuming that individuals are, in fact, likely to be colonized by 
more than one genotype, it is important to subculture and analyze each colony separately 
when several are obtained from a respiratory sample in order to prevent false conclusions 
from being drawn 4, 6.  
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DNA fragments are amplified in AFLP from random locations throughout the 
entire genome and, although in a single AFLP experiment only a very small fraction of the 
entire genome is analyzed (<0.1%), the amount analyzed by the STRAf assay is even 
smaller. In addition, unlike the AFLP assay, the STRAf approach is highly biased toward 
nine arbitrarily selected loci, so any genomic change outside these loci will remain 
undetected, as was the case for isolates M1 and M4. The AFLP technique is basically 
applicable to any organism’s genome without the need for prior sequence information.  
However, depending on the genome size and GC content, there may be a need for 
optimizing the choice of restriction enzymes and selective residues. By contrast, the 
STRAf assay is specific for A. fumigatus and requires specific sequence information for 
the detection of STR loci and flanking sequences to be used as primer binding sites. 
However, both techniques do permit improperly identified isolates to be recognized. The 
nonvariable bands that are obtained with A. fumigatus isolates may represent species-
specific markers. Upon analysis of isolates from species other than A. fumigatus, most of 
these invariable bands will not show up and a banding pattern will be obtained that is 
usually less than 30% similar to the fingerprint of A. fumigatus isolates (as was the case 
for the N. fischeri isolate). Likewise, using the STRAf approach, improperly identified 
isolates can be recognized by the absence of typical amplification products, provided that 
technical issues that may lead to PCR failure can be ruled out.  
In order to compare the different AFLP fingerprints to each other and to determine 
the genetic relatedness between multiple isolates, one has to rely on specialized computer 
software. AFLP fingerprints are usually analyzed using a pattern-based algorithm. 
However, repeat analyses may show small differences in the AFLP fingerprint due to 
small variations occurring during restriction/ligation, PCR amplification, and fragment 
analysis that may affect the final peak intensity. For the same reasons, the long-term 
reproducibility and interlaboratory comparisons of AFLP fingerprints may be quite 
challenging. Thus, identical samples are seldom identical using a patternbased approach, 
although they may appear to be so by visual examination. In the pattern-based 
dendrogram shown in figure 1, visually identical fingerprints were calculated to be 97 to 
99% similar (i.e., all samples of patient K). 
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However, in the same analysis, samples with visually recognizable differences were also 
calculated to be up to 99% similar (i.e., samples D1 and L4) (Fig. 1). Consequently, a gray 
zone was obtained during interpretation of the results of a pattern-based approach in 
which the wrong conclusions may be drawn when relying solely on the computer-based 
dendrogram. This requires a visual inspection of the fingerprints to be included in the final 
interpretation. Similar limitations apply to computer-based analysis of other pattern-based 
fingerprinting methods, such as RAPD and RFLP analyses. By contrast, due to the more 
exact nature of STRAf typing, intralaboratory reproducibility is virtually 100% and the 
typing result is unambiguous.  
Due to the large number of available restriction enzymes, an almost indefinite 
number of restriction enzyme combinations can be used to generate an AFLP fingerprint. 
The success of a particular combination is dictated primarily by the size and composition 
(i.e., GC content and the presence of multicopy elements) of the genome to be 
investigated. The number of fragments to be obtained can be modulated by changing the 
number of selective residues. In previous studies, other restrictionenzyme combinations 
such as EcoR I and Mse I 16, 20 and EcoR I and Bfa I 17 have been used to generate AFLP 
fingerprints for Aspergillus spp. To rule out the possibility that the results of this study 
may have been influenced by the specific use of the combination of HpyCH4 IV and Mse 
I, all isolates were also tested with the combination of EcoR I and Mse I. Although 
obviously completely different fingerprints were obtained, the same interstrain relatedness 
was observed (data not shown).  
A problem with any typing method is the subjective interpretation of a “genotype.” 
The assignment of a genotype is user dependent using AFLP, whereas the genotype 
resulting from STRAf typing is unambiguous. Nonetheless, two different but highly 
similar fingerprints could originate from two closely related isolates. Unfortunately, at 
present there are no established guidelines for defining a genotype for these methods 
(such as the criteria of Tenover et al. for the interpretation of pulsed-field gel 
electrophoresis fingerprints 18).  
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However, since there is an excellent correlation between the groupings of genotypes by 
using AFLP and STRAf typing, we believe that the differences between the fingerprints of 
the isolates in this study, although minor, are substantial enough to validate our 
assignment of genotypes. For instance, isolates E3 and M3 differed by only one band in 
the AFLP fingerprint but by five markers in the STRAf assay. This means that even a 
single band difference between two AFLP fingerprints could be interpreted as constituting 
different genotypes. Likewise, with the STRAf assay, any two different genotypes differ 
by a minimum of three markers. For instance, isolates from patients B and F differed by 
one repeat in marker 2B, nine repeats in marker 3A, and one repeat in marker 3C. In the 
AFLP fingerprint, there were at least two visually recognizable differences between these 
isolates. At present, it is unclear whether fewer than three differences in an STRAf 
genotype should also be interpreted as different genotypes, so more closely related 
isolates need to be analyzed.  
In conclusion, both AFLP and STRAf typing are excellent techniques for analyzing 
the interstrain relatedness of A. fumigatus isolates. Each of the two techniques has its 
specific advantages and disadvantages. Therefore, the choice should be based primarily on 
the specific goal for analyzing collections of isolates. STRAf typing offers the most 
benefits for the standardization of typing A. fumigatus isolates. 
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Abstract 
 
Retrotransposon(-like) sequences in Aspergillus fumigatus have been used as typing 
targets through restriction fragment length polymorphism (RFLP)/Southern blotting 
approaches. Differences in fingerprints between unrelated isolates are the result of 
variations in copy-number and differences in the regions flanking the retrotransposon 
elements. Here, we present retrotransposon insertion-site context (RISC) typing as a novel 
and convenient PCR-based typing alternative to the RFLP approach. RISC typing aims at 
amplifying the sequences flanking the retrotransposonlike sequences in A. fumigatus and 
allows large numbers of isolates to be analyzed in a timely fashion with excellent 
discriminatory power. 
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Introduction 
 
Aspergillus fumigatus is a common inhabitant of damp environments such as soil, 
decaying vegetation and organic debris. It releases high numbers of conidia into the air. 
Inhalation of these conidia by immunocompromised hosts can lead to respiratory diseases 
such as allergic bronchopulmonary aspergillosis, aspergilloma and invasive aspergillosis 
(IA). The systemic form of the latter disease often has fatal consequences. The incidence 
of IA has grown dramatically in recent years due to the increase in number of patients 
undergoing bone marrow or solid organ transplantation.  
Molecular biological typing methods can be used to obtain a better understanding 
of the uniqueness of each clinical isolate and its dissemination route. Various techniques 
for genotyping A. fumigatus isolates have been reported such as random amplified 
polymorphic DNA (RAPD) analysis 1, restriction fragment length polymorphism (RFLP) 
analysis followed by Southern blot hybridization 2, 5, 6, amplified fragment length 
polymorphism (AFLP) analysis 4, 12 and short tandem repeats (STR) 3. RFLP analysis has 
been shown to be an excellent typing method for A. fumigatus isolates 2, 5, 6.  
When performing RFLP analysis, genomic DNA is digested with a restriction 
enzyme and the obtained fragments are separated according to size using agarose gel 
electrophoresis and subsequently transferred to a membrane. After that, a specific DNA 
probe is used to detect certain multicopy elements. In the case of A. fumigatus, this probe 
is part of a degenerate retrotransposon-like element (Afut1) from the gypsy family 7. 
Analysis of the hybridization patterns is performed by eye or specialized software. It has 
been shown that the use of retrotransposons as typing target for A. fumigatus, yields very 
stable fingerprints 6. Differences in patterns between unrelated isolates can be expected 
because of differences in copy-number and/or flanking sequences of the target regions.  
Unfortunately, compared to PCR-based assays, RFLP analysis is a time-consuming 
and laborious method and requires relatively large amounts of high molecular weight 
genomic DNA. 
 
 
A. fumigatus RISC typing 
 81
Table 1: Overview of A. fumigatus isolates used in this study 
Patient Origin 
Date of 
isolation 
(day-mo-yr) 
Sample 
 
    
A Bronchial secretion 22-07-1992 A1 
 Tissue 25-07-1992 A2 
    
B Bronchial secretion 26-08-1992 B1 
 Bronchial secretion 28-08-1992 B2 
 Pleural abscess 31-08-1992 B3 
    
C Bronchial secretion 15-01-1993 C1 
 Lung biopsy sample 19-01-1993 C2 
 BAL fluid 19-01-1993 C3 
    
D Left lung  28-12-1993 D1 
 Right kidney  28-12-1993 D2 
 Left kidney  28-12-1993 D3 
    
E Feces 01-06-1994 E1 
 Pharynx swab 06-06-1994 E2 
 Feces 09-06-1994 E3 
 Pharynx swab 13-06-1994 E4 
 Sputum 20-06-1994 E5 
 Lung 13-07-1994 E6 
    
F Pharynx swab 04-08-1994 F1 
 Right lung  18-08-1994 F2 
 Left kidney  18-08-1994 F3 
 Left lung  18-08-1994 F4 
    
G BAL fluid 28-10-1994 G1 
 Lung 04-11-1994 G2 
    
H Sputum 18-04-1995 H1 
 Left lung 02-05-1995 H2 
    
I Pus 29-08-1995 I1 
 Feces 31-08-1995 I2 
 Pharynx swab 04-09-1995 I3 
 Feces 14-09-1995 I4 
    
J BAL fluid 16-10-1995 J1 
 Right lung 25-10-1995 J2 
 Left lung  25-10-1995 J3 
    
K Feces 29-03-1996 K1 
 Left lung  01-04-1996 K2 
 Right kidney  01-04-1996 K3 
 Heart 01-04-1996 K4 
 Left kidney  01-04-1996 K5 
 Right lung  01-04-1996 K6 
 Spleen 01-04-1996 K7 
 Liver 01-04-1996 K8 
    
L Bronchial secretion 02-01-1997 L1 
 Bronchial secretion 03-01-1997 L2 
 Bronchial secretion 09-01-1997 L3 
 Right lung 13-01-1997 L4 
    
M Lung biopsy sample 26-03-1997 M1 
 BAL fluid 26-03-1997 M2 
 BAL fluid 26-03-1997 M3 
 Lung biopsy sample 26-03-1997 M4 
    
N Pharynx swab 11-12-1997 N1 
 Left lung  17-12-1997 N2 
 Spleen 17-12-1997 N3 
 Liver 17-12-1997 N4 
    
O BAL fluid 19-01-1998 O1 
 BAL fluid 19-01-1998 O2 
 Left lung  23-01-1998 O3 
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In this study, retrotransposon insertion-site context (RISC) typing is described as a 
convenient PCR-based alternative for the RFLP procedure. RISC typing aims at 
amplifying the flanking sequences of the retrotransposon elements by using an outward 
oriented, fluorescently labeled internal primer targeting the 5′ long terminal repeat (LTR) 
of the Afut 1 element. A second primer binding site is provided by ligation of an adapter 
to cohesive ends generated by restriction enzyme digestion. Thus, RISC typing is a hemi-
nested ligation dependent PCR amplification assay. Fluorescent amplification products are 
analyzed using a high-resolution electrophoresis platform. Like in RFLP analysis, 
differences in target copy-number and/or flanking sequences will result in different DNA 
fingerprints. 
 
Materials and methods 
 
Isolates. A collection of 55 clinical A. fumigatus isolates was used. These isolates were 
collected ante- and postmortem over a period of 6 years from 15 patients with established 
invasive aspergillosis (IA) at the Academic Medical Center Nijmegen St. Radboud 
(Nijmegen, the Netherlands) (Table 1). The genetic relatedness of these isolates was 
previously established by AFLP and STRAf typing as described elsewhere4 and in chapter 
3. 
 
DNA isolation. Isolates were grown on Sabouraud agar plates at 30°C until sporulation. A 
prewetted cotton swab, saturated with conidia from a sporulating culture, was resuspended 
in a vial of MagNA Lyser Green Beads containing 350 μl Lysis buffer and 50 μl of 
proteinase K (Roche Diagnostics, Almere, the Netherlands). Next, the suspension was 
subjected to mechanical lysis in a MagNA Lyser instrument (Roche Diagnostics) for 30 s 
at 6500 rpm. Afterwards, DNA was further extracted and purified using a MagNA Pure 
LC instrument (Roche Diagnostics) in combination with the MagNA Pure DNA isolation 
kit III according to the instructions supplied by the manufacturer. 
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Adapter ligation. Following isolation of the DNA, a combined restriction–ligation 
procedure was used in which approximately 50 ng of genomic DNAwas incubated with 
50 pmol of either Bfa I, Mse I or Msp I adapter, 2 U of the corresponding restriction 
enzyme (New England Biolabs, Beverly,MA, USA), and 1 U of  T4 DNA Ligase 
(Promega, Leiden, The Netherlands) in a total volume of 20 μl of 1 × reaction buffer for 1 
h at ambient temperature, after which the mixture was diluted five times with 10 mM 
Tris–HCl pH 8.3. (Sigma, Zwijndrecht, the Netherlands). Adapters were made by mixing 
equimolar amounts of complementary oligonucleotides (a and b, Table 2) followed by 
heating the mixture to 95°C, with subsequent slow cooling to ambient temperature. 
Adapters were designed to interrupt the restriction site upon ligation. 
 
Table 2. Overview of oligonucleotides used in this study 
Adapter primers   
Mse I (a) 5’-GACGATGAGTCCTGAC-3’ 
 (b) 5’-TAGTCAGGACTCAT-3’ 
Msp I (a) 5’-GACGATGAGTCCTGAG-3’ 
 (b) 5’-CGCTCAGGACTCAT-3’ 
Bfa I (a) same as Msp I (a) 
 (b) 5’-TACTCAGGACTCAT-3’ 
Amplification primers   
Mse I 5’-GATGAGTCCTGACTAA-3’ 
Msp I 5’-GATGAGTCCTGAGCGG-3’ 
Bfa I 5’-GATGAGTCCTGAGTAG-3’ 
RISC5 5’-Flu-GCTTAYRTTRTTCYRAGCATGTGA-3’ 
 
Amplification. One microliter of the diluted restriction–ligation mixture was used for 
amplification in a volume of 25 μl using the following conditions: 1 μM of 5′ fluorescein 
labeled internal primer, 1 μM adapter primer (unlabeled), 0.2 mM each deoxynucleoside 
triphosphate, 1 × reaction buffer containing MgCl2 and 1 U of Taq DNA polymerase 
(Roche Diagnostics).  The following amplification protocol was performed in a T1 
thermocycler (Biometra, Göttingen, Germany): denaturation at 95°C for 4 min, followed 
by 40 cycles of 15 s denaturation at 95°C, 30 s annealing at 52°C and 1 min extension at 
72°C, continued with a 10 minute incubation at 72°C before the reactions were cooled to 
room temperature. All temperature transitions were performed at maximum heating and 
cooling settings (5°C/s). 
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Fragment analysis. The PCR fragments were combined with the ET550-R size standard 
(GE Healthcare, Diegem, Belgium) and analyzed on a MegaBACE 500 automated DNA 
analysis platform (GE Healthcare) equipped with a 48 capillary array, according to the 
recommendations of the manufacturer. 
 
Data analysis. Obtained data was analyzed with BioNumerics version 4.6 software 
(Applied Maths, Sint-Martens-Latem, Belgium) and the unweighted pair group method 
using arithmetic averages clustering and the Pearson correlation coefficient and is 
expressed as percent similarity. DNA fragments smaller than 60 bp or larger than 300 bp 
were excluded from the analysis. 
 
Results 
 
Principle and design of the assay.  Individual A. fumigatus isolates may contain up to 25 
copies of the Afut1 element 6. Each retrotransposon element is characterized by the 
presence of two LTR's encompassing 3 coding regions. A BLAST analysis was performed 
using the 5′-LTR sequence from clone 4.11 7 to search for other LTR copies in the 
preliminary genome sequences of A. fumigatus (Af293) 9. Since the 5′- and 3′-LTR of 
each retrotransposon element share some 90% nucleotide identity 7, this BLAST search 
will likely retrieve both LTR's. In total, more than 50 hits were obtained. The sequences 
of the 50 best hits including 40 bp of flanking sequences were aligned using ClustalX 11. 
The result is shown in figure 1. The flanking sequences of 19 hits are highly conserved at 
the 5′ end, indicating that these hits correspond to the 3′-LTR of the retrotransposon 
elements. In 23 hits, the flanking sequences of the LTR's are conserved at the 3′ end, 
indicating that these correspond to the 5′-LTR elements. In the remaining 8 hits, the 
flanking sequences were not conserved at either side. Conserved sequence differences 
between the 5′- and 3′-LTR were used to formulate an internal primer specifically 
recognizing the 5′-LTR and aimed at amplifying the 5′ flanking sequences of each 
retrotransposon element (Table 2). 
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Figure 2. Influence of an increasing annealing temperature on RISC typing. Since one of the amplification primers contains multiple 
degenerate positions, at the higher annealing temperature of 62 °C, only the primers with the most G+C bases will participate. At the lower 
annealing temperature of 50°C, all targets are allowed to participate. At the right, the applied temperature gradient is indicated. 
 
 
Assay optimization. At first, the choice for an appropriate annealing temperature was 
evaluated. Since considerable sequence variation exists in the individual copies of the 5′-
LTR's, the internal primer contained a number of degenerate positions to allow a perfect 
match with almost all of the individual copies of the LTR elements. The effect of the 
annealing temperature was determined experimentally. At a relatively low annealing 
temperature of 50°C, some 25 bands appeared. Upon increasing the annealing temperature 
up to 62°C, the number of bands gradually decreased to 10 (Fig. 2). From preliminary 
results with more isolates, 52°C was arbitrarily chosen as the annealing temperature for 
further experiments (results not shown). Secondly, the optimal restriction enzyme was 
determined. The average fragment size that will be obtained with this approach will 
depend on the prevalence of restriction enzyme recognition sites in the flanking regions 
surrounding the retrotransposon elements. Three restriction enzymes were evaluated, Mse 
I, Msp I and Bfa I since these enzymes have either an AT-rich (TTAA), GC-rich (CCGG) 
or AT/GC balanced (CTAG) recognition site, respectively. With the use of Mse I, 
multiple fragments were obtained of which the majority ranged in size from 50–150 bp 
(not shown).With Msp I, few fragments were obtained and these were all in the upper 
region of the size marker or beyond (> 500 bp, not shown). Since on average some 20 
fragments were found in the range of 60–300 bp using Bfa I, this enzyme was chosen for 
further experiments.  
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Results with clinical isolates. A collection of 55 A. fumigatus isolates from 15 patients 
with invasive aspergillosis was analyzed using RISC typing. All isolates were obtained 
from either respiratory samples or infected organs. On average, some 20 bands were 
obtained within the analyzed range of 60–300 bp (Fig. 3). When multiple isolates from 
different organs within a patient were analyzed, the obtained fingerprints were virtually 
identical to each other and visually clearly different from fingerprints derived from other 
patients' isolates or when they were compared to respiratory isolates. Even though the 
fingerprints contain both multiple strong as well as weak bands, all bands could be 
reproducibly amplified. 
 
Discussion 
 
We report RISC typing as a convenient PCR-based alternative technique for 
RFLP/Southern blot analysis. In the design of this assay, the following aspects were taken 
into consideration: first, the internal primer should be specific for either the 5′-LTR or 3′-
LTR and should be oriented outward. If not adhered to this prerequisite, a situation may 
arise in which primarily internal fragments are amplified that may only yield a poor 
discriminatory power. Second, for a similar reason, the internal primer should be located 
close to the termini of the retrotransposon element. Third, restriction enzymes with a 4-
base recognition sequence were used to generate relatively short DNA fragments (100–
500 bp) that are easily amplified by PCR. This is in marked contrast to the RFLP 
procedure where 6-base recognition sequences are used, generating large DNA fragments 
(1000–10,000 bp). Fourth, by using a fluorescently labeled internal primer, amplification 
products are easily detected on a high-resolution DNA analysis platform such as a 
capillary DNA sequencer. 
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DNA sequence alignment of the 50 highest scoring LTR sequences obtained using 
BLAST analysis and including 40 bp of flanking sequences, identified 23 5′-LTR 
elements and 19 3′-LTR elements. At the 5′ end of the 5′-LTR's, at least several bases are 
present that allow design of an internal primer specifically targeting most of the 5′-LTR's. 
Therefore, in the design of this assay, the 5′-LTR was chosen as the target for the internal 
primer. Interestingly, an additional 8 LTR's were detected with no conserved flanking 
sequences on either 5′ or 3′ side. These LTR's carry both 5′ and 3′ signature bases and 
hence are probably derived from recombination events between the 5′- and 3′-LTR's from 
an individual copy of the retrotransposon element. Since these LTR elements are no 
longer associated with a retrotransposon like element, we refer to them as orphan LTR's.  
Unfortunately, there is considerable sequence variation in the LTR regions. The 
internal primer was designed to match the 5′-LTR consensus sequence and contained a 
number of degenerate positions to cover most of the variations in this region. This 
perfectly explains the results that are illustrated in figure 2 where a temperature gradient 
was applied during the annealing phase of the PCR. As expected, at a relatively high 
annealing temperature, less DNA fragments were amplified than at a relatively low 
annealing temperature. This can be explained by assuming that at the higher annealing 
temperature, primarily the part of the primers containing the most G+C bases will be able 
to anneal to their target whereas at the lower annealing temperature also the primers with 
the A+T bases will participate. Interestingly, the intensity of some bands increases with 
increasing temperature. We believe this to be a competition effect as the result of 
relatively more resources being available for fewer bands to be amplified. Based on these 
results, 52°C was arbitrarily chosen as annealing temperature for all subsequent 
experiments.  
With the aim of generating relatively short PCR amplifiable DNA fragments, 3 
restriction enzymes with a 4-base recognition sequence were evaluated. A selection of 
enzymes was made with recognition sequences that are either GC rich (Msp I), GC neutral 
(Bfa I) or AT rich (Mse I). The genome of A. fumigatus is reported to have a GC-content 
of 49.9% 9.  
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Theoretically, because of this perfectly balanced composition, all three restriction 
enzymes have an equal chance of cutting anywhere in the genomic DNA (i.e. on average 
once in every 256 bp). The average length of the DNA fragments to be obtained using 
RISC typing was therefore expected to be around 256 bp. However, the use of Mse I 
resulted in many short DNA fragments (< 100 bp) whereas the use of Msp I resulted in 
relatively few large DNA fragments (> 300 bp). The use of Bfa I yielded both short and 
medium to long DNA fragments and this enzyme was chosen for further analyses. 
Because of these unexpected results, we analyzed the AT-content of the flanking region of 
the retrotransposon elements. The average AT-content of 200 bp of flanking region 
proved to be 70%, much higher than the average AT-content of the entire genome. This 
explains our observations when using different restriction enzymes. This also illustrates 
that the Afut1 element has a preference for inserting into AT-rich sequences. The 
underlying mechanism responsible for this preference is yet unknown.  
Upon employing RISC typing to study the genetic relationships between clinical A. 
fumigatus isolates, a clear picture emerges. Isolates from deep sites within individual 
patients were of the same genotype whereas isolates from respiratory samples often were 
of a different genotype. Identical genotypes were not found in isolates from different 
patients. Only few exceptions to these findings were observed. These results are in 
excellent agreement with other highly discriminatory molecular fingerprinting assays such 
as AFLP and/or STRAf typing 4 but small differences were observed. For instance: all 
isolates from patients K and N yielded identical fingerprints using AFLP analysis. Using 
STRAf typing, all isolates from patient K were clearly different from the isolates from 
patient N. RISC typing also yielded clearly different fingerprints for the isolates from 
these patients. Vice versa, isolates M1and M4were identical using both RISC- and STRAf 
typing but yielded a different fingerprint using AFLP analysis 4. Different AFLP types can 
be distinguished based on the differential presence or absence of only a single band 
between the corresponding AFLP fingerprints. Using RISC typing, discrimination 
between interpatient isolates is based on multiple different bands in the fingerprint. Thus, 
RISC typing appears to be more discriminatory than AFLP analysis.  
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Differences between the results of these fingerprinting techniques are not entirely 
unexpected since each of the three methods targets different parts of the fungal genome. 
Small changes may occur at certain locations in the genome that may show up using either 
of these methods, but may remain unnoticed using others.  
RISC typing employs a generic principle that can be adapted to other micro-
organisms as well. The basic requirement is the presence of a multicopy element that is 
distributed throughout the genome (rather than being clustered in a particular region). 
Retroelements have also been described in other Aspergillus species such as A. flavus 10 
and A. nidulans 8. These all qualify as targets for a similar approach as described here.  
In conclusion, RISC analysis provides a more rapid and user-friendly PCR 
alternative for the classical RFLP analysis and may be a welcome addition to existing 
molecular fingerprinting methods for studying the genetic relationships between A. 
fumigatus isolates. 
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Abstract 
 
Microsatellites, or short tandem repeats (STR's), are popular tools to discriminate between 
microbial isolates. In this chapter, we report on the robustness of a microsatellite panel for 
discrimination of Aspergillus fumigatus isolates. Two major PCR artefacts (stutter peaks 
and minus-A peaks) can complicate correct interpretation of STR data. We investigated 
the effect of alterations to the various components of the PCR amplification mixtures on 
these PCR artefacts and on the reproducibility of this assay. Some extreme conditions led 
to a loss of signal, but, under all conditions where a signal was obtained, identical typing 
results were produced. Furthermore, pitfalls with the exchange of results between labs are 
discussed. These pitfalls are primarily associated with sizing of the obtained PCR 
fragments. 
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Introduction 
 
Microsatellites, or short tandem repeats (STR's) are short repeated stretches of 
DNA, up to ten basepairs long, which are abundantly present in the genome of most 
higher organisms and which are sufficiently polymorph to serve as effective genetic 
markers 8. STR's are also increasingly being used for the purpose of strain identification 
and discrimination in a wide variety of microorganisms 1, 2, 7, 9. Among the main 
advantages of microsatellites as typing targets are their high discriminatory power, high 
throughput and the portability and exchange of typing data. An STR analysis is usually 
performed in two steps: i amplification of STR loci by PCR and ii detection and sizing of 
amplification products followed by the assignment of repeat numbers. The first step is 
routinely being done in a standard PCR thermocycler. Because of the required resolution, 
the second step is usually performed either by capillary electrophoresis or by 
polyacrylamide based slab gel electrophoresis, both in combination with fluorescent 
detection capabilities. Assignment of repeat numbers is established by comparing the 
relative electrophoretic mobility of the fragments to the mobility of reference fragments 
with established repeat numbers.  
Previously, we developed a panel of 9 STR markers for discrimination between 
Aspergillus fumigatus isolates 2. These 9 markers are divided over 3 multicolor multiplex 
PCR reactions aimed at amplifying 3 dinucleotide repeat markers (further referred to as 
the STRAf2 assay), 3 trinucleotide repeat markers (STRAf3) and 3 tetranucleotide repeat 
markers (STRAf4). The ability to study multiple STR markers in parallel with multicolor 
fluorescence detection technologies has greatly improved the amount of information that 
can be collected in a timely fashion. Results obtained so far on a collection of close to 
1000 A. fumigatus isolates with this panel of 9 markers displayed excellent discriminatory 
power and showed 100% typeability (unpublished results). Therefore, these panels could 
be excellent candidates for standardization of A. fumigatus typing using STR's. However, 
a typical problem associated with multiplex PCR reactions is the reproducibility of the 
assay in different settings. Thorough evaluation and validation of new multiplex PCR 
assays is essential in order to be successfully transferred to other labs.  
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In this chapter, we report on the robustness of the STRAf assay under different 
amplification conditions. We deliberately and systematically altered various components 
of the PCR reaction and thermocycling parameters to investigate their effect on the 
outcome of this assay. Furthermore, some pitfalls associated with interpretation of the data 
and the exchanges of results between laboratories are discussed. These pitfalls are 
primarily associated with sizing of the DNA fragments that can be obtained under 
different electrophoretic conditions or on different electrophoretic platforms.  
 
Materials and methods 
 
Standard PCR protocol. PCR primers for the STRAf2, − 3 and − 4 assay were exactly as 
described before 2 and in chapter 2. In each multiplex reaction, different fluorescent labels 
(FAM, HEX and TET, respectively) were used for the 3 markers in each panel in order to 
distinguish the different amplification products from each other. PCR reactions were 
performed in a final volume of 25 μl containing 1 ng of genomic DNA, 1 μM of all 
amplification primers, 0.2 mM of each dNTP, 3 mM MgCl2 (1.5 mM for the STRAf2 
panel), 1 U of FastStart Taq DNA polymerase (Roche diagnostics, Almere, The 
Netherlands) in 1 × reaction buffer (Roche diagnostics). Thermocycling was performed in 
a T1 thermocycler (Biometra, Göttingen, Germany) using the following protocol: 10 min 
of initial denaturation at 95°C, followed by 30 cycles of 30 s of denaturation at 95°C, 30 s 
of annealing at 60°C, and 1 min of extension at 72°C. Before the reaction mixtures were 
cooled to room temperature, an additional incubation for 10 min at 72°C was performed. 
All temperature transitions were performed with maximum heating and cooling settings 
(5°C/s). Alternative to the use of FastStart Taq DNA polymerase, regular Taq DNA 
polymerase (Roche diagnostics) or KOD DNA polymerase (Omnilabo, Breda, The 
Netherlands) was used. Changes to the experimental conditions were made as described in 
the text. 
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Separation and detection of amplification products. PCR reactions were diluted 30-
fold with distilled water. One μl of diluted PCR products were combined with 8.75 μl of 
distilled water and 0.25 μl of ET-ROX 400 marker (GE Healthcare, Diegem, Belgium). 
Following denaturation of the samples for 1 min at 95°C and rapid cooling to 4°C, they 
were injected onto a MegaBACE 500 equipped with a 48 capillary array. Injection and 
running parameters were according to the recommendations of the manufacturer (GE 
Healthcare). Alternatively, the ILS600 size marker (Promega, Leiden, The 
Netherlands) was used.  
 
Results 
 
Standard protocol. Using the standard amplification protocol, all three multiplex PCR 
reactions yielded three clearly identifiable peaks of different colors, representative for 
each of the 3 fluorescently labeled markers. In the STRAf2 reaction, a significant portion 
of the amplification products consisted of stutter peaks and of minus-A peaks 2. These, 
however, did not influence the ability to identify the principal peak in each sample. Stutter 
peaks as well as minus-A peaks were less abundant in the STRAf3 reaction and were 
virtually absent in the STRAf4 reaction. 
 
Magnesiumchloride. Concentrations from 1 to 4 mM were tested. For all magnesium 
chloride concentrations good interpretable peaks were found for all three multiplex PCR 
reactions (Table 1). The STRAf3 and −4 reactions were surprisingly insensitive to altered 
MgCl2 concentrations although at the relative low concentration of 1 mM, minus-A peaks 
appeared in the STRAf4 reaction. Increasing the MgCl2 concentration led to a reduction of 
the fraction of minus-A peaks in the STRAf2 reaction.  
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Table 1. Results of altered reaction conditions on the intensity of the principal peak (plus-A peak) in a sample 
and of the relative intensity of the principal peaks compared to the artefactual minus-A peaks 
 
   STRAf 2  STRAf 3  STRAf 4 
   principal 
peaka 
ratiob  principal 
peaka 
ratiob  principal 
peaka 
ratiob 
           
Primer concentration (µM) 1.0  ++ +/-  +++ ++  +++ ++ 
 0.5  ++ +/-  +++ ++  +++ ++ 
 0.2  + +  +++ ++  +++ ++ 
 0.1  +/- ++  ++ ++  +++ ++ 
           
FastStart Taq DNA polymerase (units) 1  ++ +/-  +++ ++  +++ ++ 
 0.5  +/- -  ++ ++  ++ + 
 0.2  - N.A.  - N.A.  - N.A. 
 0.1  - N.A.  - N.A.  - N.A. 
           
Taq DNA polymerase (units) 1  + --  + ++  + - 
 0.5  + --  + ++  + - 
 0.2  +/- --  - N.A.  +/- - 
 0.1  - N.A.  - N.A.  - N.A. 
           
Genomic DNA (ng) 100  ++ --  +++ +  +++ + 
 30  ++ --  +++ ++  +++ ++ 
 10  ++ --  +++ ++  +++ ++ 
 3  ++ -  +++ ++  +++ ++ 
 1  ++ +/-  +++ ++  +++ ++ 
 0.3  ++ +  ++ ++  + ++ 
 0.1  + ++  + ++  - N.A. 
           
Magnesium chloride (mM) 4  ++ ++  +++ ++  +++ ++ 
 3  ++ ++  +++ ++  +++ ++ 
 2  ++ +  ++ ++  ++ ++ 
 1.5  ++ +/-  ++ ++  ++ ++ 
 1  ++ -  ++ ++  ++ + 
           
 
N.A.: not applicable. 
a: Intensity of the principal peaks in a sample: +++ very strong signal; ++ strong signal; + good signal; +/- poor signal; - no signal. 
b: Difference in intensity between the principal peaks (plus-A peaks) and the minus-A peaks in a sample: ++ plus-A >> minus-A; + plus-A > 
minus-A; +/- plus-A = minus-A; - minus-A > plus-A; --minus-A >> plus-A. 
 
DNA concentration. The amount of input DNA for each of the 3 assays was varied from 
0.1 to 100 ng per reaction (Table 1). A concentration of 1 ng of genomic DNA per 
reaction was used with the standard protocol. Lower concentrations led to a reduction of 
the fraction of minus-A peaks, but also resulted in a lower signal. Increasing the 
concentration did not yield higher signals but did result in increased formation of minus-A 
peaks, especially in the STRAf2 reaction. At the highest concentrations, the peaks mainly 
consisted of minus-A peaks, the plus-A peaks were almost completely eliminated (Fig. 
1A). Again, the STRAf3 and −4 reactions were relatively insensitive to changes in the 
genomic DNA concentration. 
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Primer concentration. Equimolar primer concentrations of 0.1–1 μM each were tested 
(Table 1). The STRAf4 reaction remained virtually unaffected even by lowering the 
primer concentration 10-fold. However, for the STRAf2 and −3 reactions, the intensity of 
the peaks was reduced at lower primer concentrations. The ratio between the 3 markers 
remained stable at all tested concentrations. An a-specific product, sometimes observed in 
the STRAf3 assay, disappeared by lowering the primer concentration. Lowering the 
primer concentration also led to a reduction of the fraction of minus-A peaks in the 
STRAf2 reaction. 
 
DNA polymerase. At present it is common practice to use so-called ‘hot-start’ procedures 
to minimize the formation of primer-dimers and other unwanted artefacts in PCR 
reactions. Especially in multiplex PCR reactions this may prove to be a problem. We 
tested the STRAf panels using FastStart Taq DNA polymerase (a hot-start formulation) 
and regular Taq DNA polymerase. Both enzymes were tested in concentrations ranging 
from 0.1–1 U per reaction (Table 1). For regular Taq DNA Polymerase an initial 
denaturation step of 4 min was performed instead of the 10 min used with FastStart Taq 
DNA polymerase. With both enzymes, the intensity of the peaks dropped to undetectable 
levels when 0.2 units or less was used. FastStart Taq DNA polymerase yielded more 
intense signals than regular Taq DNA polymerase. Reducing the enzyme concentration 
also led to increased formation of minus-A peaks. Both enzymes have intrinsic template 
independent polymerase activity responsible for the addition of the unencoded A residue 
to the newly synthesized strand. Changing the enzyme to a proofreading formulation 
lacking this activity completely eliminated the formation of plus-A peaks. Hence, the sizes 
of all principle and stutter peaks in the samples were effectively reduced by 1 bp (Fig. 
1B). 
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Annealing temperature. The annealing temperature was varied from 55°C to 65°C. In 
the STRAf3 reaction an atypical peak containing the FAM label was sometimes observed. 
Increasing the annealing temperature up to 65°C reduced the intensity of this peak but 
hardly affected the intensity of the true STRAf peaks. Changing the annealing temperature 
also did not affect the balance between the markers (results not shown). 
 
Ramping. Several modern thermocyclers allow fast ramping between the different steps 
of the PCR process (up to 5 °C/s) whereas the older generation cyclers usually are 
restricted to ramping speeds of 1 °C/s. Changing ramping speeds could adversely affect 
the performance of a PCR reaction. With the STRAf panels, however, no effect was seen 
when the ramping speed was reduced from 5 °C to 1 °C/s (results not shown). 
 
Size marker. Two different size markers were compared for sizing of the fragments; the 
routinely used ET-ROX 400 and the ILS600 marker. The calculated sizes for the alleles in 
the STRAf3 panel using the different size markers differed by a minimum of 2.9 bp and up 
to 5.0 bp from each other (Fig. 2) for each of the 3 markers in the STRAf3 panel. 
 
 
 
 
Figure 1 A: Illustration of the typical effect of the DNA concentration on the formation of minus-A peaks in a dinucleotide marker. Elevated 
DNA concentrations lead to increased formation of minus-A peaks (167.8 bp) and to a reduced intensity of the principal plus-A peaks (168.9 
bp), potentially resulting in misassignment of the principal peak in a sample (indicated with a dot). Note that changes in the DNA 
concentration do not affect the formation of stutter peaks. B: Use of a proofreading enzyme (such as KOD DNA polymerase) results in the 
exclusive formation of minus-A peaks as shown for a trinucleotide marker. 
 
 
Chapter 5 
 102 
Discussion 
  
In order for any typing technique to be successfully used in another setting, the 
most important factor is reproducibility. Ideally, small pipetting errors and other minor 
changes to the reaction conditions should have no influence on the outcome of the assay. 
With this in mind, the robustness of the STRAf assay was investigated by deliberately and 
systematically changing various reaction components to suboptimal conditions and by 
varying thermocycling  parameters. This way we mimicked unintentional altered reaction 
conditions. Certain extreme conditions, such as reducing the concentration of the DNA 
polymerase 5-fold or more, led to a loss of signal, but under all of the altered conditions 
that were investigated where a signal was obtained, identical typing results were 
produced. Thus, the STRAf assay proved to be an extremely robust assay. Some of the 
changes that we made to the protocol could be considered as standard parameters that 
need to be optimized upon developing a new assay. However, examples where the 
robustness of a high resolution microbial typing assay is so convincingly demonstrated are 
only scarce. In fact, it is well known that certain other PCR typing assays (such as RAPD) 
need to be performed using highly standardized reaction conditions in order to obtain 
stable and reproducible typing results. Based on our results, one could even predict how 
reaction conditions should be modified when suboptimal results are obtained upon 
development of a new STR panel. In the light of these results, we expect that introduction 
of this assay in another setting will not yield significant problems even when a major 
alteration (such as the use of a different enzyme or thermocycler — two factors that could 
drastically affect reaction performance) is being made to the protocol.  
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Figure 2 Difference in the calculated size (in bp) of the alleles in the STRAf3 panel as the result of the use of different size markers. The use 
of a different size marker may result in misassignment of repeat numbers by more than 1 repeat unit. Note that the size difference is not 
constant, but varies with repeat number. FAM, HEX and TET are the correspondingly labeled markers. 
 
Apart from a high potential of generating reproducible PCR results, the other 
aspect that has to be taken into consideration is the interpretation of the electropherogram 
that will be obtained. Basically, interpretation of STR data can become complicated by 
two major PCR artefacts, i.e. minus-A peaks and stutter peaks. Minus-A peaks are the 
result of incomplete addition of an adenine to the 3′ end of the newly synthesized strand 
by Taq DNA polymerase. These minus-A peaks usually arise when too much DNA is 
used as input in the PCR reaction, when insufficient DNA polymerase activity is present 
(for instance as the result of suboptimal MgCl2 concentrations), or when the last residue of 
the synthesized strand is not a pyrimidine (this should preferably be a cytosine). If one is 
unaware of these artefacts, excessive formation of minus-A peaks under suboptimal 
reaction conditions could result in the assignment of the wrong peak in an STR analysis 
and thus lead to a wrong typing result. As demonstrated here, the presence of minus-A 
peaks in certain markers is strongly influenced by the specific circumstances under which 
the markers are being amplified. However, as shown, the fraction of minus-A peaks can 
easily be minimized by adjusting the appropriate reaction conditions as can be deduced 
from Table 1. Alternatively, one could opt for elimination of the plus-A peaks by 
routinely using a DNA polymerase with proofreading activity. This, however, is usually 
associated with higher costs. The second artefact, formation of stutter peaks, is the result 
of strand slippage during synthesis of the complimentary strand by the DNA polymerase.  
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The intensity of stutter peaks in the amplification products is inversely related to the size 
of the repeat unit as well as to the repeat number. Hence they occur more frequently in the 
dinucleotide repeats (STRAf2) than in the tri- and tetranucleotide repeats (STRAf3 and 
−4). Likewise, their abundance is greater in repeat numbers of >20 than in fragments with 
repeat numbers of <10. The formation of stutter peaks remained virtually unaffected by 
the variations in reaction conditions that were tested here (not shown); hence they are 
notoriously difficult to get rid of. Although it appears that stutter peaks are only associated 
with negative aspects, in certain instances, stutter peaks also can be considered as a 
blessing in disguise. Incidentally, a-specific PCR fragments are amplified (i.e. when using 
a too low annealing temperature) as the result of a single primer product or as the result of 
mispriming if both primers are at amplifiable distance and orientation. If these fragments 
contain the fluorescent labeled primer, they may show up in the final electropherogram. 
However, since such a-specific fragments lack the short tandem repeat sequence, they 
consequently lack the characteristic associated stutter peaks.  
If one is aware of the above complicating factors while interpreting STR 
electropherograms, usually it should be no problem to identify the principal peak in each 
marker. The next step in the process is assignment of the repeat number to this principal 
peak. This is routinely established by sizing of the DNA fragment and comparing it to the 
size of reference fragments with established repeat numbers. The major pitfall here is that 
DNA sizing data alone is not suitable for exchanging results between labs. It is often not 
realized that sizing DNA fragments by capillary electrophoresis only yields relative data. 
The calculated values could be multiple basepairs above or below the real value. Shortly 
after the introduction of capillary electrophoresis in DNA analyses, it has been well 
established that the electrophoretic mobility of a DNA fragment is not only influenced by 
the number of bases but also by other factors such as the exact base composition and 
sequence, the separation matrix, presence of denaturing compounds, temperature and 
fluorescent labels 5, 6. As shown here, even on the same platform and under the same 
electrophoretic conditions, different fragment sizes are obtained when different size 
markers are being used.  
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Thus, different fragments could be mistaken as identical and identical fragments could 
mistakenly be called different when results obtained on different electrophoresis 
platforms, or obtained on the same platform but using different conditions, are compared 
to each other. Therefore, sizing data alone should not be used to compare results between 
labs. In order to be able to exchange STR data between labs, it is of utmost importance 
that a careful calibration of the different available electrophoresis platforms is performed. 
Such a calibration would consist of the establishment of reference sizing values for a 
number of well characterized alleles. We reasoned that the most straightforward method 
to achieve such a calibration would be the use of a series of allelic ladders. An allelic 
ladder is a mixture of the alleles that can be expected when testing isolates. Since the 
DNA fragments in the allelic ladders are identical to the DNA fragments that will be 
obtained upon testing isolates and since they carry the same fluorescent label, their 
electrophoretic mobility will also be exactly the same, provided they are analyzed using 
the same electrophoretic conditions. The major advantage of the use of allelic ladders is 
that there is no need to use identical electrophoretic conditions between labs: each lab is 
free to use their own routine running conditions as long as these conditions suffice to 
resolve the peaks in the allelic ladders. Such allelic ladders have been introduced as 
reference tools in human forensic applications in the early 1990's 3, 4 but, to the best of our 
knowledge, have not yet been described for calibration of microbial microsatellite based 
typing schemes. Experiments aimed at providing the ‘proof of concept’ for these allelic 
ladders are currently in progress in an international interlaboratory typing study for A. 
fumigatus using the STRAf. 
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Abstract 
 
An interlaboratory study was performed aimed at investigating the reproducibility of a 
multiplex microbial microsatellite based typing assay in different settings using a variety 
of experimental and analytical conditions and with teams having variable prior 
microsatellite typing experience. In order to circumvent problems with exchange of sizing 
data, allelic ladders are introduced as a straightforward and universally applicable concept 
for standardization of such typing assays. Allelic ladders consist of mixtures of well-
characterized reference fragments to act as reference points for the position in an 
electrophoretic trace of fragments with established repeat numbers. Five laboratories 
independently analyzed 6 microsatellite markers in 18 samples that were provided either 
as DNA or as A. fumigatus conidia. Allelic data were reported as repeat numbers and as 
sizes in nucleotides. Without the use of allelic ladders, size differences up to 6.7 
nucleotides were observed resulting in interpretation errors up to 2 repeat units. 
Difficulties in interpretation were related to non-specific amplification products (which 
were resolved with explanation) and bleed-through of the different fluorescent labels. In 
contrast, standardization of sizing data by using allelic ladders enabled all participants to 
produce identical typing data. The use of allelic ladders as a routine part of molecular 
typing using microsatellite markers provides robust results suitable for interlaboratory 
comparisons and for deposition in a global typing database. 
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Introduction  
 
 Aspergillus fumigatus is the fungal species most frequently involved in human 
infections in some immunocompromized patient populations such as allogeneic stem cell 
transplant recipients. To gain more insight into the genetic and epidemiological 
relationships between isolates obtained from various origins, several molecular typing 
techniques have been developed 12, 15. Ideally, typing results should be accurate, 
reproducible and easy to interpret. Importantly, methods should be transferable to other 
settings, so that individual results can be compared to each other irrespective of laboratory 
variables such as the use of different equipment, reagents and software. Unfortunately, 
many typing methods such as random amplified polymorphic DNA (RAPD) 1, restriction 
fragment length polymorphism (RFLP) 8 and amplified fragment length polymorphism 
(AFLP) 6, yield fingerprint profiles that consist of a complex banding pattern which are 
difficult to reproduce in different settings. Only a few fingerprinting methods have been 
developed for A. fumigatus that yield exact typing data that can be unambiguously and 
easily interpreted. One such format is multi-locus sequence typing (MLST) that offers 
only limited discriminatory power to distinguish between different A. fumigatus isolates 2. 
Another exact and high-resolution typing format is based on microsatellite markers. Two 
such microsatellite based fingerprinting assays for A. fumigatus have been reported by 
Bart-Delabesse et al., and de Valk et al. 3, 5. Microsatellites, or short tandem repeats 
(STR’s), provide high resolution analysis that is consistent with RFLP 4 and AFLP 
analyses 6. The two methods primarily differ in the nature and number of markers that are 
analyzed. Amplification of microsatellite loci under high stringency conditions leads to 
reproducible amplifications that are hardly affected by minor experimental variables. 
Sizing of PCR fragments is done automatically using high-resolution electrophoresis 
platforms and such data can easily be converted into the corresponding number of repeats 
by comparison to reference fragments with established repeat numbers. Because of their 
compact and numerical output, STR typing is a very attractive system for exchanging 
results between laboratories in a digital format and to establish global typing databases.  
 
 
Allelic ladders for standardizing A. fumigatus typing 
 111
However, the interlaboratory reproducibility and transferability of microbial STR typing 
systems have not yet been demonstrated. The complicating factor, which has been well 
documented, is that the electrophoretic mobility (and thus the calculated size) of a DNA 
fragment in capillary electrophoresis platforms is influenced by multiple factors. These 
include the exact base composition and sequence of the DNA, the separation matrix, 
presence of denaturing compounds, temperature and fluorescent labels 13, 14. Additionally, 
even the size standard and the DNA polymerase that is used for amplification may affect 
the calculated size of an allele 7. Thus, sizing values alone are not suitable for exchange 
unless a careful calibration of the different platforms has been established 7, 9. Such a 
calibration could consist of the generation of calibration curves as recently demonstrated 
by Pasqualotto et al. 9. Alternatively, a more straightforward and universally applicable 
method to achieve such a calibration is through the use of allelic ladders 10, 11. An allelic 
ladder consists of a well-defined mixture of pre-amplified alleles with predetermined 
repeat numbers (by DNA sequencing), and can be used to create reference positions for 
the interpretation of typing results. Here, we report the results of an international 
multicenter study that provides the proof of concept for use of locus-specific allelic 
ladders in microsatellite-based microbial typing schemes. 
 
Material and Methods 
 
STR typing protocol. The STR markers used in this study is a subset of the panel 
described by de Valk et al. 5, and involves the M3 multiplex (containing the STRAf3A, -
3B, -3C trinucleotide repeat markers) and M4 multiplex (containing the STRAf4A, -4B 
and -4C tetranucleotide repeat markers). In each multiplex reaction different fluorescent 
labels were used to discriminate between the individual markers. For economical reasons, 
the combination of FAM (carboxyfluorescein), HEX (hexachlorocarboxyfluorescein) and 
TET (tetrachlorocarboxyfluorescein) was chosen. 
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Construction of allelic ladders. Allelic ladders were constructed for each of the three 
trinucleotide markers in the STRAf 3 panel (STRAf 3A, -3B and -3C, respectively). 
Briefly, selected alleles were amplified in monoplex PCR reactions. The resulting 
fragments were cloned into the PGEM-T Easy Vector system (Promega, Leiden, The 
Netherlands). DNA from recombinant clones was isolated using High Pure chemistry 
(Roche diagnostics, Almere, the Netherlands) and quantified by UV measurements. 
Verification of the repeat number in each construct was performed by direct sequence 
analysis of the plasmid DNA preparations as described before 5. A mixture of plasmid 
DNA preparations was made containing inserts with established repeat numbers. The 
mixture of plasmids was then amplified using monoplex PCR reactions and analyzed by 
capillary electrophoresis. Finally, the concentration of certain alleles was adjusted to 
allow unambiguous identification of each reference allele. Since PCR amplification of 
short tandem repeats leads to the formation of so called stutter peaks (e.g. additional 
fragments mostly containing fewer repeat numbers 5, 7), it was not necessary to actually 
include all alleles in the amplification mixture. The missing alleles were generated 
automatically during the amplification process. As a result, although the sample used for 
amplication contained only 22 selected alleles, after amplification of this plasmid mixture 
the STRAf 3A allelic ladder contains 68 alleles with repeat numbers ranging from 9 to 76. 
Likewise, the STRAf 3B allelic ladder contains alleles with repeat numbers from 7 to 39 
and the STRAf 3C allelic ladder from 5 to 53 as shown in figures 1A, 1B and 1C, 
respectively. An example of the use of these allelic ladders is illustrated with marker 
STRAf 3A in figure 2. 
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A  
B  
C  
Figure 1. Illustration of the allelic ladders for the trinucleotide repeat markers. The numbers above the peaks correspond to the repeat 
numbers of each allele in these ladders. Boldface alleles in a larger font were actually included in the samples; the other alleles are the result 
of the formation of stutter peaks upon PCR amplification of the included alleles. A, B and C: the STRAf 3A, -3B and -3C allelic ladder, 
respectively. 
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Study design and protocol. Five laboratories (denoted A-E throughout this manuscript) 
participated in the study. Each laboratory received 12 purified DNA samples (A1-A12), 
multiplex primermixes M3 and M4 (amplifying the 3 trinucleotide markers in the STRAf3 
panel and the 3 tetranucleotide markers in the STRAf4 panel, respectively) 5, a size 
standard (ET400-R from GE Healthcare, Diegem, Belgium), allelic ladders for the STRAf 
3 loci (including a graphical display of their appearance), and amplification instructions 
for the preparation of reaction mixes. Laboratories also received 6 A. fumigatus isolates 
(B1-B6, as conidia), that were included in order to examine the potential influence of the 
DNA quality on the outcome of the assay. Four out of these 6 isolates were also provided 
as DNA samples and should have yielded identical typing results. All participating 
laboratories had access (either in-house or through an external party) to a capillary 
electrophoresis platform with multicolor detection ability. Each participating laboratory 
was free to choose their DNA isolation procedure for samples B1-B6, preference of 
enzyme to be used for amplification (as long as it did not involve a proofreading 
formulation), and choice of thermocycler, size standard and capillary electrophoresis 
platform (including running conditions). Reference values for all samples were obtained 
independently in a blinded fashion by one of the participating laboratories. 
 
 
 
 
 
 
 Figure 2. Application of allelic ladders for calibrating 
short tandem repeat based typing data between different 
laboratories. The example shown is for the STRAf 3A 
marker. Sample 1 yields a principal peak of size X. Size X 
corresponds to an allele with 27 repeats as can be deduced 
from the pre-amplified allelic ladder which is added to 
another capillary with the same size standard as used with 
regular samples. Sample 2 yields a principal peak of size Y 
which corresponds to 31 repeats. Although sizes X and Y 
can be very precisely reproduced within a laboratory 
(usually within 0.2 nt), they can be very different in 
another laboratory on another platform and/or using 
different electrophoretic conditions. 
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Data collection and analysis. Several data sets were reported by the participating 
laboratories. First, the sizes of the peaks in the allelic ladders were determined with a free 
choice of size standard. These values were to be used as reference values for the 
interpretation of the results of the STRAf 3 markers. In order to examine the influence of 
various size standards, the sizes of peaks in the allelic ladders were also determined using 
the ET400-R size standard. The results for the markers in the STRAf3 panel for all 18 
samples were reported as repeat numbers. Second, the repeat numbers of the markers in 
the STRAf 4 panel were determined for all 18 samples using the ET400-R marker in 
combination with reference size values taken from the original publication 5. For those 
alleles which did not exactly fit the reference positions in the allelic ladders or reference 
values from the literature, but which differed by one, two or three nucleotides, the 
notation n.1, n.2 or n.3 was used indicating the allele corresponded to a size of n repeats + 
1, 2 or 3 nucleotides, respectively 5. 
 
Results  
 
 The wide variety of experimental variables and equipment utilized by the 
participating laboratories is shown in Table 1. All the participating laboratories used a 
different capillary electrophoresis platform. In addition, 3 distinct thermocyclers, at least 3 
distinct DNA isolation procedures and 4 different commercially available size standards 
were used.  
First, the effect of the choice of the internal size standard on the calculated sizes of 
the alleles in the STRAf3 ladders was determined. Differences in sizing data for alleles in 
the allelic ladders are shown in figure 3. The sizes of the alleles in the allelic ladders were 
calculated using two size standards: the size standard that was routinely used in each 
participating laboratory (see Table 1) and the ET400-R size standard as supplied to all 
laboratories. The results show that identical alleles, analyzed on different electrophoretic 
platforms with different size standards may differ up to 6.7 nucleotides. Switching to the 
use of identical size standards still yielded size differences up to 5.4 nucleotides on the 
various platforms (results not shown). 
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 Table 1. Overview of experimental variables from the participating laboratories. 
 A B C D E 
Prior STR 
experience plenty plenty plenty some none 
DNA 
isolation 
procedure 
MagNA Lyser + 
MagNA Pure 
(Roche diagnostics) 
MagNA Lyser 
(Roche diagnostics) 
+ Qiagen 
(Qiagen) 
Phenol/Chloroform 
+ Qiagen 
(Qiagen) 
FastDNA 
(Bio 101® systems) 
+ DNeasy 
(Qiagen) 
Phenol/Chloroform 
+ Chromaspin 
(Clontech) 
Enzyme FastStart Taq (Roche diagnostics) 
FastStart Taq 
(Roche diagnostics) 
FastStart Taq 
(Roche diagnostics) 
FastStart Taq 
(Roche diagnostics) 
FastStart Taq 
(Roche diagnostics) 
Thermocycler T1 (BioMetra) 
GeneAmp 9700 
(Applied Biosystem) 
GeneAmp 9700 
(Applied 
Biosystems) 
iCycler 
(BioRAD) 
GeneAmp 9700 
(Applied Biosystem) 
Capillary 
platform 
MegaBACE 500 
(GE Healthcare) 
ABI Prism 3100 
(Applied 
Biosystems) 
ABI Prism 310 
(Applied 
Biosystems) 
ABI Prism 3130 
(Applied 
Biosystems) 
ABI Prism 3700 
(Applied 
Biosystems) 
Location In-house In-house In-house External External 
Size standard ET400-R (GE Healthcare) 
400 HD Rox 
(Applied 
Biosystems) 
GeneScan 500-
TAMRA (Applied 
Biosystems) 
GeneScan 500 LIZ 
(Applied 
Biosystems) 
ET400-R 
(GE Healthcare) 
 
 The results for the determination of the repeat numbers in the trinucleotide markers 
in all 18 samples by the 5 participating laboratories are shown in Table 2. Assignment of 
alleles in the STRAf 3 panel for all samples was done by comparing the sizes of the 
fragments in the samples to the sizes of the fragments in the allelic ladders using the 
laboratory’s routine size standard (as exemplified in figure 2). Two laboratories (A and B) 
yielded 100% identical results for all markers in all samples. Laboratory C made 1 
interpretation error: sample B2 yielded a ‘9.2’ allele where the expected result was a ‘10’ 
allele. Examination of the corresponding electropherogram showed that this was the result 
of a reduced electrophoretic resolution. Under the experimental conditions as used, the 
platform (ABI Prism 310) was unable to adequately resolve minus-A peaks from plus-A 
peaks. This was apparent from the broad and round appearance of the peaks. Laboratory D 
made 3 interpretation errors. A ‘31’ allele in STRAf 3A was reported as a ‘10.1’ allele, a 
‘15’ allele in STRAf 3B was reported as a ‘10’ allele and a ‘25’ allele in STRAf 3C was 
reported as a ‘7’ allele. Since all errors occurred in a single sample (A10), we believe this 
to be a sample handling issue. When the original electropherograms were re-examined in 
light of the expected results, low intensity peaks of the correct size were detected (31, 15 
and 25 repeats, respectively). 
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Laboratory D also reported low fluorescent signals with samples A1-A12 that were 
markedly improved with use of a higher concentration of DNA in the PCR reactions. 
Repeating the A10 PCR with more DNA resulted in peaks of the expected sizes. 
Laboratory E made 8 interpretation errors. In all these cases, the reported alleles were 
reduced by 1 or 2 repeat units, probably because of the assignment of stutter peaks instead 
of the actual principle peaks. Interpretation of the results by lab E was also hampered by 
substantial bleed-through (a.k.a. cross-talk) of the different fluorescent labels on the ABI 
Prism 3700 which they were unable to resolve. With the exception of the above incidental 
interpretation errors, identical typing results were obtained for all samples that were 
provided both as isolates and DNA samples. 
 
Table 2. Results of the trinucleotide repeat markers based on calibration with allelic ladders. Shaded results 
differ from the expected reference values. 
 
  STRAf 3A  STRAf 3B  STRAf 3C 
  A B C D E  A B C D E  A B C D E 
A1*  49 49 49 49 49  11 11 11 11 11  7 7 7 7 7 
A2  48 48 48 48 46  11 11 11 11 11  7 7 7 7 7 
A3  27 27 27 27 27  9 9 9 9 8  26 26 26 26 26 
A4*  51 51 51 51 51  16 16 16 16 16  22 22 22 22 22 
A5*  26 26 26 26 26  23 23 23 23 23  22 22 22 22 22 
A6  25 25 25 25 25  8 8 8 8 8  10 10 10 10 10 
A7  35 35 35 35 35  11 11 11 11 11  33 33 33 33 33 
A8  36 36 36 36 36  11 11 11 11 11  7 7 7 7 7 
A9*  18 18 18 18 18  9 9 9 9 9  6 6 6 6 6 
A10  31 31 31 10.1 30  15 15 15 10 15  25 25 25 7 25 
A11  34 34 34 34 34  24 24 24 24 24  40 40 40 40 39 
A12  27 27 27 27 27  12 12 12 12 12  7 7 7 7 7 
B1*  51 51 51 51 51  16 16 16 16 16  22 22 22 22 22 
B2  10 10 10 10 10  10 10 9.2 10 10  10 10 10 10 10 
B3*  26 26 26 26 26  23 23 23 23 21  22 22 22 22 22 
B4*  49 49 49 49 49  11 11 11 11 11  7 7 7 7 7 
B5*  18 18 18 18 17  9 9 9 9 9  6 6 6 6 5 
B6  14 14 14 14 14  34 34 34 34 34  18 18 18 18 17 
*Isolates B1, B3, B4 and B5 correspond to DNA samples A4, A5, A1 and A9, respectively 
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Figure 3. Graphical display of the size inaccuracy for each allele in the allelic ladders on different analytical platforms. The X-axes display 
the repeat number of the alleles and the  Y-axes the difference between the calculated size and the actual size as determined by sequencing.   
 
Discussion 
 
A multicenter study was carried out to investigate the interlaboratory 
reproducibility and compatibility of a microsatellite-based typing assay in different 
settings. From a theoretical point of view, microsatellites are ideal targets for high 
resolution and exact fingerprinting of microbial isolates. The exchange of microsatellite 
typing data between laboratories is greatly hampered by the inability to accurately 
determine absolute fragment sizes by capillary electrophoresis (figure 3). Accurate sizing 
of identical DNA fragments using different high-resolution platforms is dependent on 
many experimental and environmental factors and often leads to differing results 7, 13, 14. 
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Intralaboratory sizing of alleles has been shown to be highly reproducible, yet, almost 
paradoxically; it is the sizing result itself that needs to be calibrated between laboratories. 
This is the first report of the use of allelic ladders to precisely and reproducibly determine 
repeat numbers of amplified alleles in an interlaboratory setting for typing A. fumigatus 
isolates. The use of allelic ladders for microsatellite analysis allows standardization of 
sizing results which in turn allows the direct comparison of microsatellite-based typing 
data between different laboratories and from different experimental settings. Allelic 
ladders consist of a mixture of common alleles that act as reference points for the position 
in an electrophoretic trace of fragments with specific numbers of repeats. Amplification of 
microsatellites by PCR leads to the formation of stutter peaks (e.g. additional fragments, 
mostly with fewer repeat numbers 5). In the construction of our ladders we took advantage 
of the formation of these stutter peaks in order to fill in the gaps for those alleles that were 
not actually present in the mixture of cloned alleles, e.g. the -1 stutter peak that is formed 
upon amplification of the allele with 12 repeats will reveal the reference position of the 
allele with 11 repeats (figure 1). A circumstantial advantage of this approach is that it 
should be quite easy to unambiguously assign all alleles in the ladders since the included 
alleles will yield higher peaks than their associated stutter peak(s). 
Some participants initially misassigned the repeat numbers in their chromatograms 
of the allelic ladders. As a consequence, the repeat numbers for all markers in the 
corresponding samples were effectively altered by 1 repeat unit. In retrospect, such 
misassignments could have been prevented by including the expected results for an 
additional reference DNA sample with known repeat numbers. In some cases a non-
specific peak was assigned. Non-specific amplification products usually lack the stutter 
peaks that are associated with true alleles containing a short tandem repeat. Previously, we 
reported that the intensity of such non-specific amplification products is greatly 
influenced by the annealing temperature during amplification 7. Hence, based on 
thermocycler specifications, some laboratories may experience more non-specific 
amplification products than others. After pointing this out, participants were granted the 
opportunity to reinterpret their results (Table 2). 
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The STRAf assay was developed as a multiplex assay in order to increase sample 
and marker throughput. This was easily established by using amplification primers with 
different fluorescent labels for each of the markers in the multiplex PCR reactions. For 
economical reasons, the combination of fluorescent labels. In this study five different 
capillary electrophoresis platforms were used. All platforms have multicolor detection 
capabilities either through the presence of optical (hardware) filters (MegaBACE) or 
through virtual (software) filters (ABI platforms). Theoretically, it should have been 
possible to calibrate each of these platforms to the combination of labels used in this study 
but this proved to be problematic for some of the ABI platforms. As a result, some 
participants were unable to properly calibrate their instrument and consequently suffered 
from substantial bleed-through of the different labels. This greatly complicated the 
interpretation of the results for lab E showing the most data analysis errors. Hence, being 
able to properly separate the different fluorescent labels seems to be crucial for successful 
interpretation of the data and implementation of this assay. 
Previously, we showed that sizing identical alleles using different size standards on 
the same electrophoretic platform will result in sizing differences up to 5.0 nucleotides 7. 
As shown in this study, these size differences can be as large as 6.7 nucleotides when 
different size standards are used on different electrophoretic platforms but can still amount 
up to 5.4 nucleotides when the same size standard is used on different analytical 
platforms. Furthermore, it is obvious from figure 3 that sizing differences are not constant 
across the range of alleles for a marker and that it changes with repeat number. In 
addition, individual markers behave differently on different analytical platforms. The 
examples clearly demonstrate that calculated allele sizes can not be used for the 
comparison of typing results between different laboratories (even when the same size 
standard is used) and that there is a clear need for size data to be calibrated in some 
manner. As demonstrated here, allelic ladders are ideally suited for such calibration 
purposes. All that needs to be done is to run the allelic ladders using the preferred running 
conditions to determine the relative size of all alleles using these conditions. Despite the 
substantial variations in sizing results, all laboratories were able to report identical typing 
data when the allelic ladders were used to calibrate the analysis.  
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Allelic ladders have already been in use in human forensics for more than a decade 10, 11 
but up to now, have not been reported for use with microbial microsatellite based typing 
schemes. 
No allelic ladders were provided for the markers in the STRAf 4 panel. Assignment 
of alleles in this panel for all samples was done by comparing the sizes of the fragments in 
the samples to the sizes of fragments in the original publication. In this case, all 
laboratories used the ET400-R marker. Identical alleles yielded sizing data differing up to 
3.8 nucleotides. As a consequence, the reported repeat numbers for individual alleles in 
the STRAf 4 panel differed by up to 1 repeat unit from the expected values. Without the 
option to calibrate the results to an allelic ladder and when results were only interpreted 
based on the calculated (and relative) size of an allele, a total of 118 out of 264 reported 
alleles were incorrect (results not shown). 
As might be expected, most interpretation errors were made by those participants 
with the least prior experience of microsatellite marker analysis. These were also the 
participants that left the actual electrophoretic running of the samples to an external party. 
Participants that produced identical typing results (laboratories A, B and C), had prior 
experience with this type of analyses and an in-house capillary electrophoresis platform 
(and software) that ensured correct detection and separation of the fluorescent labels. 
In a previous study we demonstrated the robustness of the STRAf assay by 
deliberately and systematically changing various reaction components to suboptimal 
conditions and by varying thermocycling parameters 7. In the current study all participants 
were allowed to use their regular DNA isolation procedure, DNA polymerase for 
performing PCR reactions, thermocycler, capillary electrophoresis platform and size 
standard. In practice, 3 distinct DNA isolation procedures, 3 different thermocyclers, 5 
different capillary electrophoresis platforms and 4 size standards were used. The fact that 
all participating laboratories were able to produce identical typing data for all the STRAf3 
markers in nearly all samples with this wide variety of experimental conditions again 
confirms the high robustness of a microsatellite-based typing assay and demonstrates the 
reproducibility and compatibility of results obtained with this assay in different settings.  
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Thus, microsatellite based typing assays are as suitable for interlaboratory comparisons as 
are sequence based typing assays such as multi-locus sequence typing. However, 
microsatellites offer a number of additional advantages in terms of speed, throughput, cost 
and discriminatory power. The present study also shows that although allelic ladders were 
shown to provide a straightforward way of standardizing microbial microsatellite-based 
typing assays, a certain level of technical experience is required in any participating 
laboratory to ensure correct data interpretation. However, for microsatellites this is no 
different than for any other molecular typing assay. 
The use of allelic ladders allows a convenient means of standardizing 
microsatellite based typing assays between laboratories. This requires that such ladders 
should be made available to other interested laboratories. However, construction of an 
allelic ladder requires considerable effort and so therefore, at present and with the aim of 
demonstrating their usefulness, allelic ladders were constructed only for the trinucleotide 
repeat markers. If there is sufficient interest, allelic ladders for the dinucleotide and 
tetranucleotide markers can be constructed as well. In addition, this approach will only be 
successful if other laboratories are willing to commit to using the same primers and 
fluorescent labels as reported. 
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Abstract 
 
The stability of 9 highly polymorphic short tandem repeat markers for Aspergillus 
fumigatus was investigated in 100 successive generations of 5 clonally expanded isolates. 
In total, 473 generations were generated and analyzed. In five cases, a change in the 
number of repeat units was observed. All alterations involved a change in 1 repeat unit 
and all changes involved expansions. All changes were observed in the two out of three 
trinucleotide repeats, especially in isolates with high number of repeats. This suggests that 
the mutation rate increases with increasing repeat numbers. Between markers of the 
STRAf assay there were also differences concerning the stability. All these findings 
should be taken into account upon interpreting STR data. 
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Introduction 
 
Short tandem repeats (STRs), also known as microsatellites, consist of tandemly 
repeated sequences loci up to ten basepaires (bp) long and are present in several 
prokaryotic and virtually every eukaryotic genome. Repeat copy number polymorphisms 
in STRs between different isolates are the result of expansions or contractions of one or 
more repeats units. The mechanisms behind these changes in repeat numbers are 
recombination and slipped-strand mispairing (SSM)5-7, 14. With the SSM model addition or 
contradiction of STRs depends on the strand orientation. When the nascent strand 
produces a loop during replication, one or more STRs will be added in the new DNA 
strand. Though, if the template strand produces a loop, one or more STRs can be deleted 9, 
11. Polymorphic STR markers can be predicted from the following characteristics: Number 
of repeated units, unit lengths and repeat purity 7. The instability of STRs and the relative 
ease of detection of these polymorphisms via PCR amplification make them ideally suited 
for genotyping 5.  
For the fungus A. fumigatus a robust typing method based on nine STRs was 
developed (STRAf assay) this thesis, 2, 4. A. fumigatus is the most common fungus, which can 
cause invasive aspergillosis in immunocompromised patients with often fatal 
consequences. Previously, the high discriminatory power of the STRAf assay was 
demonstrated by distinguishing 96 genotypes from 99 presumably unrelated isolates 2. 
The utility in epidemiological surveys was also established. Firstly, by identifying 
identical isolates from different body sites of the same patient 3. Secondly to establish 
epidemiological concordance among isolates from different outbreaks containing multiple 
isolates per outbreak 1. In this last study, epidemiologic related isolates with differences of 
one repeat unit in a single STR marker were called microvariation. It is unknown how to 
deal with these variations, since no guidelines for the interpretation of STR data have been 
postulated.  
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In order to be able to properly interpret the relationship between isolates with 
differences in the STR markers, it is necessary to understand the dynamics of the 
individual markers. Unfortunately, little is known about the stability of STR markers in A. 
fumigatus. Therefore, we investigated the stability of 9 highly polymorphic microsatellite 
markers in 100 successive generations of 5 clonally expanded A. fumigatus isolates with 
randomly chosen genotypes.  
 
Material and Methods 
 
Generations: Four randomly chosen unrelated clinical A. fumigatus isolates and one 
reference strain (CBS 487.65) were clonally expanded up to 100 generations. All isolates 
were subcultured onto sabouraud agars and incubated at 30ºC until sporulation. 
Successive generations were generated from a single spore using the following procedure: 
A suspension of A. fumigatus spores was made in aqua dest. with 0.05% Tween 40 
(Merck Nederland B.V., Amsterdam, The Netherlands). The transmission of this 
suspension was measured at a wavelength of 530 nm and adjusted to 80-82%, which 
corresponds to approximately 1.5 x 106 CFU/ml. This suspension was diluted to a 
concentration of 3 x 102 CFU/ml. About 100µl of this suspension was plated onto a 
Sabouraud agar and incubated at 30ºC and examined daily. A single non-sporulating 
colony was then picked and subcultured on a new Sabouraud agar and incubated at 30ºC 
until sporulation. Subsequent generations were made accordingly.  
 
STRAf assay: DNA of all generations was extracted as previously described 2. All DNA 
samples were analyzed using the 9 loci of the STRAf panel consisting of three di-, tri- and  
tetranucleotide repeats. PCR primers, fluorescent labels and amplification conditions were 
exactly as previous described 2. Assignment of repeat numbers in each marker was 
performed using Fragment Profiler 1.2 software (GE Healthcare, Diegem, Belgium) and 
checked by visual interpretation of the electropherograms.  
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Results 
 
 Four unrelated randomly chosen A. fumigatus isolates and one reference isolate 
were clonally expanded. Four isolates yielded 100 generations and one slow-sporulating 
isolate yielded 73 generations. In total, 473 generations were generated and analyzed with 
the nine STR markers of the STRAf assay. This yielded a total of 4257 markergenerations. 
The results are shown in table 1. 
 In two of the five isolates (number 2 and 5) no change in any of the nine STRAf 
markers were observed. The number of repeats in the STRAf 3C marker changed from 20 
to 21 in the 5th generation of isolate 1, this was the only change in this sample over 100 
generations. Isolate 3 also showed a single alteration in the STRAf 3C marker, in this 
sample the repeat number changed from 50 to 51 in the 36th generation. Most changes 
were observed in sample 4. In this isolate, the STRAf 3A marker gradually changed from 
53 repeat units to 56. The alterations were observed in the 5th, 48th and 66th generation.  
 In total, five times a change in the number of repeat units was observed. All 
alterations involved an increase in 1 repeat unit. All changes occurred in the trinucleotide 
repeat markers.  
 
Table 1. Overview of the markergenerations of five randomly chosen isolates. 
   STRAf  STRAf  STRAf 
Isolate Generation  2A 2B 2C  3A 3B 3C  4A 4B 4C 
              
1-5  18 12 8  27 12 20  9 9 5 1 6-100  18 12 8  27 12 21  9 9 5 
              
2 1-100  18 12 13  14 10 14  8 11 5 
              
1-36  23 23 15  39 11 50  10 26 8 3 37-100  23 23 15  39 11 51  10 26 8 
              
1-5  23 19 15  53 11 7  13 9 5 
6-48  23 19 15  54 11 7  13 9 5 
49-66  23 19 15  55 11 7  13 9 5 4 
67-100  23 19 15  56 11 7  13 9 5 
              
5 1-73  10 17 10  25 11 23  7 5 6 
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Discussion 
 
A better understanding of the epidemiological relation between isolates can be 
provided by molecular fingerprinting methods. Isolates with differences in more than two 
STRAf markers are considered to be unrelated, as it is unlikely that two changes in the 
genome occur at the same time. The interpretation of the relationship between 
epidemiological related A. fumigatus isolates with minor variations between genotypes is 
unknown. To know how to interpret the relationships between these isolates, the stability 
of individual markers has to be taken into account. Therefore we studied the variation in 
repeat numbers in successively clonally expanded A. fumigatus isolates. Generations can 
be obtained by subculture multiple spores or by subculture a single spore. A. fumigatus 
isolates releases millions of spores. If a change in repeat numbers would occur in a part of 
these spores, this will not be recognized in the electropherogram. Thus, subcultures need 
to be obtained from a single spore. Totally 473 generations were generated from 5 
randomly chosen isolates. All generations were analyzed with nine loci of the STRAf 
panel, consisting of three di-, tri- and tetranucleotide repeat markers. In these 4257 
markergenerations 5 changes were observed. This means that the average marker in the 
STRAf panel is stable for approximately 1000 generations.  
The number of copies within a marker seems to have great influence on the 
stability of that marker, since four out of 5 alterations were found in markers with 50 or 
more repeat numbers. This suggests that the mutation rate may increase with increasing 
repeat numbers. Several other studies have indeed shown that the number of repeats is a 
good predictor of the level of variability in other organisms, like Escherichia coli, 
Saccharomyces cerevisiae and maize (Zea mays supsp. mays) 7, 15, 16. So, for A. fumigatus 
as well as for other organisms a higher copy number decreases the stability of STR 
markers. This means that expansion of one extra repeat unit to a repeat consisting of 10 
units is less likely to occur in the same period of time than the expansion of a unit to a 
repeat that already contain 50 units. For the calculation of relations between isolates with 
these variations in a marker, this means that a difference of 10 to 11 repeats in a marker 
should be given more weight than a change from 50 to 51 repeat numbers.  
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All 5 mutations were found in the trinucleotide repeat markers, STRAf 3A and 
STRAf 3C, and none in the di- and tetranucleotide repeats. The unit length is thought to be 
one of the major parameters to predict the (in)stability 7 and that longer repeat units have 
higher mutations rate 13. Weber and Wong tested both di- and tetranucleotide repeats in 
cell lines representing human pedigrees and found more mutations in tetranucleotide 
repeats than in dinucleotide repeats 17. However, the opposite relationship has been 
observed in humans where dinucleotide repeat motifs mutated at a faster rate than those 
with larger repeat motifs and this was also found in some other organisms, including 
Drosphilia 13 and maize 15. For our data, it could be a coincidence that most variations 
were found in the trinucleotide repeats since two out of the five randomly chosen isolates 
already had high copynumbers in the trinucleotide repeat markers. To confirm that the 
unit length has influence on the mutation rate in A. fumigatus, this experiment could be 
repeated using isolates with selected numbers of repetition for the different markers. 
All five mutations were expansions of one repeat unit. It seems logical that more 
expansions are observed than contractions, otherwise the repeat would not have existed 
anymore. Vigouroux et al. analyzed the mutation in dinucleotide repeats in maize, they 
observed that there is a higher probability to change to a higher repeat number than to a 
lower one 15. Noller et al. also observed that the majority of mutations in a hexanucleotide 
repeat for E. coli were single additions of repeat units 11. Vogler et al. found a balance 
between expansions and contradictions in these loci for 8 E. coli isolates. One isolate also 
showed that the majority of repeats were insertions 16.  
Another factor which could have an effect on the stability of markers is the 
location of repeat markers. All loci in the STRAf 2 panel are located in or nearby a gene. 
The most polymorphic marker of the STRAf panel, namely STRAf 3A, is located within 
the coding region of the Afu4g09070 gene 12, a putative ATP binding L-PSP 
endoribonuclease family protein. The remaining STRAf loci are not positioned nearby 
genes. The repeat number could be influenced in repeats located in active proteins by 
selection. Isolates tend to adjust to the environment. On the other hand, variation in repeat 
number may allow an isolate to evade a host defense.  
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In the Afu3g08990 gene 8 a change in the phenotype has been described, due to 
recombination events in their internal tandem repeats. In humans, the expansion of coding 
repeats is associated with various diseases, including Huntington’s disease and fragile X 
syndrome 10. For the selected STRAf loci it is not obvious if their stability was influenced 
by the location in genes.  
Assays based on short tandem repeats have been shown to be a powerful tool for 
epidemiological studies of a wide range of organisms. The interpretation of data obtained 
with these assays requires proper understanding of the dynamics of repeat numbers in 
STR markers. High numbers of repeats in a marker seems to have the most influence on 
the variability in a marker. There are also differences in the stability between markers of 
the STRAf assay. All these findings should be taken into account in the interpretation of 
STR data.   
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Abstract 
 
A microsatellite assay based on short tandem repeats (STRAf) has been recently described 
as a discriminatory, high throughput assay for fingerprinting Aspergillus fumigatus 
isolates. However, the STRAf assay has not been tested for its utility in outbreak settings 
where it is critical to distinguish clonal clusters from genetically unrelated genotypes. In 
the present study, employing a panel of epidemiologically linked A. fumigatus isolates 
obtained from 6 different outbreaks of invasive aspergillosis (IA), we demonstrate that the 
STRAf assay can be a valuable molecular tool to support epidemiological investigations. 
We also report for the first time the detection of microvariation events in the A. fumigatus 
population studied. 
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Introduction 
 
Invasive aspergillosis (IA) is a life-threatening disease in immunocompromised 
patient populations and evidence suggests that such infections may be acquired from 
hospital environments; accordingly, numerous outbreaks of IA, largely due to Aspergillus 
fumigatus, have been reported 2, 8, 9, 11. A molecular typing method that can distinguish 
“clonally related” or genetically related isolates from unrelated isolates can be a powerful 
tool in outbreak investigations where the assumption is that isolates with identical 
genotypes (or “clonal” clusters) could indicate a common source of exposure, whereas 
epidemiologically unrelated isolates will have different genotypes 12. Thus, genotyping 
methods can indicate the source and map the route of transmission of IA, thereby 
informing epidemiological investigations and ultimately guide prevention strategies. 
Numerous molecular methods have been evaluated for subtyping A. fumigatus 
including microsatellite based fingerprinting assays. Recently, a robust microsatellite 
assay, the STRAf assay, based on nine, short tandem repeat loci has been described for 
high resolution fingerprinting of A. fumigatus 3, 5. Previously, the STRAf assay was able to 
segregate 99 presumably unrelated A. fumigatus isolates into 96 unique genotypes 
demonstrating its very high discriminatory power 3, delineate unique genotypes amongst 
A. fumigatus isolates recovered from multiple different patients in a single hospital, and 
finally identified genetically related isolates from different body sites of the same patient 
4. Thus, the STRAf assay satisfies a critical measure of a good typing system, that is, it can 
provide distinctive fingerprints from genetically unrelated isolates and identical or highly 
similar fingerprints from closely related organisms. According to the guidelines of the 
European Study Group on Epidemiological markers (ESGEM), another important 
criterion of an ideal typing scheme is the system's capacity to establish epidemiological 
concordance among strains recovered from the same outbreak, which can be evaluated by 
testing sets of isolates from different outbreaks containing multiple isolates per outbreak 
13. However, it is not known whether the STRAf assay can fulfill this criterion, and the 
present study was designed to evaluate the STRAf assay for its utility as a molecular tool 
to support outbreak investigations of aspergillosis. 
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The Mycotic Diseases Branch at the Centers for Disease Control and Prevention 
has a collection of several A. fumigatus isolates from multiple outbreak investigations 
across Northern America 6, 10, 11. These isolates have been subjected to several genotyping 
methods to assess their genetic relatedness to support epidemiological investigations 
including the Afut1 DNA hybridization profiles (Afut1 method) and a recently developed 
single locus sequencing typing method employing the putative cell surface protein gene 
Afu3g08990, designated as “CSP typing” method 1. Given the availability of relevant 
epidemiological data for each outbreak investigation, this panel was uniquely suited and 
was therefore chosen to test the suitability of the STRAf method to type epidemiologically 
linked A. fumigatus isolates.  
 
Materials and methods 
 
Aspergillus isolates used in the study. A total of 55 A. fumigatus isolates obtained from 
six different outbreak investigations (denoted as OB1–OB6) were included in this study.  
Isolates in cluster OB1 were obtained from a renal transplant unit in California. 
This outbreak was thought to be associated with construction related activities; however 
genotyping results using the Afut1 method showed that the isolates recovered from the 
environment were unrelated to the clinical isolates from patients 10. Outbreak OB2 
occurred among liver transplant recipients. Debridement of a patient's wound infected 
with A. fumigatus caused aerosolization of Aspergillus conidia resulting in patient-to-
patient transmission and was implicated in a subsequent outbreak of pulmonary 
aspergillosis in the intensive care unit 11. Here, analyses with the Afut1 assay 
demonstrated that isolates recovered from infected abdominal tissue of one patient, 
environmental isolates recovered from the immediate vicinity of the wound debridement 
procedure, and an isolate from another patient housed in the same unit had 
indistinguishable genotypes 11. 
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Cluster OB3 included isolates from an outbreak of IA in a cardiac transplant unit in 
New York 6. Cluster OB4 isolates were obtained from a surgical unit in a Colorado 
hospital where patients had undergone prosthetic heart valve replacement surgery and 
subsequently had IA. OB5 isolates were recovered from a poultry farm outbreak 
investigation in which A. fumigatus was recovered from lungs of chickens and from 
chicken litter. Previous genotyping results with  Afut1 method indicated that isolates from 
OB3, 4 and 5 were unique isolates representing multiple different genotypes (unpublished 
data).  
Cluster OB6 included isolates obtained from a heart transplant unit in a Canadian 
hospital where genotypes of isolates collected from the ventilation system of rooms in 
which the patients were housed and clinical isolates from patient with documented IA 
were shown to be highly related by Afut1 analyses; here the source of the infection was 
considered to be the ventilation system in the room (unpublished data). All the isolates 
had been genotyped using the Afut1 assay and/or the CSP typing method 1. 
 
STRAf assay. Fungal DNA was extracted and purified from all isolates as described 
previously 6. PCR primers and fluorescent labels for the STRAf2, 3 and 4 panels were as 
previously described 3. The obtained PCR products were diluted 30-fold with distilled 
water. One microliter of diluted PCR products was combined with 8.75 μl of distilled 
water and 0.25 μl of ET-ROX 400 marker (GE Healthcare, Diegem, Belgium). Following 
denaturation of the samples for 1 min at 95°C and rapid cooling to 4°C, they were injected 
onto a MegaBACE 500 equipped with a 48 capillary array. Injection and running 
parameters were according to the recommendations of the manufacturer (GE Healthcare). 
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Data analysis. Electropherograms were analyzed using Fragment Profiler 1.2 software 
(GE Healthcare). Typing data was imported into BioNumerics 4.6 software (Applied 
Maths, Sint-Martens-Latem, Belgium) and analyzed using the multi-state categorical 
similarity coefficient with UPGMA clustering. Isolates possessing alleles with the same 
number of repeat units in all 9 loci were defined as a “clonal” cluster. Microvariants were 
defined as epidemiologically related isolates that differed by less than 2 repeat units in a 
single locus. 
 
Results 
 
Results of the STRAf assay for cluster OB1 showed that 3 clinical isolates 607, 683 
and 686 belonged to a clonal cluster while all other isolates representing mostly 
environmental isolates consisted of unrelated genotypes (Fig. 1A). In cluster OB2, 11 
isolates formed a clonal cluster and 1 clinical isolate had an unrelated genotype (Fig. 1B). 
Here, isolates B5850, B5864, B5852 and 38 recovered from a single patient (whose 
abdominal wound was implicated as the source of the outbreak), isolate B5856 from a 
second patient housed in the vicinity, and several other environmental isolates recovered 
from the air of this room grouped together as one clonal cluster. One environmental 
isolate collected from the same environment several days after the outbreak, isolate 
B5865, differed from this clonal cluster by a change in locus STRAf3C from allele 35 to 
allele 36, a change of one trinucleotide repeat unit (Fig. 1B, circled). Isolates from OB3 
(Fig. 1C), OB4 (Fig. 1D) and the poultry outbreak (OB5, Fig. 1E) had unrelated 
genotypes when analyzed with the STRAf assay.  
Seventeen isolates obtained from OB6 were grouped into 3 different clonal 
clusters. Twelve isolates formed one clonal cluster that included clinical isolates, isolates 
recovered from the air vent and from the environment of the infected patient. Within this 
clonal cluster, 2 isolates, one clinical (B6074) and an environmental isolate (B6081) 
differed at a single locus from the genotypes of the clonal group in that there was a change 
from allele 33 to allele 34 in one locus, STRAf3A (Fig. 1F, shown within a circle).  
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Three isolates (97, 99 and 101) formed the second clonal cluster and included clinical 
isolates recovered from 3 different patients who were housed in a different ward of the 
same hospital; here isolates 97 and 99 differed from each other in STRAf 3C, while isolate 
101 had a change of allele 17 to 18 in STRAf2C (Fig. 1F, highlighted within a circle). The 
third clonal cluster included 2 environmental isolates (B6084 and 127) also recovered 
from the air of the patient's room. This outbreak collection also included 4 isolates with 
unrelated genotypes.  
There was good agreement between the STRAf and Afut1 typing method. Of the 55 
outbreak isolates typed by both methods, only 2 isolates (607 and 633) belonging to OB1 
showed discordant genotypes (Fig. 1A). When the results of the CSP typing were 
compared with that of the STRAf assay, a total of 5 isolates had discordant genotypes 
(Figs. 1A, C and F, denoted with an asterisk). 
 
Discussion 
 
Recently, a method that employs a panel of short repeats from 9 loci in multiplex 
PCRs where the reaction amplified three di-, tri-, or tetranucleotide repeats respectively 
(the STRAf assay) has been described for fingerprinting A. fumigatus isolates 3.With this 
assay, the combination of all nine markers yielded a Simpson's diversity index of 0.9994, 
indicating that the method had a high discriminatory power. Theoretically this panel of 
markers can discriminate between up to 27 × 109 genotypes. Although the STRAf assay 
has been shown to be highly discriminatory and reproducible 3, 4, the method has never 
been rigorously examined for its ability to identify clonally related or epidemiologically 
linked A. fumigatus isolates.  
The present study demonstrated that the STRAf assay results were in overall 
agreement with previous genotyping results obtained using the Afut1 and CSP genotyping 
methods 1, in that the clusters OB2 and OB6 were outbreaks that could be traced to a 
common source exposure while all other outbreaks were multi-source outbreaks with 
several unrelated genotypes identified.  
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The STRAf and CSP typing method were not concordant for all outbreak isolates 
emphasizing a previous observation that the CSP typing method has a lower 
discriminatory power and at best can be a first line typing strategy for A. fumigatus 
isolates 1. Conversely, except for one outbreak cluster (OB1) results from both the Afut1 
and the STRAf assays were in excellent agreement (Figs. 1A–F). Thus, the STRAf assay 
appears to be a useful molecular tool that is suitable for use in A. fumigatus outbreak 
related epidemiological investigations. The only disadvantage of the STRAf assay appears 
to be the requirement for expensive equipment and skilled personnel and thus limiting its 
use to specialized laboratories. A few serial isolates in clusters OB2 and OB6 showed 
variation at a single locus over time (Figs. 1B and F). Interestingly, both these isolates 
were recovered several days later than the other isolates in the respective outbreak cluster. 
In another instance, 3 isolates recovered from 3 different patients with documented 
infection (OB6, isolates 96, 99, 101) also showed a single repeat difference. These 
observations are suggestive of microvariation in the A. fumigatus population. Similar 
microvariation events have also been recently documented in C. parapsilosis and Candida 
albicans using microsatellite markers 7, 14. Nevertheless, the present study demonstrates 
that the STRAf assay can be used effectively to detect subtle genetic changes in A. 
fumigatus isolates that were not previously observed with other genotyping methods. An 
alternate and plausible explanation for the slight genetic variation in the genotype of these 
isolates could be attributed to instability: it is well known that microsatellite instability 
can occur due to polymerase and strand slippage during DNA replication. In practice, 
changes in tandem repeats are expected to occur at faster rates than do spontaneous point 
mutations, in the end contributing to high discriminatory power of the microsatellite based 
typing assay. 
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Abstract 
 
Aspergillus fumigatus is a chronic colonizer of the respiratory tract of patients with cystic 
fibrosis (CF). A total of 204 A. fumigatus isolates from 36 CF patients from three different 
medical centers, collected over a period of four months till 9½ years, were genotyped 
using the short tandem repeat panel for A. fumigatus (STRAf assay). Four different 
colonization patterns were observed. Colonization patterns with only unique genotypes 
were found in 36% of the patients. In contrast 17% of the patients were chronically 
colonized by a single genotype. The remaining patients showed a predominant genotype 
or genotypes that succeed each other. In this collection no relation was found between 
colonization pattern and allergic bronchopulmonary aspergillosis.
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Introduction 
 
Cystic fibrosis (CF) or mucoviscidosis is an autosomal recessive disorder with an 
incidence of approximately one in 2500 live births in the Caucasian population. Mutations 
in the gene encoding the chloride channel cystic fibrosis transmembrane regulator (CFTR) 
result in dysfunction of the exocrine glands. As a consequence of this deficient transport 
mechanism, copious amounts of viscous respiratory mucus are secreted, which is difficult 
to clear and provides a breeding ground for microorganisms 2. Early in life, CF patients 
become infected with a limited spectrum of bacteria, mostly Staphylococcus aureus and 
Haemophilus influenzae. As the disease progresses, Pseudomonas aeruginosa becomes 
the most common pathogen 16. Aspergillus fumigatus is by far the most isolated 
filamentous fungus from the respiratory secretions of CF patients and up to 57% are 
chronically colonized with this fungus. A commonly recognized complication of 
Aspergillus infection in CF patients is allergic bronchopulmonary aspergillosis (ABPA), 
with a prevalence of approximately 1 to 15% 18, 22, 23. Although persistent inflammation 
and the resulting pulmonary injury can finally progress to fibrosis 24, knowledge about the 
epidemiology of A. fumigatus in CF patients is still scarce 4, 15. 
A better understanding of the airway colonization by A. fumigatus in CF patients 
may be achieved by accurate molecular typing of sequential isolates from sputum 
samples. For A. fumigatus, several typing techniques have been described previously, 
including microsatellite based fingerprinting assays. The STRAf assay, based on nine 
microsatellite or short tandem repeat (STR) markers, is a robust 11, reproducible 8 typing 
technique with a very high discriminatory power 9. These characteristics differentiate the 
STR based assays from many other previously employed typing techniques, such as 
random amplified polymorphic DNA (RAPD) 3 and restriction fragment length 
polymorphism (RFLP) 20, which suffer from poor interlaboratory reproducibility and 
subjective interpretation of the fingerprinting data 14. 
 Up to now, four studies comprising a total of 20 CF patients have described the 
colonization pattern of A. fumigatus 7, 19, 21, 26. Verweij et al. 26 performed molecular typing 
of sequential isolates from two patients using RAPD.  
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With the Afut1-RFLP method, a predominant genotype in sequential sputum samples of 
one patient was detected. In another patient about nine different genotypes were seen in 
12 sputum samples. Neuveglise et al. 19 collected 412 A. fumigatus isolates from 6 patients 
over a 2½-year-period. These isolates yielded 54 unique genotypes with the Afut1-RFLP 
method. In all samples of the six patients, several A. fumigatus genotypes were found, 
whereas two patients harboured a predominant genotype. The two other studies 7, 21 used 
solely the low discriminatory molecular typing assay RAPD, which suggested the 
majority of isolates to be of the same genotype 7. 
In this study we report the colonization patterns of 196 A. fumigatus genotypes in 
36 different CF patients from 3 European medical centres. The isolates were collected 
from sequential sputum samples and analyzed using the highly discriminatory STRAf 
assay. 
 
Material and Methods 
 
Isolates. A total of 204 isolates from 36 CF patients were included in this study. Sputum 
samples were collected from these patients during routine clinical visits or during an 
admission to hospital because of exacerbation of their pulmonary disease. The time period 
between the first and the last A. fumigatus isolate per patient varied from four months to 
nine and a half years. The numbers of isolates per patient varied from two till 27. The 
patients originated from three different centers; 100 isolates from 14 patients were 
obtained from the Cystic Fibrosis Center Dekkerswald (Nijmegen, The Netherlands); 58 
isolates from 15 patients were collected from the University of Aachen (Aachen, 
Germany); another 46 isolates from 7 patients were from the University Medical Center 
Würzburg (Würzburg, Germany)  
 
Collection of A. fumigatus isolates. Sputum samples obtained from patients were 
routinely cultured on Sabouraud agars for 7 days at 30 and 35ºC. A. fumigatus isolates 
were identified at the time of collection by their macroscopic and microscopic 
characteristics and their ability to grow at 48ºC.  
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The obtained isolates were stored as spore suspensions in regular microbial freezing broth 
containing 12.5% (vol/vol) glycerol at -80ºC until testing. The isolates were revived by 
scraping off part of the frozen broth, plated on Sabouraud’s or potato agar, and cultivated 
at 30ºC. 
 
STRAf assay. Genomic fungal DNA was extracted and purified from all isolates with the 
MagNA Lyzer and MagNA Pure LC Instruments (Roche Diagnostics, Almere, The 
Netherlands) and PCR primers and conditions were exactly as described before 9. The 
obtained PCR fragments were diluted 30 fold with distilled water. One µl of diluted PCR 
products was combined with 0.25 µl of ET-ROX 400 marker (GE Healthcare, Diegem, 
Belgium) and denaturated for 1 min at 95ºC followed by rapid cooling to 4ºC in a total 
volume of 10 µl. The denaturated fragments were analyzed on a MegaBACE 500 
automated DNA platform (GE Healthcare), according to the manufacturer’s instructions. 
 
Data analysis. Electropherograms were analyzed using Fragment Profiler 1.2 software 
(GE Healthcare). Identical isolates were those that possessed alleles with the same number 
of repeat units in all nine loci. Isolates with genotypes that differed in a single locus were 
considered to be genetically related. The term unique was used for genotypes that were 
only found once in a patient. 
 
Results 
 
 A. fumigatus isolates from 36 CF patients were analyzed using the STRAf assay. 
For 196 isolates of the 204 isolates, a single genotype was obtained. Eight samples 
displayed multiple peaks for all nine loci, indicating to be a mixture of two or more 
different A. fumigatus isolates. An overview of the remaining 196 genotypes is shown in 
figure 1 and described below. 
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Six CF-patients (#1, #6, #8, #9, #17 and #29) harbored only identical or related A. 
fumigatus isolates. From five of these patients, two to four isolates were cultured with a 
maximum time interval of 1½ year. Moreover, patient #29 even showed 7 related isolates 
over a 3½ years period. From 7 patients (#3, #7, #16, #18, #26, #34 and #35) it turned out 
that most of the isolates were identical, since all patients had one or two unique isolates 
besides the predominant genotype. For patient #35 this predominant isolate was observed 
consecutively over a period of 9½ years.  
 In three patients (#25, #28 and #32), identical isolates were found successively in a 
period of about one year. The isolates cultured before or after this period demonstrated 
unique genotypes. Patient #27 and #30 also showed identical and unique isolates. 
However in these patients during a period in which identical genotypes were found, also 
unique genotypes were present. For example, genotype P from patient #27 was found in 
month 11, two years later three other genotypes were found in the sputum samples of this 
patient, but after three years genotype P appeared again. 
 In the following group of patients, several genotypes were found more than once. 
For instance, in patient #20 genotype M was found twice, followed by genotype N that 
was also found twice. In patient #36 a genotype ‘ε’ was found four times in a period of 9½ 
years, whereas second genotype ‘λ’ was observed after 8 years and onwards. In patient 
#31, three genotypes (T, V and W) were observed in successive time intervals varying 
from one to five months. They alternated with unique genotypes. Patient #11 and #33 
demonstrated the most complex colonization patterns. Patient #11 with 9 isolates showed 
six different genotypes of which two types were isolated more than once. Patient #33 
yielded 16 different genotypes for 27 isolates. Six genotypes were found more than once. 
The remaining 12 patients only showed unique genotypes. 
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Discussion 
 
 The A. fumigatus colonization patterns in 36 CF patients were investigated by 
typing 204 isolates with the STRAf assay, the largest study so far. From 196 A. fumigatus 
isolates a genotype was obtained, the remaining isolates were mixed genotypes. In 
general, four different colonization patterns can be discriminated as shown in figure 2. 
First, continuous colonization patterns were found. The patients yielded identical or 
related genotypes for all isolates over a prolonged period of time, indicating that they 
were not able to clear the A. fumigatus isolate. In this collection 17% of the patients 
showed colonization with only one genotype. The second colonization pattern consisted of 
a predominant genotype, meaning that most of the isolates are identical. These groups of 
patients were also not able to clear the A. fumigatus isolate and were occasionally co-
colonized with a second genotype. This was the case in 19% of the patients. The third 
colonization pattern, found in 28% of the patients, contained genotypes which succeed 
each other. These patients were eventually able to clear the A. fumigatus isolate, but were 
easily recognized. The remaining 36% of the patients yielded colonization with only 
unique A. fumigatus isolates, indicating that these patients were continuously able to clear 
the fungus from the respiratory tract. In some other studies the relation between 
colonization patterns of CF patients and clinical symptoms was investigated 17, 24. In our 
study population, we did not found an obvious correlation between colonization pattern 
and the development of ABPA, because only three CF patients in this study were 
diagnosed with ABPA. To get more insight in these relations, this study should be 
expanded with a larger number of CF patients with proven ABPA. 
 
Figure 2. Schematic view of the colonization patterns of A. fumigatus in CF patients. 
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Molecular fingerprinting of A. fumigatus isolates from the environment and from 
clinical samples showed that a high extent of genetic variability can be found 6. Therefore 
typing techniques with high discriminatory power are necessary to differentiate isolates 
from each other. Both the STRAf assay and the Afut1-RFLP method have shown to fulfill 
this criterion 6, 9. Individuals may constantly be exposed to a large variety of different 
genotypes; this is in concordance with the 36% of the patients where only unique 
genotypes were found. It is therefore even more surprising that in the remaining group of  
patients identical genotypes were found more than once over longer periods. In patient 
#35 and #36 identical genotypes were found for more than 9 years. It is likely that inside 
the CF lung a different environment (local immunosuppression, different pH and growth 
nutrition) is present compared to healthy lungs. This may cause a different growth and 
virulence of A. fumigatus. Beauvais et al.5 and Mowat et al. 17 recently demonstrated that 
Aspergillus has the ability to produce a matrix that surrounds hyphae which protects from 
the action of antifungals. Future studies may show if the mucus and the self produced 
matrix causes a barrier against the human defense and antifungals and therefore lead to a 
longer persistence. However, despite the presence of the viscous mucus, 36% of the 
patients in our collection with a unique colonization pattern were able to clear the fungus 
from the respiratory tract. 
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The colonization patterns of A. fumigatus in CF patients was comparable with 
other patients categories. In previous studies successive A. fumigatus isolates were typed 
from non CF-patients. Several patients with invasive aspergillosis 10, 13 and aspergilloma 12 
were colonized with multiple genotypes, whereas other patients harbored unique isolates. 
However, there is a difference between our study and the latter, since almost all of the 
isolates were collected within one month. Symoens et al. 25 collected A. fumigatus isolates 
from eight lung transplant recipients. From three of these patients several isolates were 
collected over a period of 1 to 3 years also showing a continuous, predominant and unique 
type of colonization. To compare the colonization patterns in CF patient with those with 
other underlying diseases, similar studies should be performed with more non CF patients 
colonized with A. fumigatus. Such a group could be the patients with other chronic 
respiratory diseases, like bronchial asthma and chronic obstructive pulmonary diseases, 
since these patients also are prone to develop ABPA 1.  
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Abstract 
 
Based on nine highly polymorphic short tandem repeat loci, genotyping of Aspergillus 
fumigatus was achieved from cultured isolates and tissue samples from five patients with 
invasive aspergillosis. In one patient it was also possible to obtain a genotype from several 
serum samples. Within three patients identical genotypes were found in all samples, one 
patient showed a dominant genotype, which was also found in the lung tissue. In two of 
the three lung biopsies of the fifth patient more than two genotypes were found. With this 
STR assay the presence of A. fumigatus in combination with a genotypic profile was 
obtained directly from tissue and serum samples, without culture. This allows 
(retrospective) examination of dissemination routes of A. fumigatus in patients with IA.
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Introduction 
 
Aspergillus fumigatus is the most important species responsible for invasive fungal 
disease. Invasive aspergillosis (IA) affects immunocompromised patients and despite 
treatment options, the mortality is high 13. It is difficult to diagnose IA, as cultivation of 
Aspergillus has poor sensitivity and tissue biopsies are difficult to obtain 9. Even if a 
biopsy is performed they are mostly sent to the laboratory in formalin fixative because IA 
is often not suspected clinically. It is therefore impossible to culture A. fumigatus from 
such tissues 6. Unlike with many other serious pathogens, A. fumigatus is virtually never 
isolated from blood cultures 8. Major advances have been achieved in the past decade by 
the determination of galactomannan in blood 7. There are also several PCR-based assays 
developed for the direct detection of A. fumigatus DNA in serum, bronchoalveolar lavage 
(BAL) and lung tissue samples 8, 9, 11. 
Closer insight in the pathogenesis of IA can be obtained, when the interstrain 
relatedness of A. fumigatus isolates obtained from respiratory and tissue samples is 
investigated. A few studies have already examined the genetic relatedness between 
isolates obtained from different body sites using highly discriminatory typing techniques 4, 
5. It was established that respiratory isolates are not necessarily identical to the isolate 
found in tissue samples. Isolation of Aspergillus from respiratory specimens may reflect 
colonization of the airway instead of invasive infection and even environmental 
contamination of the culture is possible 9. To exclude contamination and to compare the 
isolates obtained from respiratory samples with the isolate which is responsible for 
invasive infections, it is important to obtain a genotype. IA is often diagnosed solely on 
histopathology of paraffin embedded samples. This is a definitive diagnosis of invasive 
fungal infection but this does not necessarily mean diagnosis of invasive aspergillosis 13. 
PCR assays for direct detection of A. fumigatus in clinical samples have been described 
before 8, 9, 11, 12. Recently direct genotyping of Paracoccidioides brasiliensis from paraffin 
embedded tissue has been reported with success 10. In contrast, typing of A. fumigatus and 
most other fungal pathogens has always been performed on cultured isolates.  
 
 
Direct genotyping of A. fumigatus from serum and tissue samples 
 167
Our aim was to genotype A. fumigatus by high-resolution STRAf typing 3 directly from 
formalin-fixed paraffin-embedded (FFPE) tissue and serum samples, and to compare these 
genotypes with cultured isolates from respiratory samples.  
 
Material and Methods 
 
Patients. Isolates, FFPE tissue and serum samples of five patient (A-E) in the age of 58 to 
67 years old, hospitalized on the ICU from our hospital, were collected. All patients were 
histologically diagnosed with invasive aspergillosis and all five patients were treated with 
antifungal antibiotics. An overview of the patients is given in table 1.  
 
Table 1. Patients with histologically proven invasive aspergillosis 
Patient Age Underlying disease Diagnosis Treatment Outcome 
1 67 COPD, Influenzae pneumoniae ICU treatment 
Disseminated 
IA 
Itraconazole 
Caspofungin Died 
2 62 COPD, Legionella pneumoniae ICU treatment 
Disseminated 
IA 
Itraconazole 
Caspofungin Died 
3 59 COPD, Lung carcinoom ICU treatment 
Pulmonary 
aspergillosis Caspofungin Died 
4 58 COPD, ? Pulmonary aspergillosis Itraconazole Survived 
5 65 COPD, ? Pulmonary aspergillosis Itraconazole Survived 
 
A. fumigatus isolates and DNA extraction. Samples obtained from patients were 
routinely cultured on Sabouraud agars for 7 days at 30 and 35ºC. A. fumigatus isolates 
were identified at the time of collection by their macroscopic and microscopic 
characteristics and their ability to grow at 48ºC. The obtained isolates were stored as spore 
suspensions in regular microbial freezing broth containing 12.5% (vol/vol) glycerol at -
80ºC until testing. The isolates were revived by scraping off part of the sample, plating on 
Sabouraud’s agar and cultivate at 30ºC until sporulation. DNA from A. fumigatus spores 
was extracted and purified with the MagNA Lyzer and MagNA Pure LC Instruments 
(Roche Diagnostics, Almere, The Netherlands) as described before 3. 
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DNA extraction from serum. DNA was extracted from 200µl serum using the High Pure 
Viral Nucleic Acid Kit (Roche Diagnostics) according to the instructions from the 
manufacturer. 
 
DNA extraction from FFPE tissue samples. For each FFPE tissue sample, 5 sections 
(thickness, 10µM) were cut using a sterile microtome blade and transferred to a 2 ml 
centrifuge tube. To remove paraffin wax, the samples were washed twice with 500 µl 
xylene, twice with 500 µl ethanol absolute and once with 500 µl acetone. The pellet was 
dried at 56ºC. Next, 300µl of Puregene cell lysis solution from Gentra Systems (Biozym 
B.V., Landgraaf, The Netherlands) and ProteïnaseK was added and incubated overnight at 
56ºC during continue mixing. Following mechanical lysis in a MagNA Lyzer instrument 
(Roche Diagnostics), the DNA was purified using the method described by Boom et al. 
with minor modifications 2.  
 
Genotyping using the STRAf assay. Reaction conditions and PCR primers were as 
described by de Valk et al. 3, Amplification mixtures contained 1 ng of genomic DNA for 
isolates or 5 µl of the total DNA extracted from tissue or serum samples. The total volume 
of all PCR reactions was kept constant at 25µl. The number of amplification cycles was 
increased to 40. Electropherograms were analyzed using Fragment Profiler 1.2 software 
(GE Healthcare, Roosendaal, The Netherlands). 
 
Results 
 
 An overview of the results is shown in table 2. From patient A five identical 
genotypes of A. fumigatus isolates were found, four of these were cultured from sequential 
sputum samples and one from bronchoalveolar lavage (BAL) in a one week period. 
Another, different genotype was obtained from a lung abscess. Galactomannan negative 
serum samples from this patient showed no characteristic amplification products using the 
STRAf assay. Lung biopsies were obtained on two different days.  
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In two of these lung biopsies (A8 and A10) multiple peaks were found for all nine 
markers, being a typical result of a mixture of two or more different genotypes in these 
samples. In another lung biopsy (A11) the same genotype was found as in the isolates 
from the four sputum samples and the BAL. 
 A total of 15 A. fumigatus isolates were obtained from clinical samples from 
patient B. Thirteen sequential isolates were cultured from sputum samples collected over a 
six-week period, one from ascitis fluid and one from a BAL. The genotypes from all these 
isolates are identical. From this patient three serum samples were analyzed using the 
STRAf assay. The value obtained with the galactomannan test was 0.4, 4.0 and 5.6 for the 
samples B10, B16 and B18, respectively. No genotype was obtained with the serum 
sample with the lowest galactomannan value, the other two serum samples yielded an 
identical genotypes as the 15 sputum isolates. The same genotype was found in the FFPE 
lung tissue sample. 
 From patient C, a total of 22 A. fumigatus isolates were cultured from sequential 
sputum samples during a nine-week period. Nineteen of these A. fumigatus isolates were 
of the same genotype. Isolates C2, C5 and C22 showed unique genotypes. The four, 
galactomannan negative, serum samples of this patient yielded no genotype in the STRAf 
assay. The first lung biopsy (C3) of this patient showed peaks in 6 of the nine loci, the 
remaining three loci were negative. The values in the six positive loci were identical to the 
genotype of the 19 sputum isolates. The second biopsy (C28) was also of the same 
genotype as the 19 sputum isolates. 
 Direct genotyping of the FFPE lung tissue of patient D yielded a genotype that was 
identical to five cultured A. fumigatus isolates from this patient. The isolates were 
collected from sputum, BAL, a lung abscess and lung tissue. Samples from patient E 
showed identical genotypes in an isolate obtained from BAL and in the FFPE bronchial 
biopsy.  
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Table 2: An overview of the typing results of all samples. 
 
 STRAf type Patient + 
no. Origin 
Date of 
isolation 
(day-mo-yr) 
Cultured 
isolate  2A 2B 2C  3A 3B 3C  4A 4B 4C 
                
A1 Sputum 03-01-2005 Yes  25 22 19  28 9 27  10 9 5 
A2 Sputum 05-01-2005 Yes  25 22 19  28 9 27  10 9 5 
A3 Serum, GM 0.1 06-01-2005 No  neg neg neg  neg neg neg  neg neg neg 
A4 Serum, GM 0.1 09-01-2005 No  neg neg neg  neg neg neg  neg neg neg 
A5 Sputum 10-01-2005 Yes  25 22 19  28 9 27  10 9 5 
A6 Lung abscess 10-01-2005 Yes  23 21 8  46 9 6  8 9 5 
A7 Sputum 10-01-2005 Yes  25 22 19  28 9 27  10 9 5 
A8 Biopsy lung 10-01-2005 No      > 2 genotypes     
A9 BAL 12-01-2005 Yes  25 22 19  28 9 27  10 9 5 
A10 Biopsy lung 12-01-2005 No      > 2 genotypes     
A11 Biopsy lung 12-01-2005 No  neg 22 19  28 9 27  10 9 5 
                
B1 Sputum 26-09-2005 Yes  18 12 8  28 10 18  9 8 5 
B2 Sputum 27-09-2005 Yes  18 12 8  28 10 18  9 8 5 
B3 Sputum 29-09-2005 Yes  18 12 8  28 10 18  9 8 5 
B4 Sputum 03-10-2005 Yes  18 12 8  28 10 18  9 8 5 
B5 Sputum 06-10-2005 Yes  18 12 8  28 10 18  9 8 5 
B6 Sputum 10-10-2005 Yes  18 12 8  28 10 18  9 8 5 
B7 Sputum 12-10-2005 Yes  18 12 8  28 10 18  9 8 5 
B8 Sputum 16-10-2005 Yes  18 12 8  28 10 18  9 8 5 
B9 Sputum 26-10-2005 Yes  18 12 8  28 10 18  9 8 5 
B10 Serum, GM 0.4 26-10-2005 No  neg neg neg  neg neg neg  neg neg neg 
B11 Sputum 27-10-2005 Yes  18 12 8  28 10 18  9 8 5 
B12 Sputum 31-10-2005 Yes  18 12 8  28 10 18  9 8 5 
B13 Sputum 03-11-2005 Yes  18 12 8  28 10 18  9 8 5 
B14 BAL 07-11-2005 Yes  18 12 8  28 10 18  9 8 5 
B15 Ascitis fluid 07-11-2005 Yes  18 12 8  28 10 18  9 8 5 
B16 Serum, GM 4.0 08-11-2005 No  18 12 8  28 10 18  9 8 5 
B17 Sputum 08-11-2005 No  18 12 8  28 10 18  9 8 5 
B18 Serum, GM 5.6 09-11-2005 No  18 12 8  28 10 18  9 8 5 
B19 Biopsy lung 09-11-2005 No  18 12 8  28 10 18  9 8 5 
                
C1 Sputum 10-05-2007 Yes  21 25 18  27 12 7  21 10 8 
C2 Sputum 10-05-2007 Yes  18 20 15  28 11 21  26 26 8 
C3 Bronchial biopsy 11-05-2007 No  neg neg 18  27 12 7  neg 10 8 
C4 Serum 11-05-2007 No  neg neg neg  neg neg neg  neg neg neg 
C5 Sputum 14-05-2007 Yes  18 28 15  16 10 19  8 8 5 
C6 Sputum 15-05-2007 Yes  21 25 18  27 12 7  21 10 8 
C7 Sputum 31-05-2007 Yes  21 25 18  27 12 7  21 10 8 
C8 Sputum 04-06-2007 Yes  21 25 18  27 12 7  21 10 8 
C9 Serum 04-06-2007 No  neg neg neg  neg neg neg  neg neg neg 
C10 Sputum 11-06-2007 Yes  21 25 18  27 12 7  21 10 8 
C11 Sputum 18-06-2007 Yes  21 25 18  27 12 7  21 10 8 
C12 Sputum 21-06-2007 Yes  21 25 18  27 12 7  21 10 8 
C13 Sputum 24-06-2007 Yes  21 25 18  27 12 7  21 10 8 
C14 Sputum 25-06-2007 Yes  21 25 18  27 12 7  21 10 8 
C15 Sputum 28-06-2007 Yes  21 25 18  27 12 7  21 10 8 
C16 Sputum 02-07-2007 Yes  21 25 18  27 12 7  21 10 8 
C17 Sputum 09-07-2007 Yes  21 25 18  27 12 7  21 10 8 
C18 Sputum 11-07-2007 Yes  21 25 18  27 12 7  21 10 8 
C19 Sputum 16-07-2007 Yes  21 25 18  27 12 7  21 10 8 
C20 Sputum 19-07-2007 Yes  21 25 18  27 12 7  21 10 8 
 
 
Direct genotyping of A. fumigatus from serum and tissue samples 
 171
 STRAf type Patient + 
no. Origin 
Date of 
isolation 
(day-mo-yr) 
Cultured 
isolate  2A 2B 2C  3A 3B 3C  4A 4B 4C 
C21 Sputum 23-07-2007 Yes  21 25 18  27 12 7  21 10 8 
C22 Sputum 23-07-2007 Yes  18 12 18  27 22 21  18 9 5 
C23 Serum 26-07-2007 No  neg neg neg  neg neg neg  neg neg neg 
C24 Sputum 26-07-2007 Yes  21 25 18  27 12 7  21 10 8 
C25 Serum 28-07-2007 No  neg neg neg  neg neg neg  neg neg neg 
C26 Sputum 30-07-2007 Yes  21 25 18  27 12 7  21 10 8 
C27 Sputum 30-07-2007 Yes  21 25 18  27 12 7  21 10 8 
C28 Bronchial biopsy 30-07-2007 No  21 25 18  27 12 7  21 10 8 
                
D1 Sputum 12-12-2004 Yes  11 12 17  26 21 21  14 8 5 
D2 BAL 13-12-2004 Yes  11 12 17  26 21 21  14 8 5 
D3 BAL 13-12-2004 Yes  11 12 17  26 21 21  14 8 5 
D4 Lung tissue 15-12-2004 Yes  11 12 17  26 21 21  14 8 5 
D5 Lung abscess 15-12-2004 Yes  11 12 17  26 21 21  14 8 5 
D6 Serum 16-12-2004 No  neg neg neg  neg neg neg  neg neg neg 
D7 Serum, GM 0.2 16-12-2004 No  neg neg neg  neg neg neg  neg neg neg 
D8 Biopsy lung 16-12-2004 No  11 12 17  26 21 21  14 8 5 
                
E1 BAL 22-02-2006 Yes  18 23 16  38 11 46  10 9 8 
E2 Bronchial biopsy 22-02-2006 No  18 23 16  38 11 46  10 9 8 
                
 
 
Discussion 
 
We have shown here that it is technically feasible to genotype A. fumigatus directly 
from serum and FFPE tissue samples without the need for cultivation of the isolate. To be 
able to obtain genotypes directly from FFPE tissue and serum samples, it is important that 
only DNA of the fungus is amplified. With previously described high resolution typing 
assays for A. fumigatus such as AFLP 4 and RAPD 1, human DNA will also be amplified 
and will corrupt the banding patterns. Current PCR protocols to specifically detect A. 
fumigatus, like real-time assays targeting the ITS region 8, 11 or mitochondrial DNA 9 in 
clinical samples are not suitable to distinguish between isolates from different origin. 
With the STRAf assay, not only an identification of the histopathologically identified 
fungus is possible, but also a STRAf genotype can be assigned to the fungus seen by 
histology. This assay only amplified specific A. fumigatus targets and the method is highly 
discriminating 3  
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The genotypes found within the patients B, D and E were identical for all samples. 
Patient C showed isolates obtained from sputum with different genotypes, the dominant 
genotype was also found in the lung tissue. These results are in concordance with previous 
studies, where A. fumigatus isolates obtained from respiratory and deeper tissue samples 
were investigated 4, 5. Five of the six cultured isolates of patient A were identical to a lung 
biopsy sample of this patient. A remarkable result in this patient was that more than 2 
genotypes were found in two other lung biopsies. An explanation would be that the 
sample was contaminated by several isolates from the respiratory tract of this patient 
during the biopsy.  
In one patient (B) it was also possible to obtain a genotype from several serum 
samples. The samples with the highest galactomannan values contained sufficient fungal 
DNA to determine the genotype of the isolate. To obtain signals from the low amount of 
fungus DNA in FFPE tissue and serum samples optimal PCR conditions are required. All 
samples used in this study were amplified using multiplex PCR reactions. These multiplex 
reactions should be perfectly balanced to obtain optimal amplification of all the targets. 
Therefore, another option to increase the sensitivity of PCR amplification is to use 
monoplex reactions for each target. In this study no monoplex reaction were tested, 
because in only one biopsy (C3) two dinucleotide repeats (STRAf2A and STRAf 2B) and 
one tetranucleotide repeat (STRAf 4A) remained negative, while the six remaining loci 
yielded good interpretable peaks. These six loci showed identical repeat numbers as the 
cultured isolate of this patients and were considered to be identical to each other. 
Therefore, there is no guarantee that monoplex reaction will yield good interpretable 
results, since each individual PCR reactions may have a different sensitivity leading to 
failure of amplification with some markers in samples with very low loads.  
In conclusion, the STRAf assay allows simultaneous detection as well as high 
resolution genotyping of A. fumigatus directly in clinical samples without the need for 
culture. This approach allows (retrospective) examination of dissemination routes of A. 
fumigatus in patients with IA and might be used towards a better understanding of the 
pathogenesis of this disease.  
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Summarizing discussion 
 
 Aspergillus species are widely distributed fungi that release large amounts of 
airborne conidia that are dispersed in the environment. Several Aspergillus species have 
been described as human pathogens. Aspergillus fumigatus is the species most frequently 
isolated from human infections. To investigate the epidemiologic relation between 
environmental and clinical isolates molecular typing techniques have been developed. 
Fingerprinting techniques for A. fumigatus require a high discriminatory power and need 
to be highly reproducible, since a high extent of genetic variability has been demonstrated 
for this species 8, 10. The RFLP (Restriction Fragment Length Polymorphism) method in 
combination with the Afut1 hybridization probe is highly discriminatory 11, 20. The time-
consuming and labor intensive performance together with the difficult interpretation of the 
complex RFLP banding patterns, makes the RFLP method far from ideal for typing large 
amount of isolates. In contrast, typing techniques which yield sequence data, like MLST 2 
and CSP 3, are 100% reproducible and the data can be readily exchanged between 
laboratories. Unfortunately these methods lack sufficient discriminatory power for large 
scale studies. Microsatellites or short tandem repeats (STRs), however, have shown to 
provide a high level of discrimination between different isolates in a wide variety of 
micro-organisms. They are also extensively being used for high-resolution fingerprinting 
of the human genome. Bart-Delabesse et al. 4 firstly used STRs to type A. fumigatus, the 
so-called MLP method (Microsatellite Length Polymorphism). Because no genomic 
sequences were available at that time, among 17.000 clones were screened with a CA10 
oligonucleotide probe. Four polymorphic CA-microsatellite loci were retained for further 
analysis. The discriminatory power of these four markers is almost equal to that of RFLP 
5, 15. STR analysis yielded highly reproducible and exact typing results, which allow the 
easy exchange of data. In two of the MLP loci a second repeat sequence was located next 
to the CA-repeat. Different combinations of two repeat sequences in a single PCR 
amplicon may lead to the formation of fragments of the same length. This makes it 
impossible to determine the exact repeat number for each of the two repeats and 
compromises the exact nature of the STR assay.  
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Therefore in chapter 2 we describe the development of a novel assay based on nine short 
tandem repeats for exact and high-resolution fingerprinting of A. fumigatus, the so-called 
STRAf assay. The repeats were searched in silico in the available genomic sequences of A. 
fumigatus. The availability of genomic sequences simplified the analysis for the presence 
of STRs. Three multiplex PCRs were made for three perfect di-, tri- and tetranucleotide 
repeats. The STRAf assay was able to differentiate all unrelated A. fumigatus isolates from 
nonoutbreak situations. The Simpson’s diversity index 14 for the nine loci is 0.9994, which 
confirms the high discriminatory power of this assay. In theory this panel is able to 
discriminate between 27 x 109 different genotypes. This is an improvement of close to 
106-fold over that obtained with the previously reported MLP panel 4.  
 In the remaining part of this thesis, the technical aspects of the STRAf assay are 
described as well as the application of the assay for clinical purposes. 
 
Part 1: Technical aspects 
 
 In chapter 3 the performance of STRAf panel was compared to AFLP (Amplified 
Fragment Length Polymorphism), which is another high discriminatory molecular 
fingerprinting assay. A total of 55 A. fumigatus isolates, obtained from 15 different 
patients suffering from invasive aspergillosis, were analyzed using the STRAf panel and 
the AFLP method. This set of isolates was also analyzed with a new method, RISC 
(Retrotransposon Insertion-Site Context)-typing, which is described in detail in chapter 4. 
In general, there was an excellent agreement between the STRAf, RISC and AFLP 
methods. The slight differences that were observed were not entirely unexpected since 
each of the three methods target different parts of the fungal genome. A clear advantage of 
the STRAf assay compared to AFLP and RISC is its ability to identify mixture of isolates. 
It has been demonstrated that specimens from respiratory origin and environmental 
samples may contain multiple different genotypes 6, 9, 13, 26. A major difference between the 
typing methods is the interpretation of the obtained fingerprint results. Amplification 
products of the STRAf assay are sized automatically and converted into repeat numbers, a 
genotype consist of nine repeat numbers, which is easy to interpret.  
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The AFLP and RISC results consist of complex banding patterns with multiple strong as 
well as weak bands. To determine the genetic relationship between multiple isolates, one 
has to rely on specialized computer software which rely on patterns based algorithms. 
Visual identical banding patterns were never calculated to be 100% identical with 
computerized analysis using a pattern based algorithm. The long-term reproducibility and 
intralaboratory comparisons may also be quite challenging for both the AFLP and RISC 
methods. Because small differences in the AFLP and RISC fingerprints exist, due to small 
variations occurring during restriction/ligation, PCR amplification and fragment analysis, 
these may affect the final peak intensity. However, the intralaboratory reproducibility of 
the STRAf assay is 100%. In order for any typing technique to be successfully used in 
other settings, the most important factor is reproducibility. The STRAf assay offers the 
most benefits compared to AFLP and RISC-typing. The robustness of the STRAf assay 
under different amplification conditions was investigated in chapter 5. Various 
components of the PCR reaction and thermocycling parameters were deliberately and 
systemically altered to investigate their effect on the outcome of this assay. Some extreme 
conditions let to a loss of signal, but, under all conditions where a signal was obtained, 
identical typing results were produced. Thus, the STRAf assay proved to be extremely 
robust and should be used in other settings without problems. A major pitfall concerning 
the exchange of STRAf data between different laboratories is the assignment of the repeat 
numbers to the principal peak, which is routinely established by sizing of the DNA 
fragment and comparing it to the size of the reference fragments with established repeat 
numbers. It is often not realized that sizing DNA fragments only yield relative data, 
because the electrophoretic mobility of a DNA fragment is influenced by multiple factors. 
Thus, sizing values alone are not suitable for exchange unless a careful calibration of the 
different platforms has been established. Such a calibration could consist of the generation 
of calibration curves as demonstrated by Pasqualotto et al. 22. But the most straightforward 
method to achieve such a calibration is the use of allelic ladders. An allelic ladder consist 
of a mixture of well-defined alleles with predetermined repeat numbers.  
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Such allelic ladders have been introduced as reference tools in human forensic 
applications in the early 1990’s 23, 24, but have not yet been described for calibration of 
microbial micosatellite based typing schemes.  
In chapter 6 allelic ladders were developed for the STRAf 3 marker. The 
reproducibility and compatibility of the STRAf assay was investigated in different 
settings, with the use of these ladders for calibration purposes. Five laboratories 
independently analyzed 18 samples that were provided either as DNA or as A. fumigatus 
conidia. All laboratories were allowed to use their own equipment. The results 
demonstrate that identical alleles, analyzed on different platforms with different size 
standards may differ up to 6.7 nucleotides. This results in interpretation errors up to 2 
repeats units for the trinucleotide repeats. In contrast, with the use of the allelic ladders all 
participants were able to produce identical typing data for all the STRAf 3 markers in 
nearly all samples with a wide variety of experimental conditions.  
In chapter 7 the stability of the individual markers of the STRAf assay was 
investigated. Knowledge of the rate of repeat change is important when using STRAf as 
part of an outbreak investigation, in order to be able to interpret the relationship between 
isolates with different typing results. To investigate the dynamics of the STRAf markers, 
five unrelated A. fumigatus isolates were clonally expanded for 100 generations. All 
subcultures were generated from a single spore and analyzed with the nine STRAf loci. In 
total, five times a change in the number of repeat units was observed. All changes 
occurred in the trinucleotide repeats and four of the five alterations were found in markers 
with 50 or more repeat numbers. For the interpretation of the typing results this means that 
expansion of one repeat unit to a repeat consisting of five units may, for example, have a 
relative larger effect than adding a unit to a repeat that already contain 40 units.  
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Part 2: Clinical applications 
 
A. fumigatus plays an important role in several clinical manifestations. Invasive 
aspergillosis, for example, is a life-threatening disease of immunocompromised patients.   
The incidence of IA has grown dramatically in recent years due to the increase in the 
number of patients undergoing bone marrow or solid organ transplantation 12, 16, 28. The 
STRAf assay can be used to provide a better understanding of the uniqueness of each 
clinical isolate and of its dissemination route. Pulmonary infections are thought to arise by 
local tissue invasion, and eventually disseminate to other deep seated organs. In chapter 3 
the genetic relatedness between 55 isolates obtained from respiratory and tissue samples 
obtained from 15 patients with proven IA was examined. Within the patients all 
nonrespiratory isolates belonged to the same genotype. However, multiple genotypes were 
detected in isolates originated from respiratory samples from the same patient. These 
results are consistent with a scenario in which the respiratory tract may be colonized by 
several different genotypes, as inhalation of fungal conidia is assumed to be the first step 
towards infection, but where a single genotype gains supremacy and invades the 
surrounding tissue eventually disseminating to other organs. Besides comparing clinical 
isolates with each other, it is also important to compare patient isolates with isolates 
obtained from the environment, since evidence suggest that IA infections may be acquired 
from hospital environment 7, 18. Therefore the STRAf assay was tested for its utility in 
outbreak settings in chapter 8, where it is critical to distinguish clonal clusters from 
genetically unrelated isolates. A panel of epidemiologically linked isolates obtained from 
6 different outbreaks of IA were analyzed with the STRAf assay. These isolates have also 
been subjected to the RFLP method including the Afut1 DNA hybridization probe and to 
CSP-typing. Isolates from three of the six outbreaks showed no relation to each other, 
while in the three other outbreaks identical genotypes were found. In two of these 
outbreaks clinical and environmental isolates were of the same genotype. The results 
found with the STRAf assay were in good agreement with the Afut1-RFLP method.  
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Besides IA, A. fumigatus can also colonize the respiratory tract of patients with 
compromised airways 25. The most common complication of Aspergillus colonization is 
allergic bronchopulmonary aspergillosis (ABPA), which can occur in children, 
adolescents and adults with cystic fibrosis (CF). In 57% of the CF patients the respiratory 
tract is colonized by Aspergillus species, 1 to 15% of these patients developed ABPA 1, 19, 
27. In chapter 9 204 A. fumigatus isolates obtained from 36 CF patients were typed, to 
gain more insight in the airway colonization by A. fumigatus in CF patients. The isolates 
were collected from sequential sputum samples over a period of 4 months till 9 ½ years. 
In general, four different colonization patterns can be discriminated in this collection of 
CF patients: i Continuous colonization patterns: all isolates consist of identical or related 
genotypes. ii Colonization patterns with a predominant genotype: most of the isolates are 
identical. iii Succeeding colonization patterns: isolates with identical genotypes that 
succeed each other. iv Unique patterns: all isolates within a patient have unique 
genotypes. Most patients have a colonization pattern with unique isolates (36%), the 
smallest group of patients (17%) have a continuous colonization pattern. A notable result 
in this study is, that at two patients identical isolates were found over a period longer than 
nine years. This also indicates that the STRAf markers are sufficiently stable for 
epidemiological questions. 
 The aim of the study described in chapter 10 was to genotype A. fumigatus 
directly in formalin-fixed paraffin-embedded (FFPE) tissue and serum samples. This is 
desirable since A. fumigatus cultures are not available in all cases, because the tissue 
biopsy specimens are directly embedded into formalin fixative 17 and A. fumigatus is 
virtually never isolated from blood cultures 21. The STRAf assay was performed on 
cultured isolates, tissue and serum samples of five patients. Genotypes were obtained from 
the lung biopsies and in one patient even in serum samples. This allows detection as well 
as genotyping of A. fumigatus directly on clinical samples without the need of cultivation. 
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In conclusion 
 
In this thesis a novel assay for fingerprinting A. fumigatus is described and 
evaluated. This assay demonstrate several characteristics important for a good typing 
assay. Of major importance was the ability to discriminate between unrelated isolates. 
Typing results from epidemiological related collections showed identical genotypes and 
the results are in concordance with other high discriminatory typing techniques. Other 
advantages include the requirement of low amounts of DNA, and the automated sizing of 
amplification products result in the relatively easy interpretation of the data. The STRAf 
assay is also rapid and has a high throughput by multiplexing. The assay is robust, which 
makes it possible to successfully use the assay in other settings. Together with the use of 
allelic ladders it is even possible to exchange fingerprint typing data between laboratories, 
provided that they have access to high resolution electrophoresis platforms. In CF patients 
different colonization patterns were found with the STRAf assay. In IA patients the 
uniqueness of clinical isolate and the dissemination route are evaluated. With the option to 
genotype A. fumigatus directly in FFPE-tissue samples and serum samples, it is possible 
to retrospectively examine dissemination routes in IA patients without A. fumigatus 
cultures. In outbreak settings, where besides clinical isolates also environmental isolates 
were analyzed, variations in a single loci between epidemiological related isolates were 
found. The knowledge of the rate of change of the individual markers of the STRAf assay, 
may provide good guidelines for the interpretation of different STRAf typing patterns. 
 The high throughput of samples, the low costs, the robustness and the 
interlaboratory reproducibility together with the high discrimination power makes this 
assay suitable for fingerprinting large amount of isolates and exchange of results between 
labs worldwide.  
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Samenvatting 
 
Aspergillus soorten zijn schimmels die wereldwijd veel voorkomen. Deze 
schimmels kunnen grote hoeveelheden sporen produceren die in de omgeving worden 
verspreid. Er zijn verschillende Aspergillus soorten beschreven die pathogeen blijken te 
zijn voor de mens. Van alle soorten is Aspergillus fumigatus het meest betrokken bij 
humane infecties. Om besmettingsroutes tussen omgeving en klinische isolaten beter in 
kaart te brengen zijn er veel verschillende moleculaire typeringsmethoden ontwikkeld. De 
genetische variabiliteit binnen A. fumigatus isolaten blijkt erg hoog te zijn, zodat 
typeringsmethoden een hoog discriminerend vermogen en een goede reproduceerbaarheid 
moeten hebben om ongerelateerde isolaten van elkaar te kunnen onderscheiden 8, 10. De 
RFLP (Restriction Fragment Length Polymorphism) methode in combinatie met de Afut1 
hybridisatie probe heeft een goed onderscheidend vermogen 11, 20. De RFLP methode heeft 
een aantal nadelen als het gaat om het analyseren van grote hoeveelheden isolaten, omdat 
de techniek arbeidsintensief is en de complexe bandenpatronen die worden gegenereerd 
moeilijk te interpreteren zijn. In tegenstelling zijn typeringsmethoden waarbij sequentie 
data wordt verkregen, zoals MLST (Multilocus Sequence Typing)2 en CSP (Cell Surface 
Protein) typing 3, 100% reproduceerbaar, waardoor data gemakkelijk kunnen worden 
uitgewisseld tussen verschillende laboratoria. Helaas hebben ook deze methoden te weinig 
discriminerend vermogen voor studies met grote hoeveelheden isolaten. Echter 
microsatellieten of short tandem repeats (STRs) laten een hoog discriminerend vermogen 
zien tussen verschillende isolaten uit een grote variëteit aan micro-organismen. Ze worden 
ook veel gebruikt als hoge resolutie fingerprinting-techniek voor het humane genoom. 
Bart-Delabesse et al. 4 gebruikte als eerste STRs voor het typeren van A. fumigatus, de 
zogenoemde MLP methode (Microsatellite Length Polymorphism). Aangezien er 
toentertijd geen genomische sequenties van A. fumigatus beschikbaar waren, werden zo´n 
17.000 klonen gescreend met een CA10 oligonucleotide probe. Vier CA-microsatellieten 
merkers werden geselecteerd voor verdere analyse. Het onderscheidende vermogen van 
deze vier merkers was vergelijkbaar met de RFLP 5, 15. STR analyses resulteren in goed 
reproduceerbare en exacte typeringsresultaten, die makkelijk uitwisselbaar zijn.  
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In twee MLP merkers zit een tweede repeat sequentie naast de CA-repeat. Hierdoor 
kunnen fragmenten van dezelfde lengte verschillende combinaties van deze twee repeat 
sequenties bevatten. Het wordt dan onmogelijk om op basis van de fragment grootte het 
precieze aantal repeats te bepalen, waardoor het exacte karakter van de techniek verloren 
gaat. Daarom wordt in hoofdstuk 2 voor A. fumigatus een nieuwe typeringsmethode 
beschreven, de zogenoemde STRAf methode, gebaseerd op negen short tandem repeats 
voor exacte en hoge resolutie typering. Deze negen merkers zijn geselecteerd uit grote 
delen van genomische A. fumigatus sequenties die op dat moment bekend waren. Het 
zoeken naar STRs is sterk vereenvoudigd doordat genomische sequenties ter beschikking 
zijn gekomen. Er zijn drie multiplex PCRs ontwikkeld voor respectievelijk drie di-, tri- en 
tetranucleotide merkers. Met de STRAf methode was het mogelijk om ongerelateerde 
isolaten van elkaar te onderscheiden. De Simpson’s diversity index 14 voor de negen 
merkers is 0.9994, hetgeen aangeeft dat het discriminerende vermogen erg hoog is. In 
theorie is het zelfs mogelijk om met deze negen merkers 3 x 1013 verschillende genotypen 
van elkaar te onderscheiden. Dit is een 106-voudige verbetering ten opzichte van de eerder 
genoemde MLP methode 4. 
 In de volgende onderdelen van dit proefschrift worden naast de technische 
aspecten van de STRAf methode ook de klinische toepassingen van deze methode 
beschreven. 
 
Deel 1: Technische aspecten 
 
 In hoofdstuk 3 wordt de STRAf methode vergeleken met de AFLP (Amplified 
Fragment Length Polymorphism) methode, een andere goed discriminerende moleculaire 
fingerprint-techniek. In totaal worden 55 A. fumigatus isolaten, verkregen van 15 
verschillende patiënten met invasieve aspergillosis, geanalyseerd met zowel de STRAf als 
de AFLP methode. Deze isolaten zijn ook getest met een nieuwe methode, namelijk de 
RISC (Retrotransposon Insertion-Site Context)-typering. Deze techniek staat in detail 
beschreven in hoofdstuk 4. Over het algemeen was er een zeer goede overeenkomst van 
de resultaten van de STRAf, RISC en AFLP methode.  
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De verschillen die zijn gevonden waren niet geheel onverwacht omdat elke methode een 
ander deel van het genoom analyseert. Een duidelijk voordeel van de STRAf methode 
vergeleken met de AFLP en de RISC methoden is de mogelijkheid om mengsels van 
meerdere isolaten te identificeren. Het is gebleken dat klinische monsters uit de 
luchtwegen en omgevingsmonsters meerdere verschillende genotypen kunnen bevatten 6, 9, 
13, 26. Een ander verschil tussen de drie typeringsmethoden is de interpretatie van de 
resultaten. De bepaling van de grootte van een PCR product voor de STRAf methode is 
geautomatiseerd. Aan de hand van de grootte van een fragment worden het aantal kopieën 
van de STR merker bepaald. Een genotype bestaat uit negen getallen, die gemakkelijk te 
interpreteren zijn. De AFLP en de RISC resultaten bestaan uit complexe bandenpatronen 
met meerdere sterke en zwakke banden. Om de genetische relatie tussen meerdere isolaten 
te kunnen bepalen, moet er gebruik worden gemaakt van speciale computer software met 
patroon gebaseerde algoritmen. Met deze algoritmen worden op het oog identieke 
bandenpatronen nooit als 100% gelijk berekend. Een goede reproduceerbaarheid op de 
lange termijn en het vergelijken van resultaten tussen verschillende experimenten binnen 
een laboratorium is voor de AFLP en RISC methode moeilijk haalbaar, zoniet onmogelijk. 
Dit wordt veroorzaakt doordat kleine verschillen in de AFLP en RISC methode ontstaan 
door geringe variaties tijdens de restrictie/ligatie stap, gedurende de PCR amplificatie en 
de analyse van de PCR producten. De reproduceerbaarheid van de STRAf methode binnen 
een laboratorium daarentegen is 100%. De reproduceerbaarheid moet goed zijn om een 
methode succesvol te kunnen gebruiken in een ander laboratorium. In vergelijking met de 
AFLP en de RISC methode lijkt de STRAf methode hiervoor het meest geschikt. De 
robuustheid van de STRAf methode is onderzocht in hoofdstuk 5 door de amplificatie 
condities van de methode te variëren. Hier is gekeken wat het effect is van het stapsgewijs 
variëren van verschillende PCR reactie componenten en thermocycler parameters. 
Extreme condities zorgde ervoor dat het signaal verdween, echter als er een signaal 
verkregen werd, dan waren de resultaten identiek. Dit betekent dat de STRAf methode 
zeer robuust is en dat deze zonder problemen in andere instellingen gebruikt zou moeten 
kunnen worden.  
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Een valkuil voor het uitwisselen van STRAf data tussen verschillende laboratoria wordt 
veroorzaakt door de toekenning van het aantal kopieën aan het PCR product. Normaal 
gesproken wordt het DNA fragment vergeleken met de lengte van een referentie product 
waarvan het aantal kopieën bekend is. Vaak realiseert men zich niet dat de lengte van een 
fragment alleen relatieve data oplevert, omdat de electroforetische mobiliteit van een 
DNA fragment beinvloedt wordt door vele factoren. Dus het bepalen van de lengte van 
PCR fragmenten alleen is niet voldoende voor uitwisseling, tenzij de verschillende 
electroforese platforms gekalibreerd worden. Een dergelijke kalibratie kan tot stand 
komen door het maken van kalibratie curven 22. De beste manier om platforms te 
kalibreren is echter door gebruik te maken van allelische ladders. Een allelische ladder 
bestaat uit een mix van goed gedefinieerde allelen waarvan het aantal STR kopieën vooraf 
is bepaald. Deze allelische ladders zijn in de vroege jaren ’90 als referentie middel 
geïntroduceerd in humane forensische bepalingen 23, 24, maar zijn nog niet eerder 
beschreven op microsatellieten gebaseerde microbiële typeringsmethoden. 
 Hoofdstuk 6 beschrijft de ontwikkeling van de allelische ladders voor de STRAf 3 
merkers. De reproduceerbaarheid en de toepasbaarheid van de STRAf methode is getest in 
verschillende instellingen waarbij gebruik gemaakt is van allelische ladders. Vijf 
laboratoria hebben onafhankelijk van elkaar 18 monsters geanalyseerd, die toegestuurd 
zijn als DNA of als A. fumigatus sporen. Alle laboratoria hebben gebruik gemaakt van hun 
eigen apparatuur. De resultaten laten zien dat identieke allelen, geanalyseerd op 
verschillende platforms met verschillende interne standaarden een verschil kunnen 
opleveren tot 6,7 nucleotiden. Dit zou een interpretatiefout opleveren van meer dan 2 
kopieën voor de trinucleotide repeats. Echter met het gebruik van de allelische ladders 
was het voor alle deelnemers mogelijk om identieke resultaten te genereren voor alle 
STRAf 3 merkers in bijna alle monsters met een grote verscheidenheid aan experimentele 
condities.  
In hoofdstuk 7 wordt de stabiliteit van de individuele markers onderzocht. Het is 
belangrijk om te weten hoe snel een repeat verandert wanneer de STRAf methode ingezet 
wordt om een uitbraak te onderzoeken, zodat het mogelijk is de relatie tussen isolaten met 
verschillende genotypen goed te interpreteren.  
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Om de veranderingen van de STRAf merkers te onderzoeken, zijn vijf ongerelateerde A. 
fumigatus isolaten 100 keer overgeënt. Alle subculturen zijn verkregen vanuit een enkele 
spore en geanalyseerd met de negen STRAf merkers. In totaal, zijn er vijf veranderingen 
opgetreden in het aantal kopieën. Alle veranderingen kwamen voor in de trinucleotide 
repeats en vier van de vijf veranderingen zijn gevonden in merkers met 50 of meer 
kopieën. Voor de interpretatie van typeringsresultaten betekent dit dat een verandering 
van één kopie in een merker met vijf kopieën een relatief groter effect heeft dan een 
toevoeging van een repeat aan een merker met 40 kopieën.  
 
Deel 2: Klinische toepassingen 
 
A. fumigatus speelt een belangrijke rol in meerdere klinische ziektebeelden. 
Invasieve aspergillosis (IA), bijvoorbeeld, is een levensbedreigende ziekte bij immuun-
gecompromitteerde patiënten. Met de toename van het aantal patiënten met een beenmerg- 
of orgaantransplantatie, is ook het aantal patiënten met IA dramatisch gestegen 12, 16, 28. De 
STRAf methode kan ingezet worden om een beter inzicht te krijgen in hoe uniek elk 
klinisch isolaat is en op welke wijze verspreidingsroute gaat. Van luchtweginfecties wordt 
gedacht dat deze dissemineren door lokale ingroei in het weefsel, waarna er een verdere 
verspreiding ontstaat naar dieper gelegen organen. In hoofdstuk 3 wordt de genetische 
relatie van 55 isolaten bekeken. Dezw isolaten zijn afkomstig uit luchtweg en weefsel 
materialen van 15 patiënten met bewezen IA. Alle isolaten binnen een patiënt, die niet 
afkomstig zijn uit de luchtwegen, behoren tot hetzelfde genotype. Echter, als bij één 
patiënt meerdere genotypen gevonden zijn, zijn deze isolaten allemaal gekweekt uit 
respiratoire monsters. Deze resultaten tonen aan dat de luchtwegen gekoloniseerd zijn met 
meerdere verschillende genotypen, als gevolg van inhalatie van schimmelsporen, waarvan 
één enkel genotype dominant wordt en de omliggende weefsels binnendringt en zich 
uiteindelijk verspreidt naar andere organen.  
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Naast de vergelijking van klinische isolaten met elkaar, is het ook belangrijk om deze 
isolaten te vergelijken met isolaten verkregen uit de omgeving, ook omdat er gedacht 
werd dat IA infecties kunnen ontstaan uit de ziekenhuis omgeving 7, 18. Daarom wordt in 
hoofdstuk 8 gekeken wat het nut is van de STRAf methode in uitbraak situaties, waar het 
van belang is om klonale clusters te onderscheiden van genetisch ongerelateerde isolaten. 
Een set van epidemiologisch gerelateerde isolaten, verkregen uit 6 verschillende IA 
uitbraken, werden geanalyseerd met de STRAf methode. Deze isolaten zijn ook getest met 
de RFLP methode inclusief de Afut1 hybridisatie probe en met CSP typering. Isolaten 
afkomstig van drie van de zes uitbraken hebben geen relatie met elkaar, terwijl in de 
andere drie uitbraken identieke genotypen zijn gevonden. In twee van deze uitbraken zijn 
identieke genotypen gevonden in klinische- en omgevingsisolaten. De resultaten 
verkregen met de STRAf methode komen goed overeen met de Afut1-RFLP methode. 
 Naast het veroorzaken van IA, kan A. fumigatus ook de luchtwegen van patiënten 
met gecompromitteerde luchtwegen koloniseren 25. De meest voorkomende complicatie 
van Aspergillus kolonisatie is allergische bronchopulmonale aspergillose (ABPA), 
hetgeen voorkomt bij kinderen, ouderen en volwassenen met cystic fibrosis (CF). Bij 57% 
van de CF patiënten zijn de luchtwegen gekoloniseerd met Aspergillus soorten en 1 tot 
15% van deze patiënten ontwikkelen ABPA 1, 19, 27. In hoofdstuk 9 worden 204 isolaten 
verkregen van 36 CF patiënten getypeerd om meer inzicht te krijgen in de luchtweg 
kolonisatie van A. fumigatus bij CF patiënten. De isolaten zijn verzameld uit 
opeenvolgende sputum monsters over een periode van 4 maanden tot 9 ½ jaar. Over het 
algemeen kunnen er vier verschillende kolonisatie patronen onderscheiden worden in deze 
verzameling van CF patiënten namelijk: i Continue kolonisatie patroon: alle isolaten 
bestaan uit identieke of gerelateerde genotypen. ii Kolonisatie patroon met een 
overheersend genotype: bijna alle isolaten zijn identiek. iii Opeenvolgend kolonisatie 
patroon: isolaten met identieke genotypen wisselen elkaar af. iv Unieke patronen: alle 
isolaten binnen een patiënt hebben unieke genotypen. De meeste patiënten hebben een 
uniek kolonisatie patroon (36%), de kleinste patiënten groep heeft een continue 
kolonisatie patroon (17%).  
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Een opmerkelijk resultaat uit deze studie is dat bij twee patiënten identieke isolaten zijn 
gevonden over een periode langer dan 9 jaar. Dit laat tevens zien dat de STRAf merkers 
voldoende stabiel zijn voor epidemiologische vraagstukken. 
Het doel van de studie beschreven in hoofdstuk 10 was om A. fumigatus direct in 
formaline gefixeerde paraffine (FFPE) weefsels en sera monsters te typeren. Dit is van 
belang omdat A. fumigatus kweken niet altijd beschikbaar zijn, omdat weefsel biopten 
direct gefixeerd worden in formaline 17 en omdat A. fumigatus vrijwel nooit wordt 
geïsoleerd uit bloed 21. De STRAf methode is ingezet om gekweekte isolaten, weefsel- en 
serummonsters van vijf patiënten te analyseren. In alle long weefsels was het mogelijk een 
genotype te genereren en in één patiënt was het zelfs mogelijk een genotype in serum aan 
te tonen. Dit maakt het mogelijk om A. fumigatus te detecteren en te typeren in klinische 
materialen, zonder deze schimmel eerst te kweken.  
 
Conclusie 
 
 In dit proefschrift wordt een nieuwe methode, namelijk de STRAf,  beschreven 
voor de typering van A. fumigatus en geëvalueerd. Deze methode laat verschillende 
karaktereigenschappen zien die evident zijn voor een goede typeringsmethode. Het 
belangrijkste is dat deze methode ongerelateerde isolaten van elkaar kan onderscheiden. 
Typeringsresultaten van epidemiologisch gerelateerde verzamelingen laten identieke 
genotypen zien en de resultaten komen overeen met andere goed discriminerende 
typeringstechnieken. Andere voordelen van deze methode zijn de lage hoeveelheid DNA 
die nodig is, het automatisch toekennen van lengtes aan PCR producten en het relatief 
gemakkelijk interpreteren van de data. De STRAf methode is snel en er kunnen veel 
monsters tegelijk geanalyseerd worden doordat de PCRs bestaan uit multiplex reacties. 
Samen met het gebruik van allelische ladders is het zelfs mogelijk om data uit te wisselen 
met andere labs, mits deze de beschikking hebben over een hoog resolutie electroforese 
platform. Met de STRAf methode worden verschillende kolonisatiepatronen gevonden bij 
CF patiënten. Bij IA patiënten is gekeken hoe uniek isolaten zijn en naar de verspreiding 
van isolaten binnen een patiënt.  
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Met de mogelijkheid om A. fumigatus direct in FFPE-weefsels en sera monsters te 
typeren, kan met terugwerkende kracht de verspreiding van isolaten in IA patiënten 
onderzocht worden, zonder dat een stam gekweekt is. In uitbraak situaties, waar naast 
klinische isolaten ook omgevingsisolaten worden geanalyseerd, worden tussen 
epidemiologische verwante isolaten variaties gevonden in een enkele merker. Door inzicht 
te krijgen in de mate van verandering van individuele merkers van de STRAf methode, 
kunnen goede richtlijnen opgesteld worden voor de interpretatie van verschillende STRAf 
typeringsresultaten. 
 Door de lage kosten, de robuustheid en de reproduceerbaarheid tussen 
verschillende instellingen, in combinatie met het hoge onderscheidend vermogen van deze 
methode is het mogelijk om grote hoeveelheden isolaten te analyseren en data uit te 
wisselen tussen verschillende laboratoria over de hele wereld.  
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vrijgeroosterd werd, bedankt daarvoor. Jitske, als stagiaire heb je veel werk verzet voor dit 
onderzoek, ik ben blij dat je je plek hebt gevonden op het laboratorium 
kindergeneeskunde en neurologie van het UMCN St. Radboud in Nijmegen.  
Aan de overige medewerkers van de afdeling medische microbiologie en 
infectieziekten van het Canisius Wilhelmina Ziekenhuis dank voor jullie belangstelling, 
die jullie getoond hebben tijdens mijn onderzoek. Dit geldt ook voor mijn collega’s van de 
klinische chemie en pathologie. 
Tot slot wil ik mijn familie en vrienden bedanken voor hun interesse en 
vriendschap tijdens mijn onderzoek. Pap, mam, Grad en Riek, wij zijn ontzettend 
dankbaar dat jullie altijd voor ons klaarstaan en voor jullie onvoorwaardelijke steun. 
Gerwin, zonder jou was het nooit gelukt! Inge en Bas, mama heeft de laatste bladzijde van 
het proefschrift echt af! 
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